Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,microtubule motor activity (GO:0003777),0.9080188525848615,2.087451655236588,0.0,0.0,0.0,14/51,1.09%,KIF11;KIF18B;KIF15;KIF20B;KIF4A;CENPE;KIF14;KIF23;KIF2C;KIF24;KIFC1;KIF18A;KIF20A;KIF22
prerank,motor activity (GO:0003774),0.8939046123299836,2.0671214746839692,0.0,0.0,0.0,14/60,1.09%,KIF11;KIF18B;KIF15;KIF20B;KIF4A;CENPE;KIF14;KIF23;KIF2C;KIF24;KIFC1;KIF18A;KIF20A;KIF22
prerank,DNA replication origin binding (GO:0003688),0.8760066919698787,1.8948708529242655,0.0,0.02925328436837388,0.086,16/23,7.65%,MCM5;POLA1;ORC1;DDX11;MCM8;CDC45;MCM10;MCM6;MCM7;MCM2;CDC6;DHX9;MCM3;MCM4;ORC2;ORC3
prerank,microtubule binding (GO:0008017),0.785443711748424,1.8844952388818184,0.0,0.030411830283953042,0.117,48/222,5.68%,PRC1;KIF18B;TPX2;KIF15;KIF20B;CENPE;KIF14;KIF23;KIF2C;NUSAP1;DLGAP5;KIFC1;SKA1;PLK1;BIRC5;FAM83D;SPAG5;RACGAP1;KNSTRN;GTSE1;KIF18A;CEP295;KIF20A;KIF22;CDK5RAP2;CKAP5;GAS2L3;VASH2;SKA2;HAUS8;TERF1;CEP57;MAST2;PSRC1;MAP4K4;CCDC61;HAUS4;HAUS6;MACF1;FAM161A;KIF27;TUBGCP5;SPEF1;CEP57L1;NUMA1;PRNP;MAPT;HAUS7
prerank,single-stranded DNA helicase activity (GO:0017116),0.9059275237746612,1.8699276217741043,0.0,0.03718932389009115,0.173,13/19,6.48%,POLQ;PIF1;RAD51;MCM5;DSCC1;RFC4;MCM6;MCM7;MCM2;DNA2;DHX9;RFC2;RFC3
prerank,single-stranded DNA binding (GO:0003697),0.7781746384823488,1.8688619499643588,0.0,0.03200483091787439,0.178,34/93,7.37%,NEIL3;RAD51AP1;RAD51B;RAD51;MCM5;POLA1;DDX11;RAD51AP2;HMGB2;BRCA2;MCM8;CDC45;DMC1;SMC6;FAM111A;MCM10;MCM6;MCM7;MCM2;RBBP8;RPA1;STN1;MSH3;ERCC4;TDP2;DHX9;HNRNPA1;BLM;MAPT;MCM3;RPA2;MCM4;MLH1;NUCKS1
prerank,DNA secondary structure binding (GO:0000217),0.8225884040412538,1.8053887560127266,0.001201923076923077,0.14895590343160675,0.607,16/31,9.84%,NEIL3;RAD51AP1;CLSPN;RAD51B;GEN1;RAD18;HMGB2;XRCC2;RBBP8;LIN54;BLM;MAPT;RAD51C;HMGB3;HMGB1;KMT2A
prerank,DNA polymerase activity (GO:0034061),0.8412177176348898,1.7984637662856182,0.00646830530401035,0.15140746934225194,0.66,8/22,5.93%,POLQ;POLK;POLE;POLA1;POLH;PRIMPOL;POLD3;POLD1
prerank,"DNA binding, bending (GO:0008301)",0.878114152252046,1.791424114656953,0.007052186177715092,0.15978279085695968,0.727,3/14,1.68%,TOP2A;HMGB2;TERF1
prerank,kinesin binding (GO:0019894),0.8323068553613049,1.7864483462743177,0.0011904761904761906,0.15840219030756114,0.758,3/27,0.71%,PRC1;KIF18B;FAM83D
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.8480074535571007,1.7863595775070458,0.007989347536617843,0.1445549335574911,0.759,8/21,5.93%,POLQ;POLK;POLE;POLA1;POLH;PRIMPOL;POLD3;POLD1
prerank,MHC class II protein complex binding (GO:0023026),-0.6823360717871882,-1.765954738588581,0.005698005698005698,1.0,0.532,5/11,10.73%,HSP90AB1;ATP1B1;ANXA11;PKM;CD81
prerank,tubulin binding (GO:0015631),0.736067699093831,1.7627424893586892,0.0,0.2063659912125385,0.882,39/295,2.52%,PRC1;KIF18B;TPX2;KIF15;KIF20B;CENPE;KIF14;BRCA1;KIF23;KIF2C;NUSAP1;DLGAP5;KIFC1;SKA1;PLK1;BIRC5;FAM83D;SPAG5;RACGAP1;GTSE1;KIF18A;CEP295;KIF20A;KIF22;CDK5RAP2;CKAP5;GAS2L3;VASH2;BRCA2;SKA2;HAUS8;TERF1;CEP57;STMN1;MAST2;PSRC1;MAP4K4;CCDC61;HAUS6
prerank,3'-5' DNA helicase activity (GO:0043138),0.8685488815676057,1.748713250635082,0.011095700416088766,0.24249257202237726,0.925,9/16,6.09%,NAV2;MCM5;MCM6;MCM7;MCM2;DHX9;BLM;RECQL;ERCC3
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.8945077679650585,1.7355701714590395,0.0028089887640449437,0.2769338504632622,0.959,4/13,4.70%,EXO1;ZGRF1;GEN1;DNA2
prerank,ligand-gated anion channel activity (GO:0099095),-0.6114324487300464,-1.7261317783727528,0.0,0.9122828015432709,0.65,11/17,15.05%,GABRB1;GABRB3;GABRA2;GLRB;GLRA1;GABRA3;GLRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.7782190629279845,1.722430592129767,0.007909604519774011,0.3119384877696898,0.985,10/42,6.37%,CCNF;CCNB1;CCNE2;CKS2;CCNB2;CDKN2D;CDKN2C;CCNA2;CCNA1;CCNE1
prerank,GABA-A receptor activity (GO:0004890),-0.5885998700774074,-1.7197990336064752,0.011904761904761904,0.6528861227669981,0.676,8/18,15.05%,GABRB1;GABRB3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,endodeoxyribonuclease activity (GO:0004520),0.8010715383451904,1.7192530037826939,0.01971090670170828,0.3065621106302053,0.987,6/20,5.31%,EXO1;ZRANB3;RBBP8;ERCC4;DNA2;MRE11
prerank,microtubule plus-end binding (GO:0051010),0.8043304059634433,1.7117162465463098,0.01673101673101673,0.321445379253413,0.991,4/20,4.91%,KIF2C;KNSTRN;KIF18A;NUMA1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.5175975060936182,-1.710893191007924,0.0,0.5246944436621701,0.694,15/27,17.84%,PRKN;DCUN1D3;RNF180;RNF144B;ZMYM2;RNF19B;DCUN1D5;SIAH1;DCUN1D4;RNF217;ARIH2;RNF125;DCUN1D2;UBE3D;AUP1
prerank,damaged DNA binding (GO:0003684),0.7539962290081882,1.7079566390961043,0.011273957158962795,0.31922767248854206,0.991,18/44,11.89%,NEIL3;POLQ;RAD18;HMGB2;AUNIP;SMC6;RBBP8;RPA1;ERCC4;RAD1;POLD1;RPA2;ERCC3;CUL4B;HMGB1;XPA;PCNA;FANCG
prerank,ATP hydrolysis activity (GO:0140603),0.7501435769439111,1.6993007576324652,0.00903954802259887,0.33782284256776113,0.997,6/41,4.75%,KIF20B;KIF14;ABCA4;CHD1L;DNA2;DHX9
prerank,glycine binding (GO:0016594),-0.6740292571412904,-1.6957700825631308,0.009230769230769232,0.48243262271536796,0.744,6/11,14.10%,GRIN3A;GLRB;GLRA1;GRIN2B;GLRA3;GRIN1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.8759413183282901,1.6906336685741563,0.019637462235649546,0.35794724244212733,0.997,2/11,3.96%,NEIL3;APEX2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5204386398223751,-1.68408112085413,0.015873015873015872,0.44747810414261174,0.784,10/26,15.78%,SLC6A6;SLC16A12;SLC6A1;MPC1;SLC27A1;ABCG2;SLC5A6;SLC16A1;SLC16A4;SLC6A11
prerank,methylation-dependent protein binding (GO:0140034),0.7214936490166045,1.680165713821469,0.00544069640914037,0.3838097111754401,0.998,14/57,8.80%,UHRF1;PHF19;NCAPG2;ATRX;NCAPD3;CBX5;SGF29;SUZ12;MPHOSPH8;FMR1;PHF1;PHF2;ING4;MSL3
prerank,glutamate receptor binding (GO:0035254),-0.5773534186507886,-1.6685234102723916,0.03007518796992481,0.4429581232926864,0.83,9/17,14.03%,SHANK3;SYNDIG1;IGSF11;HOMER1;SQSTM1;SHISA6;SHANK1;DLG4;HIP1
prerank,acylglycerol lipase activity (GO:0047372),-0.6414514213007738,-1.655753667745084,0.016778523489932886,0.43316483145118145,0.861,4/11,9.48%,ABHD6;ABHD12;ABHD16A;ABHD2
prerank,methylated histone binding (GO:0035064),0.704070236811934,1.652069578899082,0.0053705692803437165,0.5006103231806557,1.0,14/62,8.80%,UHRF1;PHF19;NCAPG2;ATRX;NCAPD3;CBX5;SGF29;SUZ12;MPHOSPH8;FMR1;PHF1;PHF2;ING4;MSL3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.8043567062172521,1.64299880732195,0.03187250996015936,0.5258413238786862,1.0,1/16,0.14%,NEIL3
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.8510614698788319,1.6388065449258338,0.03303303303303303,0.5239161857608149,1.0,3/10,5.93%,EXO1;MGME1;POLD1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5843137146267755,-1.6289815764976208,0.011538461538461539,0.472421702166274,0.913,9/15,15.37%,HS3ST4;HS3ST1;HS6ST3;NDST3;NDST1;HS3ST3B1;HS3ST3A1;NDST2;NDST4
prerank,ligand-gated ion channel activity (GO:0015276),-0.47664994650482384,-1.6268147905020187,0.034482758620689655,0.43316483145118145,0.915,8/30,6.05%,GRIK1;GRIN3A;GABRB1;GRIN2A;GRID2;ANXA6;GRIN2B;GRIK4
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6319108026382656,-1.625159813922106,0.012944983818770227,0.3994019441934056,0.919,8/12,15.05%,GABRB1;GABRB3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,MHC class I protein binding (GO:0042288),-0.5945207745895816,-1.614520677569234,0.031746031746031744,0.3981349798642598,0.935,7/13,29.48%,TAPBP;DERL1;ATP5F1A;ATP5F1B;TAP2;TUBB4B;ABCB9
prerank,amino acid binding (GO:0016597),-0.47130176613363106,-1.6070070545159578,0.006289308176100629,0.3881388683692325,0.948,8/31,7.45%,GRM7;GRIN3A;GLRB;GLRA1;GRIN2B;NOS3;GLRA3;AARS1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.4733345907417267,-1.6065100049352699,0.013513513513513514,0.36170608658569464,0.949,17/33,20.05%,PRKN;DCUN1D3;RNF180;RNF144B;ZMYM2;RNF19B;DCUN1D5;SIAH1;DCUN1D4;RNF217;ARIH2;RNF125;DCUN1D2;UBE3D;AUP1;TCERG1;PARK7
prerank,ligand-gated channel activity (GO:0022834),-0.4784544480550783,-1.6037104879351451,0.028409090909090908,0.3446234288020878,0.95,8/29,6.05%,GRIK1;GRIN3A;GABRB1;GRIN2A;GRID2;ANXA6;GRIN2B;GRIK4
prerank,anion channel activity (GO:0005253),-0.4085009537790033,-1.6002058075972994,0.0,0.33137109606015375,0.952,21/61,15.73%,GABRB1;ANO3;GABRB3;GABRA2;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;CLCN7;GPR89B;GPR89A;GABRA5;GABRB2;ANO4;GABRG2;LRRC8B;LRRC8D;GABRG1;TTYH3
prerank,phospholipase A2 activity (GO:0004623),-0.47610205432490044,-1.5872086252653226,0.02242152466367713,0.34334129044335077,0.968,10/26,30.81%,PLA2G4A;PLAAT3;PNPLA8;PLA2G7;PLA2G12A;PLA2G15;PRDX6;PNPLA3;PLA2G4E;PLA2G4C
prerank,GABA receptor activity (GO:0016917),-0.5221415758342265,-1.5835040459614071,0.01694915254237288,0.3343948795454048,0.972,9/21,15.05%,GABRB1;GABRB3;GABRA2;GABBR1;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,histone acetyltransferase binding (GO:0035035),0.7501447262224401,1.5821845439099231,0.0560625814863103,0.8199724572103089,1.0,2/21,1.27%,KANSL1;GLI3
prerank,four-way junction DNA binding (GO:0000400),0.763835751666385,1.5789188501847138,0.047493403693931395,0.8094559794589304,1.0,10/17,13.93%,RAD51B;GEN1;HMGB2;XRCC2;BLM;RAD51C;HMGB3;HMGB1;MSH6;YY1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.4692666826550972,-1.574048737266892,0.015228426395939087,0.34066381984700694,0.977,11/27,17.79%,APOE;HSP90B1;SYT1;LRP1;DNAJA1;RELN;AP2M1;ANKRA2;LDLRAP1;AP2A1;APBB1
prerank,protein kinase C binding (GO:0005080),0.7039376128386857,1.568782234713057,0.026018099547511313,0.8394308794990807,1.0,1/43,0.01%,TOP2A
prerank,glutamate receptor activity (GO:0008066),-0.5207789946079138,-1.566705431322688,0.030042918454935622,0.3408818890985384,0.98,11/19,21.40%,GRM7;GRIK1;GRM3;GRID2;GRIK4;GRIA1;GRM5;GRM1;GRIA2;GRIK2;GRID1
prerank,RNA polymerase binding (GO:0070063),0.7458174954919887,1.565111488165895,0.07307171853856563,0.830553291550734,1.0,4/18,4.75%,BRCA1;ANP32B;NEDD4;DHX9
prerank,poly(U) RNA binding (GO:0008266),0.7360877604806939,1.5463343262827536,0.06550802139037433,0.9204147926036982,1.0,12/20,16.11%,PABPC4;PATL1;KHDRBS1;FMR1;HNRNPH1;RBMS2;ATXN1;RBMS3;DAZAP1;RBMS1;PABPC1;PNPT1
prerank,5'-3' exonuclease activity (GO:0008409),0.7589177514078485,1.5412968310232256,0.07658959537572255,0.9209860755896562,1.0,2/14,5.31%,EXO1;MRE11
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.622280932331106,-1.5383941771887546,0.026865671641791045,0.3969691117878902,0.99,6/11,24.04%,PRMT3;PRMT2;PRMT8;PRMT1;PRMT9;FBXO11
prerank,nuclear export signal receptor activity (GO:0005049),0.7752699298747,1.5359249748019483,0.08558558558558559,0.9236787605321556,1.0,5/11,6.04%,RANBP17;XPO1;XPO4;EIF4ENIF1;CSE1L
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.6969303605035911,1.52796315101018,0.059453032104637336,0.9427938922224408,1.0,7/34,8.14%,CCNB1;INCENP;CKS2;DBF4;STK3;ETAA1;CAB39L
prerank,DNA polymerase binding (GO:0070182),0.7240351216076857,1.5276918605963536,0.08991825613079019,0.9155672403754246,1.0,9/18,13.90%,FANCD2;RAD51;FANCI;RTEL1;SMARCA4;LONP1;HMGB1;PCNA;SMG6
prerank,gamma-tubulin binding (GO:0043015),0.6921071885415642,1.5273813178748104,0.08735332464146023,0.8904021671623599,1.0,4/21,4.54%,RACGAP1;CDK5RAP2;BRCA2;TUBGCP5
prerank,ubiquitin binding (GO:0043130),0.6613969085144137,1.5266254236359516,0.012618296529968454,0.8690832185717094,1.0,14/73,11.69%,TOP2A;CKS2;RNF168;NEDD4;FAF1;CXCR4;BUB3;FBXW7;UBE2N;RNF31;USP16;IKBKG;ADRM1;ILRUN
prerank,WW domain binding (GO:0050699),0.7025905391037877,1.5260104027539236,0.07125307125307126,0.8478866555912592,1.0,4/26,9.23%,KIF20B;NFE2;PMEPA1;CDC25C
prerank,deoxyribonuclease activity (GO:0004536),0.7455474766308503,1.5205271543494676,0.09256661991584852,0.8542084283772262,1.0,4/14,10.28%,ZRANB3;ERCC4;MRE11;MBD4
prerank,protein kinase regulator activity (GO:0019887),0.6466222236848582,1.5167307812370685,0.021649484536082474,0.8509595970054983,1.0,13/95,6.76%,TPX2;CCNF;CCNB1;CCNE2;CCNB2;SPDYA;PARVA;GPRC5A;CCNA2;FAF1;CCNA1;CCNE1;WNK1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6228214014985409,-1.5100970638899969,0.047337278106508875,0.4568604886341235,0.995,6/10,13.64%,SHANK3;IGSF11;SQSTM1;SHISA6;SHANK1;DLG4
prerank,magnesium ion binding (GO:0000287),0.6391495468013062,1.5042669556999237,0.003045685279187817,0.892904704974349,1.0,27/135,10.25%,TOP2A;PIF1;PLK1;FIGNL1;GEN1;MAST2;NLK;IDH3A;TDP2;DYRK3;GSS;HPRT1;NUDT5;STK3;PDXK;RAP2A;MAP3K20;HPGDS;CDC42BPA;LRRK2;PGM1;TPPP;PPA1;MARK2;TKT;EYA2;CDC42BPG
prerank,voltage-gated cation channel activity (GO:0022843),-0.33309858680485627,-1.5037005828854433,0.0,0.455928503122907,0.997,30/97,20.42%,CACNA2D1;GRIN3A;GRIN2A;KCNC2;HCN1;KCNB1;GRIN2B;KCNQ3;KCNH1;CACNG7;CACNA1B;CACNG4;KCNS3;KCNH7;OPRM1;NCS1;KCNA6;KCNA2;CACNG2;CACNB2;GRIN1;KCNC1;CACNG3;CACNG8;CACNB1;CACHD1;KCNQ1;CACNA2D2;KCNK1;LRRC38
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.5549398605358307,-1.5017624914059715,0.05387205387205387,0.4411375754503553,0.997,9/13,33.01%,TRMT11;THUMPD3;TRMT10B;TRMT1;METTL1;TRMT10A;WDR4;TRMT1L;TRMT10C
prerank,poly-pyrimidine tract binding (GO:0008187),0.7058973227952189,1.4989514945183422,0.09102730819245773,0.8977572299822939,1.0,13/23,16.11%,PABPC4;PATL1;KHDRBS1;FMR1;HNRNPH1;RBMS2;HNRNPU;ATXN1;RBMS3;DAZAP1;RBMS1;PABPC1;PNPT1
prerank,water transmembrane transporter activity (GO:0005372),0.7526283561424512,1.4917700616994503,0.10425844346549193,0.9133933612599946,1.0,2/11,5.71%,AQP1;PDPN
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.5348224304900903,-1.4882557398435978,0.06293706293706294,0.4428422263478165,0.999,6/16,15.04%,ATP6V0A1;ATP6V0D1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP5F1B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.5348224304900903,-1.4882557398435978,0.06293706293706294,0.4428422263478165,0.999,6/16,15.04%,ATP6V0A1;ATP6V0D1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP5F1B
prerank,nuclear localization sequence binding (GO:0008139),0.7106156478714153,1.4878639760127663,0.10052910052910052,0.9116928822811176,1.0,7/18,15.76%,KPNA2;KPNA3;BRAP;TNPO1;NUP214;KPNA4;IPO5
prerank,nuclease activity (GO:0004518),0.6469212946620374,1.4864392214777136,0.05914567360350493,0.8975026193101492,1.0,7/52,7.56%,EXO1;ANKLE1;REXO5;RNASE6;DNA2;MRE11;RNASEH2A
prerank,ATPase binding (GO:0051117),-0.34629430670804234,-1.4825030846045186,0.0,0.4398890004933544,0.999,31/71,24.18%,ATP6V0A1;PSEN1;ATP1B1;ATXN3;CAV1;ATP6V1E1;AR;RALB;ATP6V0A4;NCSTN;ESR1;TMEM106B;DERL1;ATP1B3;SELENOS;TRPC1;NUFIP1;NKD2;METTL21A;UBXN1;SNU13;NR1H2;SYVN1;PDE4D;SVIP;GABARAPL2;PEX26;S100A1;PIH1D1;SNX10;WFS1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.7731304362438801,1.4811778349635052,0.09365558912386707,0.902382197938464,1.0,9/11,18.76%,TERF1;RPA1;STN1;HNRNPA1;RPA2;TERF2;HNRNPA2B1;TERF2IP;RAD50
prerank,transcription corepressor binding (GO:0001222),0.6867125673685153,1.4743188828783345,0.10960591133004927,0.9163712010259324,1.0,8/27,7.90%,EZH2;SUZ12;HDGF;EED;WIZ;CTBP1;LCOR;PHF1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.4107636611316774,-1.466902735500261,0.047244094488188976,0.4489847644259202,1.0,18/34,25.20%,NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;NDUFB6;NDUFB10;NDUFA10;NDUFS6;NDUFA1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.4107636611316774,-1.466902735500261,0.047244094488188976,0.4489847644259202,1.0,18/34,25.20%,NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;NDUFB6;NDUFB10;NDUFA10;NDUFS6;NDUFA1
prerank,chloride channel activity (GO:0005254),-0.3788620493149146,-1.4658464614793318,0.03225806451612903,0.4365297060839037,1.0,18/59,15.73%,GABRB1;ANO3;GABRB3;GABRA2;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;CLCN7;GABRA5;GABRB2;ANO4;GABRG2;TTYH2;GABRG1;TTYH3
prerank,DNA binding (GO:0003677),0.6122451736303854,1.4657970612231195,0.0,0.9362310286918316,1.0,157/694,12.81%,TOP2A;NEIL3;BRCA1;EXO1;RAD51AP1;POLQ;NR2E3;PHF19;BRIP1;POLE;CLSPN;RAD51B;E2F2;ATAD5;RAD51;PBX4;MCM5;POLA1;GLI2;ORC1;RAD18;TCFL5;WDR76;DDX11;RAD51AP2;HMGB2;E2F1;BRCA2;TIPIN;FOXE1;MCM8;TERF1;CDC45;ILF3;DMC1;MND1;AUNIP;CCDC25;SMC1A;TIMELESS;SMC6;FAM111A;MCM10;CBFB;MCM6;SETX;MCM7;MCM2;PDS5B;TEAD1;RBBP8;HDGF;CTCF;E2F3;RPA1;NFE2;STN1;MSH3;SMARCAD1;MBD1;ERCC4;RAD1;KHDRBS1;CUX1;DNA2;TDP2;DHX9;AIFM2;PRKDC;HNRNPA1;TCF7L1;BLM;MRE11;TSHZ1;NFIB;THRAP3;MAPT;MAEL;MCM3;IKZF1;POLD1;RPA2;MCM4;GZF1;ERCC3;RFC1;YAF2;TCF7L2;PSIP1;SOX6;HP1BP3;RFC3;HOXA7;GRHL2;TCF4;DNASE2;ARID1A;RFX2;MLH1;TAF12;NUCKS1;POLR2A;POU2F1;POU3F2;SIM1;RC3H2;PHF1;LIN9;FOXO3;TRIM28;KDM2B;PLAGL2;IRF1;RAD51C;HMGB3;BCLAF1;GTF3C4;SMARCA4;MSL3;TIGD2;NFYA;CUL4B;ARID4A;PLAGL1;LONP1;HMGB1;MEOX2;NR4A2;CARF;MBD4;CXXC5;SFPQ;HNRNPU;CRLF3;XPA;GTF2A1;PCNA;CHD2;QRICH1;AHR;NKX2-1;TAF4;FANCG;APLP2;SPTY2D1;FUBP1;RBPJ;NR4A1;MSH6;ZIC4;KMT2D;SOX9;SMAD4;HDAC2;ATF5;ZNF496;ILF2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.49847359438951544,-1.4634145042668445,0.07755102040816327,0.428814957407436,1.0,13/18,36.43%,PIK3R3;SOCS2;PIK3R1;SOCS5;PIK3R6;PIK3R2;WDR81;PIK3R5;SOCS6;CISH;SOCS3;CCKBR;AGAP2
prerank,telomeric DNA binding (GO:0042162),0.6676585854761342,1.4613409114524858,0.08079625292740047,0.9379600057485458,1.0,16/32,19.61%,PIF1;TERF1;RPA1;HNRNPD;STN1;BLM;TERF2;SMG6;HNRNPA2B1;PURA;UPF2;TINF2;ACD;TERF2IP;RAD50;TERT
prerank,transmitter-gated ion channel activity (GO:0022824),-0.43472866008244615,-1.4556735542794743,0.04790419161676647,0.4352364893407305,1.0,11/29,11.29%,GRIK1;GABRB1;GABRB3;GABRA2;GRID2;GRIK4;GABRA3;GLRA3;GABRA5;GABRB2;GABRG2
prerank,acetyltransferase activity (GO:0016407),0.6535665959942448,1.4555322116581062,0.10589651022864019,0.9467492403873478,1.0,2/31,1.96%,ESCO2;NAT14
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.550458326274943,-1.4535432298653421,0.07419354838709677,0.42775455134293744,1.0,8/13,15.05%,GABRA2;GLRB;GLRA1;GABRA3;GLRA3;GABRA5;GABRG2;GABRG1
prerank,protein kinase activator activity (GO:0030295),0.6307191119197986,1.4520231971742403,0.07127429805615551,0.9438484423869883,1.0,17/60,15.22%,TPX2;INCENP;DBF4;SPDYA;GPRC5A;STK3;WNK1;ETAA1;CAB39L;ABI1;MARK2;CALM2;STRADA;CAB39;STK11;RPTOR;TAOK1
prerank,kinase activator activity (GO:0019209),0.6629619632201401,1.4511644766444334,0.09112709832134293,0.9289684569479967,1.0,9/30,14.77%,TPX2;SPDYA;GPRC5A;WNK1;MARK2;STRADA;CAB39;STK11;RPTOR
prerank,histone deacetylase binding (GO:0042826),0.6123635107706725,1.450710941699071,0.05687693898655636,0.9131897430754057,1.0,15/88,11.37%,TOP2A;KPNA2;GLI3;MIER1;SP2;BCOR;BHLHE41;LCOR;RBBP4;NIPBL;MIER3;MTA3;SFPQ;TAL1;HDAC1
prerank,microtubule minus-end binding (GO:0051011),0.7033879755282992,1.4455386845192737,0.12735166425470332,0.9185375333565379,1.0,5/13,5.68%,HAUS4;MACF1;TUBGCP5;NUMA1;HAUS7
prerank,exonuclease activity (GO:0004527),0.6288691638818958,1.4423867473852523,0.09684684684684684,0.9153223162174569,1.0,19/46,19.05%,EXO1;REXO5;APEX2;RAD1;MRE11;EXD1;ERI1;ENPP2;ENPP3;CNOT6;ENPP1;EXOSC7;DXO;CNOT7;EXOSC10;DCLRE1C;RAD50;XRN2;ISG20L2
prerank,nuclear import signal receptor activity (GO:0061608),0.6923750996182498,1.4309904630561954,0.14208389715832206,0.9494927414791011,1.0,3/15,5.14%,KPNA2;KPNA3;TNPO1
prerank,amyloid-beta binding (GO:0001540),-0.34153795871983705,-1.4213440774561243,0.017857142857142856,0.501939442030438,1.0,29/79,18.54%,ITM2B;CST3;GRIN2A;APOE;APBA1;ITM2A;INSR;GRIN2B;TGFB2;TLR4;LRP1;EPHB2;CACNA1B;TM2D1;FZD4;CHRNA7;GRIA1;ATP1A3;CRYAB;GSAP;APBB2;PFDN5;LDLRAP1;GRIN1;GRIA2;APBB1;SORL1;NLGN1;APBA2
prerank,BMP binding (GO:0036122),-0.5687063133004355,-1.4198888253898998,0.1,0.49074077799189747,1.0,3/11,14.92%,NBL1;BMPR2;ENG
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5521591613859222,-1.4171301330262425,0.10344827586206896,0.48359609926747843,1.0,7/12,14.54%,INSR;IGF1;SOCS2;PIK3R1;IGF2;IRS1;SHC1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5250403300130649,-1.407219339931622,0.10094637223974763,0.4973607756845809,1.0,7/12,20.57%,VEGFC;CDH5;CADM4;VEGFA;VEGFB;VEGFD;ITGB3
prerank,phospholipase inhibitor activity (GO:0004859),0.7435707455319167,1.4067202877571459,0.14088820826952528,1.0,1.0,4/10,11.47%,ANXA9;ANXA2;ANXA5;ANXA1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.6510547478406723,1.406217899283806,0.11976047904191617,1.0,1.0,7/34,7.49%,EZH2;KMT5A;SETD6;ATPSCKMT;SETD3;EEF1AKMT2;SETD2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.6455297293628681,1.4056702937957777,0.14320388349514562,1.0,1.0,6/28,11.49%,EXO1;AGO2;RNASEH2A;RPP40;RPP30;POP1
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.3955127204834508,-1.4027354921334239,0.05223880597014925,0.4961273717115453,1.0,9/32,19.40%,KCNC2;KCNB1;KCNQ3;KCNH1;KCNS3;KCNA6;KCNA2;KCNC1;KCNQ1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.6536188291020142,1.3978207948795398,0.14885496183206107,1.0,1.0,3/22,9.30%,CDKN3;DUSP12;MTMR2
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.545116479636405,-1.395254942110553,0.09907120743034056,0.5034563285147644,1.0,6/11,25.07%,LEF1;ZXDC;SRRM2;GATA2;HMGA2;THAP7
prerank,carboxylic acid binding (GO:0031406),-0.38863068262164946,-1.3934909837848768,0.07534246575342465,0.4951639021093244,1.0,9/38,7.38%,GRM7;GRIN3A;GLRB;GLRA1;GRIN2B;NOS3;SESN3;PSAP;GLRA3
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.705732475084934,1.3933455362210239,0.14243759177679882,1.0,1.0,1/12,0.46%,CDK1
prerank,lysine N-methyltransferase activity (GO:0016278),0.6743568806339739,1.3922881969678176,0.17209908735332463,1.0,1.0,6/20,7.49%,KMT5A;SETD6;ATPSCKMT;SETD3;EEF1AKMT2;SETD2
prerank,lipase activity (GO:0016298),-0.37262388736352897,-1.3903726337899336,0.045871559633027525,0.4908405220524649,1.0,9/43,9.48%,LIPA;ABHD6;ABHD12;ABHD5;ABHD16A;PLA1A;LYPLA1;PNPLA8;ABHD2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.6966340601346894,1.3894424559756737,0.15664335664335666,1.0,1.0,6/12,15.29%,PNLDC1;CNOT1;CNOT6L;CNOT6;PAN3;CNOT7
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6365790427981206,1.3887344084572306,0.15105386416861827,1.0,1.0,4/35,2.43%,MELK;MATK;DYRK1A;STYK1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.7085045094422774,1.383503221684266,0.14537444933920704,1.0,1.0,4/11,6.99%,ALDH3A1;RDH11;RDH12;RDH14
prerank,chemorepellent activity (GO:0045499),-0.4222250217772973,-1.3826147965101954,0.0594059405940594,0.49813058795288656,1.0,9/25,19.19%,NRG3;SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;SEMA5B
prerank,retinoic acid binding (GO:0001972),0.6998977564577631,1.37984017517668,0.15664335664335666,1.0,1.0,1/12,3.24%,CYP26B1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.7024030447379878,1.376805430382987,0.16228070175438597,1.0,1.0,3/10,7.49%,NSD2;SETD3;SETD2
prerank,retinoid binding (GO:0005501),0.6437173643363976,1.3748342988648465,0.1702127659574468,0.9991273645365717,1.0,3/22,4.11%,CYP26B1;ABCA4;ALDH1A2
prerank,phospholipid transfer activity (GO:0120014),-0.4318155468759768,-1.3733738347472773,0.10176991150442478,0.509181098535779,1.0,12/21,25.83%,CERT1;PLTP;MTTP;GLTP;TNFAIP8L3;PRELID3B;OSBPL2;PLEKHA8;PITPNC1;PRELID3A;PRELID1;ABCA3
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.4987327152570112,-1.3702047076632753,0.1037037037037037,0.5066145202624687,1.0,11/15,35.27%,PIK3R3;SOCS2;PIK3R1;SOCS5;PIK3R6;PIK3R2;PIK3R5;SOCS6;CISH;SOCS3;CCKBR
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.48120469015407985,-1.363425171888322,0.09848484848484848,0.5134698245515221,1.0,10/17,23.70%,GRIK1;GRIN3A;GRIN2A;GRIN2B;GRIK4;GRIA1;GRIN1;GRIA2;GRIK2;PTK2B
prerank,MAP-kinase scaffold activity (GO:0005078),0.6962091035357167,1.358516696011778,0.18222222222222223,1.0,1.0,4/11,11.80%,KSR1;SPAG9;SH3RF1;MAPK8IP3
prerank,nucleotidyltransferase activity (GO:0016779),0.6523107677810212,1.3548649749441226,0.18050065876152832,1.0,1.0,9/19,16.11%,TENT2;CRPPA;NUDT5;TENT4A;PAPSS2;TUT1;TUT7;TUT4;PNPT1
prerank,kinase binding (GO:0019900),0.5709555192989167,1.3535249978678756,0.004,1.0,1.0,48/434,6.98%,KIF11;PRC1;TPX2;KIF14;CCNB1;SGO1;PLK1;FAM83D;BARD1;RACGAP1;CKS2;BORA;KIF20A;AURKB;CEP192;CEP152;POLA1;CDK5RAP2;CIT;SPDYA;CNTLN;CDKN2D;FBXO5;CDKN2C;TRIML2;RB1;AURKA;TICAM1;TRIP6;TTC28;RHOA;CEP43;CDC6;GSK3B;MAPK4;CHEK2;CCNA2;ADD2;MAPT;VRK2;FAF1;EIF4ENIF1;PTPN2;MAP3K1;TCF7L2;USP37;WNK1;CDC25B
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.6422979140906196,1.3523900711204044,0.16601815823605706,1.0,1.0,2/21,2.68%,CDK1;CDK14
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.6422979140906196,1.3523900711204044,0.16601815823605706,1.0,1.0,2/21,2.68%,CDK1;CDK14
prerank,histone methyltransferase binding (GO:1990226),0.678905404498046,1.345287178320288,0.1678832116788321,1.0,1.0,5/11,10.12%,LCORL;WIZ;LCOR;PHF1;CBX1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.480838389656543,-1.3360728729408908,0.13620071684587814,0.5738410470340036,1.0,8/14,28.38%,SPOCK1;TIMP3;SPOCK2;SPOCK3;BST2;TIMP2;LXN;TIMP4
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.4281132190834937,-1.3327908074812262,0.13004484304932734,0.5699984361171846,1.0,9/22,17.79%,APOE;HSP90B1;SYT1;DNAJA1;AP2M1;ANKRA2;LDLRAP1;AP2A1;APBB1
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.3337815489373792,-1.332321559064403,0.05194805194805195,0.5592534639105579,1.0,14/60,6.42%,EPHA5;ACVR1;FLT1;TEK;NTRK2;MERTK;ACVR2A;TGFBR2;INSR;ACVRL1;PDGFRB;EPHB2;NTRK3;TIE1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.3925030005169924,-1.3308267698071434,0.1043956043956044,0.552175619748026,1.0,9/28,15.05%,GRIK1;GABRA2;GRID2;GRIK4;GABRA3;GABRA5;CHRNA7;GABRG2;GABRG1
prerank,protein kinase binding (GO:0019901),0.5618061252651841,1.3292280695119187,0.003,1.0,1.0,48/479,6.98%,TOP2A;KIF11;PRC1;TPX2;KIF14;CCNB1;PLK1;FAM83D;RACGAP1;CKS2;BORA;KIF20A;CEP192;CEP152;POLA1;CDK5RAP2;CIT;SPDYA;CNTLN;CDKN2D;FBXO5;PPM1D;CDKN2C;TRIML2;AURKA;TICAM1;RHOA;CEP43;MAP4K2;GSK3B;MAPK4;CHEK2;KHDRBS1;CCNA2;SPAG9;PDE3B;ADD2;MAPT;VRK2;FAF1;PTPN2;MAP3K1;TCF7L2;CAVIN3;USP37;TPR;WNK1;CDC25B
prerank,chloride transmembrane transporter activity (GO:0015108),-0.45820252506372694,-1.326692648470532,0.16205533596837945,0.5515883297192261,1.0,9/16,37.47%,CLCN7;SLC4A8;SLC1A1;SLC26A2;SLC26A6;CFTR;CLCN6;SLC26A8;SLC12A5
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.43184800520478117,-1.3265736735129459,0.1050228310502283,0.5409796687832249,1.0,7/22,15.04%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP5F1B
prerank,miRNA binding (GO:0035198),0.6011913492418784,1.3231339956986359,0.18912237330037082,1.0,1.0,17/30,18.92%,ZC3H7A;AGO2;HNRNPA1;FMR1;MATR3;TUT7;PUM2;TUT4;RBM4;DDX21;RC3H1;HNRNPA2B1;ZC3H7B;PNPT1;RBM10;ZNF346;SPOUT1
prerank,histone methyltransferase activity (GO:0042054),0.5965676259951157,1.3142026088116274,0.20046620046620048,1.0,1.0,5/32,7.49%,EZH2;KMT5A;SUZ12;EED;SETD2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.45216754040919915,-1.3113256638095983,0.1417910447761194,0.5589141100024071,1.0,7/16,15.73%,ANO3;ANO6;ANO1;ANO10;ANO4;TTYH2;TTYH3
prerank,intracellular chloride channel activity (GO:0061778),-0.45216754040919915,-1.3113256638095983,0.1417910447761194,0.5589141100024071,1.0,7/16,15.73%,ANO3;ANO6;ANO1;ANO10;ANO4;TTYH2;TTYH3
prerank,transcription coregulator binding (GO:0001221),0.5760314125775993,1.3110510732346807,0.19444444444444445,1.0,1.0,15/50,14.80%,EZH2;CIT;SUZ12;HDGF;CTCF;EED;WIZ;CTBP1;LCOR;PHF1;AHR;SMAD4;RORA;SMAD3;PER1
prerank,ion channel activity (GO:0005216),-0.30281896651153084,-1.310185847612476,0.04,0.5515771692726832,1.0,15/80,10.86%,GRIK1;GRIN3A;GABRB1;TRPM7;UNC80;GRIN2A;GRID2;ANXA6;GRIN2B;GRIK4;TMEM63B;TRPC1;CHRNA7;GRIA1;TRPM3
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4603141070469428,-1.3088176422666238,0.15708812260536398,0.5355101121244916,1.0,5/16,8.99%,PTPRG;PTPRB;PTPRD;PTPRZ1;PTPRO
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4603141070469428,-1.3088176422666238,0.15708812260536398,0.5355101121244916,1.0,5/16,8.99%,PTPRG;PTPRB;PTPRD;PTPRZ1;PTPRO
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.564258633603134,1.3077941527352352,0.17109458023379384,1.0,1.0,17/60,17.66%,CDKN3;PPM1G;PPM1D;LRRC40;PHLPP2;TAB1;CTDSPL2;PPP3CA;LRRK2;LRRK1;PPP1CC;MTMR3;PTEN;CTDSPL;UBLCP1;PPP3R1;CDC14A
prerank,double-stranded DNA binding (GO:0003690),0.5499599290105127,1.306875618760288,0.003,1.0,1.0,77/531,10.50%,NEIL3;RAD51AP1;E2F7;E2F8;UHRF1;EN1;RAD51B;E2F2;RAD51;GLI2;TCFL5;GLI3;DDX11;RAD51AP2;HMGB2;E2F1;FOXE1;TERF1;DMC1;MND1;ZNF32;SP3;ZFP41;ELF2;TEAD1;SP2;ZSCAN29;RBBP8;HDGF;E2F3;NFE2;TFCP2L1;MSH3;MBD1;HIVEP1;CUX1;DHX9;PRKDC;BHLHE41;KLF5;SRF;TCF7L1;MRE11;ELF4;NFIB;KLF13;MAPT;SP8;HOXC4;PSIP1;ELF1;HOXA7;GMEB1;TCF4;MYBL2;RFX2;ELK1;NUCKS1;ZBTB2;POU3F2;ZBTB7B;PRRX2;OLIG2;FOXO3;LMX1B;ZNF23;HMGB3;CREB5;KLF11;ZIC5;ZBTB20;HMGB1;HOXB6;MEOX2;NR4A2;NR3C1;HNRNPU
prerank,chloride channel regulator activity (GO:0017081),-0.48155364980409776,-1.303225997215838,0.14527027027027026,0.539913034155413,1.0,6/14,16.13%,STX8;STX7;SGK1;WNK2;CHRNA7;VAMP8
prerank,ankyrin binding (GO:0030506),0.6204596882911403,1.301348768710358,0.22580645161290322,1.0,1.0,3/19,9.40%,RHAG;SPTB;SLC8A1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3574147003709623,-1.3011767421012344,0.11564625850340136,0.5356696845190293,1.0,8/38,6.00%,PLA2G4A;KIF16B;PLEKHA5;SNX13;WDR45B;TECPR1;SNX3;SNX21
prerank,metalloendopeptidase activity (GO:0004222),0.5516194751677866,1.297793450228043,0.15287958115183245,1.0,1.0,19/76,14.20%,KEL;MMP28;MMP24;MMP25;TRABD2B;MMP14;NLN;ADAMTS10;ADAMTS5;ADAMTS14;ADAMTS9;ADAMTSL2;ADAMTS2;ADAMTS16;ADAM17;ADAMTSL3;ADAM9;ADAM19;ADAMTS1
prerank,sequence-specific mRNA binding (GO:1990825),0.684785906118395,1.2886316252705774,0.22054380664652568,1.0,1.0,4/10,13.54%,TYMS;DHX9;FMR1;DHFR
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.5248451498886333,-1.2874909152386116,0.18786127167630057,0.5619842856740546,1.0,3/10,13.17%,ATXN3;CYLD;YOD1
prerank,methyl-CpG binding (GO:0008327),0.6222684692202104,1.286118359090811,0.2193877551020408,1.0,1.0,4/22,11.68%,UHRF1;MBD1;CXXC5;ERH
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5674221536487389,1.2836897668948688,0.2164009111617312,1.0,1.0,5/38,9.77%,SERPINB8;SERPINA9;ANXA2;SERPINE1;AGT
prerank,nucleoside-triphosphatase activity (GO:0017111),0.5342363734878535,1.2743823756950525,0.043,1.0,1.0,36/248,12.20%,KIF18B;KIF15;KIF20B;KIF14;RAB33B;RHOA;GNG8;ABCA4;CHD1L;DNA2;DHX9;RHOT1;RAP2A;ATL2;EFL1;ATL3;GNA13;RAB22A;RAB29;AGAP3;LRRK2;MFN2;SMCHD1;GNAQ;RHOQ;DNM2;TPPP;SRPRA;ABCB10;RAB1A;ATP2B1;DRG1;RND2;RAC1;RRAS;TSR1
prerank,syntaxin binding (GO:0019905),-0.3076863141055277,-1.2692299916931051,0.12121212121212122,0.5981943544829011,1.0,25/61,20.69%,UNC13B;STX8;STXBP5L;SNAP47;NAPG;SYT1;STX7;STX6;SYNPR;VPS11;SNPH;ABL1;SNAP29;SYT12;CPLX1;VAMP8;VAMP3;SNAP25;SYT10;SYPL1;RAB11A;SYT6;VPS52;SYT2;VAMP1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.6212508064383915,1.2689737989038004,0.22983870967741934,1.0,1.0,9/17,18.81%,LBR;PTGR1;DPYD;PTGR2;SRD5A3;TM7SF2;DHCR7;BLVRB;BDH2
prerank,mRNA methyltransferase activity (GO:0008174),-0.4869844615894766,-1.2678173673276363,0.17857142857142858,0.5918704978511568,1.0,6/12,16.24%,METTL16;NSUN2;TRMT61B;METTL14;PCIF1;CMTR1
prerank,SH3 domain binding (GO:0017124),-0.32929101141910133,-1.2670672986662392,0.08974358974358974,0.5844626850621243,1.0,24/62,18.94%,SGIP1;ENAH;PRKN;SHANK3;RUFY2;ELMO1;WIPF1;AFAP1L1;ADAM15;PTPN22;RUFY1;ABL1;GRB2;ARHGAP27;SHANK1;SYNJ2;CASP9;CBLB;SYNJ1;CBL;GPX1;AFAP1L2;MICAL1;PTPN12
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5471995103893605,1.2666464991698025,0.21129943502824858,1.0,1.0,7/48,12.52%,RHD;RHAG;AQP1;CALHM2;TRPM2;PIEZO1;TRPM4
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.5569723742149432,1.2652205873520461,0.23059617547806524,1.0,1.0,13/44,16.42%,EZH2;NSD2;KMT5A;EED;SETDB2;SETD3;SETD2;KMT2A;KMT2D;KMT5C;ASH1L;SETD4;SUV39H2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.5304382848444074,1.2651379492741373,0.006,1.0,1.0,105/597,12.74%,BRCA1;KIF2C;E2F7;E2F8;EN1;E2F2;MCM5;POLA1;GLI2;CDK5RAP2;ORC1;TCFL5;GLI3;DDX11;HMGB2;E2F1;FOXE1;MCM8;CDC45;MCM10;ZNF32;MCM6;SP3;MCM7;MCM2;ZFP41;ELF2;TEAD1;SP2;ZSCAN29;CDC6;CTCF;E2F3;NFE2;TFCP2L1;BCOR;HIVEP1;CUX1;DHX9;BHLHE41;KLF5;SRF;TCF7L1;ELF4;NFIB;ZW10;KLF13;ZNF568;TBL1XR1;MCM3;SP8;MCM4;HOXC4;TCF7L2;SOX6;ELF1;ORC2;HOXA7;GMEB1;TCF4;PSPC1;MYBL2;RFX2;ELK1;ZBTB2;ORC3;POU3F2;ZBTB7B;PRRX2;OLIG2;FOXO3;LMX1B;SMAD6;ZNF23;BNC2;IRF1;CREB5;KLF11;YAP1;NONO;NFYA;ARID4A;ZIC5;ZBTB20;HMGB1;HOXB6;MEOX2;NR4A2;MBD4;NR3C1;SFPQ;HNRNPU;TAL1;HNRNPL;XPA;CPSF4;AHR;NKX2-1;TBX18;NR4A1;ZIC4;KMT2D;SOX9;SMAD4;ATF5
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.5654643002986752,1.264447734287913,0.21328671328671328,1.0,1.0,16/34,21.11%,PNLDC1;ERI2;CNOT1;CNOT6L;ERI1;CNOT6;PAN3;EXOSC7;ERI3;CNOT7;PNPT1;ANGEL2;EXOSC10;XRN2;PAN2;DIS3
prerank,regulatory RNA binding (GO:0061980),0.5694867420945361,1.2640650778549676,0.2134433962264151,1.0,1.0,18/38,18.92%,ZC3H7A;AGO2;DHX9;HNRNPA1;FMR1;MATR3;TUT7;PUM2;TUT4;RBM4;DDX21;RC3H1;HNRNPA2B1;ZC3H7B;PNPT1;RBM10;ZNF346;SPOUT1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5899946744785455,1.261670211177053,0.2170439414114514,1.0,1.0,1/18,0.69%,BIRC5
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6082665827675424,1.2557216477274789,0.236,1.0,1.0,4/18,8.47%,ALDH3A1;ALDH8A1;ALDH1A2;ALDH1A1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.4509731865146799,-1.2549479083585233,0.17405063291139242,0.605581772919631,1.0,1/15,0.17%,PLA2G4A
prerank,leak channel activity (GO:0022840),0.5943342315754996,1.2520365170064225,0.2543507362784471,1.0,1.0,4/18,12.53%,RHAG;KCNK2;KCNK12;KCNK6
prerank,amino acid:sodium symporter activity (GO:0005283),-0.4918083694530395,-1.2502247002393532,0.19461077844311378,0.608361172519643,1.0,5/11,19.59%,SLC1A2;SLC6A1;SLC6A11;SLC1A1;SLC6A15
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.40639882837823643,-1.2478437623102951,0.1826086956521739,0.5871477611519972,1.0,5/22,16.39%,CHRM2;HTR2C;HTR4;CHRM3;HTR2A
prerank,serotonin receptor activity (GO:0099589),-0.40639882837823643,-1.2478437623102951,0.1826086956521739,0.5871477611519972,1.0,5/22,16.39%,CHRM2;HTR2C;HTR4;CHRM3;HTR2A
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.40639882837823643,-1.2478437623102951,0.1826086956521739,0.5871477611519972,1.0,5/22,16.39%,CHRM2;HTR2C;HTR4;CHRM3;HTR2A
prerank,protein serine/threonine kinase activity (GO:0004674),0.5205893469558573,1.2474443487071474,0.047,1.0,1.0,100/335,18.83%,PBK;NEK2;MELK;CDK1;TTK;PLK1;MASTL;AURKB;NEK3;CIT;PLK4;HUNK;MAST2;MAP4K4;DYRK1A;STK17B;BMPR1A;CDK14;AURKA;MAP3K14;ROCK2;MAP4K2;GSK3B;STK10;NLK;MAPK4;CHEK2;MYLK3;CASK;PRKDC;DYRK3;VRK2;STK24;STK3;NRK;MAP3K1;WNK1;MAP3K20;CHEK1;CDC42BPA;CDK2;LRRK2;GRK5;RIOK3;MAP3K4;ROCK1;PIM1;MARK2;CSNK2A2;CDC42BPG;CAMK1D;TGFBR1;RPS6KC1;SRPK1;EIF2AK3;PRKCB;GAK;PRKCA;ULK2;PDPK1;GRK3;AAK1;CSNK1G2;SIK2;MAPKAPK3;BRD4;CDK19;PRKCE;PKMYT1;PRKD1;PRKCI;PLK2;NRBP1;VRK1;CDK8;STK11;TAOK1;PRKD2;STK39;PASK;ATP23;HIPK3;ATR;WNK3;CDKL4;CSNK1A1;MAST4;CSNK1G1;SRPK2;PIKFYVE;MAST1;PKN2;OXSR1;MAP3K8;MAPK14;LIMK2;HIPK1;RIPK1;BRAF;CAMKV
prerank,ATP binding (GO:0005524),0.5225307720681024,1.2466229091484136,0.06506506506506507,1.0,1.0,52/266,11.79%,KIF14;KIFC1;PIF1;PLK1;TRIP13;SMC4;RAD51;HASPIN;MAST2;RRM1;MAP4K4;KSR1;STK17B;MCM6;BMPR1A;RTEL1;MTHFD1L;MAP4K2;GCK;NLK;CARS2;DHX9;PMVK;DYRK3;BLM;GSS;SARS2;STK3;MYH10;PDXK;WNK1;MAP3K20;CDC42BPA;DARS2;GUK1;ABCF3;LONP1;PIM1;PPIP5K1;MARK2;PXK;P2RY1;CDC42BPG;MYO9B;TGFBR1;HNRNPU;SRPK1;PRPS1L1;PRPS1;TWF1;ABCA1;ENPP1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.5700366975740352,1.2463843629358253,0.2642679900744417,1.0,1.0,3/28,2.75%,TTK;AURKB;AURKA
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.6382462562117464,1.2419032237812644,0.27934621099554235,1.0,1.0,1/11,1.82%,AQP1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.40990217902731213,-1.2411843752412108,0.1969111969111969,0.5946655197605247,1.0,10/19,21.40%,GRIK1;GABRA2;GRID2;GRIK4;GABRA3;GABRA5;GABRG2;GABRG1;GRIK2;GRID1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.6541306285928683,1.2406148116765705,0.25148809523809523,1.0,1.0,2/10,2.33%,CDKN2D;CDKN2C
prerank,MHC protein binding (GO:0042287),-0.39833036909753283,-1.2405560418572557,0.16956521739130434,0.5878377027093765,1.0,9/20,29.48%,TAPBP;DERL1;ATP5F1A;CD81;ATP5F1B;TAP2;TUBB4B;CD74;ABCB9
prerank,PDZ domain binding (GO:0030165),0.5260200256022532,1.235454825027774,0.22077922077922077,1.0,1.0,9/61,10.75%,KIF14;CIT;ATP2B4;PDZK1;TGFBR3;CRIM1;LLGL2;ERC1;ATP2B1
prerank,3'-5' exonuclease activity (GO:0008408),0.5364770006396414,1.2275413048221178,0.23432343234323433,1.0,1.0,20/45,21.22%,PNLDC1;ERI2;RAD1;CNOT6L;MRE11;POLD1;EXD1;ERI1;CNOT6;EXOSC7;ERI3;CNOT7;PNPT1;ANGEL2;EXOSC10;RAD50;XRN2;PAN2;DIS3;TRIR
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5009355011394229,-1.2227265714851083,0.25153374233128833,0.6265769643913214,1.0,5/10,15.05%,GABRA2;GABRA3;GABRA5;GABRG2;GABRG1
prerank,calcium-release channel activity (GO:0015278),0.5799643841007587,1.2226168140594207,0.2616822429906542,1.0,1.0,8/17,16.38%,ITPR1;RASA3;TRPA1;TPCN1;TRPM2;ITPR3;PKD2;TPCN2
prerank,peptidoglycan binding (GO:0042834),-0.5051532699509709,-1.2222847677525632,0.26345609065155806,0.619046391333441,1.0,3/10,15.46%,NOD1;HK1;PGLYRP1
prerank,protein homodimerization activity (GO:0042803),0.5084696952691954,1.2187135256026318,0.024,1.0,1.0,98/589,12.60%,TOP2A;CENPF;KIF20B;ECT2;CIP2A;BARD1;KNSTRN;PON1;GEN1;TERF1;CEP57;RBM44;TRIM37;TRIML2;BMPR1A;DGCR8;CEP43;UPB1;MTHFD1L;FGFR2;STK10;CRPPA;MAPK4;MSH3;CHEK2;ACTN4;KIT;WDR54;DCK;TPM4;BHLHE41;ADD2;SNX1;LHPP;SRF;BLM;GSS;DPYD;PDLIM4;NUDT5;XDH;PDXK;EXD1;SOX6;TPR;PML;FMR1;ATG7;PDGFRA;TXN;HPGDS;SPPL2B;ZBTB7B;SH3GLB1;HSPB6;FBLN5;ZHX2;DARS2;RNF40;LRRK2;GOLGA5;SMCHD1;TYR;CPQ;MTMR1;DSCAML1;CDA;TPPP;ABCB10;NPR3;AGXT;IKBKG;KMT2A;TKT;SRGAP2;MYO9B;TARS2;SFPQ;BOK;RBPMS2;XPA;PRPS1L1;PRPS1;AHR;CLCN1;TERF2;TBX18;HOGA1;ENPP1;ZHX3;APPL2;ACHE;ASMT;MSH6;GYG1;CPOX;TRIM6;SMAD4
prerank,U6 snRNA binding (GO:0017070),0.5924809913611015,1.216803695116143,0.2859135285913529,1.0,1.0,8/14,18.89%,LSM3;DDX39B;TUT1;LSM2;LSM7;LSM4;PRPF4;LARP7
prerank,neuropeptide binding (GO:0042923),-0.42559085014355685,-1.2156651250756687,0.2,0.6276495630215815,1.0,12/18,52.56%,GPR37;OPRM1;GPR149;SORL1;OPRK1;NMUR2;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,lipase activator activity (GO:0060229),0.6389812145052062,1.2138062954541602,0.28290468986384265,1.0,1.0,4/10,15.32%,ARHGAP6;PDPK1;BTK;SRC
prerank,adenyl ribonucleotide binding (GO:0032559),0.5087504266812897,1.2109240250205717,0.0980980980980981,1.0,1.0,56/291,11.79%,KIF14;KIFC1;PIF1;PLK1;TRIP13;SMC4;RAD51;HASPIN;MAST2;RRM1;MAP4K4;KSR1;STK17B;MCM6;BMPR1A;RTEL1;MTHFD1L;MAP4K2;GCK;NLK;CARS2;DHX9;PMVK;DYRK3;BLM;GSS;SARS2;STK3;MYH10;PDXK;SLC19A1;WNK1;MAP3K20;CDC42BPA;DARS2;GUK1;ABCF3;LONP1;PIM1;PPIP5K1;MPPED2;MARK2;PXK;P2RY1;CDC42BPG;MYO9B;MIEF1;TGFBR1;HNRNPU;RAPGEF4;SRPK1;PRPS1L1;PRPS1;TWF1;ABCA1;ENPP1
prerank,carboxy-lyase activity (GO:0016831),0.5753520186437506,1.2095080702336236,0.28280254777070063,1.0,1.0,2/23,3.64%,ACMSD;GGCX
prerank,CARD domain binding (GO:0050700),-0.45404241108310583,-1.2059497798373098,0.23875432525951557,0.6441282298873101,1.0,4/14,12.06%,CARD16;CASP4;NOD1;IRGM
prerank,MAP kinase kinase activity (GO:0004708),-0.43720081744628114,-1.204624473461848,0.25084745762711863,0.6386610779299957,1.0,4/15,3.76%,MAPK10;MAP2K6;PAK3;MAP2K5
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.4185272339827771,-1.2030846106776627,0.20532319391634982,0.6340227360199762,1.0,9/16,45.74%,PIR;ETHE1;ALOX12;ADI1;BCO2;HGD;ALOXE3;HAAO;ALOX5
prerank,insulin-like growth factor binding (GO:0005520),-0.41923747606841316,-1.202897522846003,0.23193916349809887,0.6260371721920759,1.0,5/15,13.81%,ITGA6;INSR;ITGB4;IGFBP4;IGF2R
prerank,lysophospholipase activity (GO:0004622),-0.3923544189204399,-1.1998360481016854,0.20869565217391303,0.6254988217730058,1.0,7/20,14.75%,PLA2G4A;ABHD12;ABHD16A;PNPLA6;LYPLA1;GDPD3;GDPD1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5476924128180823,1.199035064569605,0.2871046228710462,1.0,1.0,6/27,10.75%,AQP1;ATP2B4;ITPR1;MAGT1;CNNM4;ATP2B1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.5536399323399853,1.1982102877541865,0.30193236714975846,1.0,1.0,9/31,14.64%,UBE2T;UBE2C;UBE2S;UBE2K;UBE2N;UBE2R2;UBE2J1;UBE2QL1;BIRC6
prerank,poly-purine tract binding (GO:0070717),0.5487948687692424,1.1952320363526374,0.2840909090909091,1.0,1.0,15/27,16.11%,PABPC4;PATL1;KHDRBS1;FMR1;RBMS2;HNRNPU;ATXN1;RBMS3;LARP4;DAZAP1;RBMS1;PABPC1;ZC3H14;DDX1;PNPT1
prerank,death receptor binding (GO:0005123),0.5917775104779842,1.1952085353398996,0.28746594005449594,1.0,1.0,8/15,23.27%,FADD;CASP8AP2;EDA;NGF;RIPK1;FEM1B;DAB2IP;BID
prerank,voltage-gated sodium channel activity (GO:0005248),-0.3878568775150652,-1.193154675763804,0.24888888888888888,0.6329711644068567,1.0,6/22,14.98%,HCN1;SCN1A;SCN9A;SCN3A;SCN8A;SCN1B
prerank,protein heterodimerization activity (GO:0046982),0.5060932760337407,1.1921379363784712,0.1636546184738956,1.0,1.0,35/178,16.55%,TOP2A;BARD1;SAE1;SMC1A;AURKA;SMC3;TPM4;BHLHE41;ADD2;SNX1;BMP6;TCF4;FMR1;SIM1;ZHX2;BDKRB2;IKBKG;CYBB;NR4A2;BOK;GTF2A1;AHR;ZHX3;MICU1;NR4A1;ITGB1;ARNT;VAPA;KCNB2;FXR1;ADD1;TP53;GABBR2;METTL3;ARNT2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.5412650067731171,1.1899903296784082,0.29694835680751175,1.0,1.0,9/34,14.64%,UBE2T;UBE2C;UBE2S;UBE2K;UBE2N;UBE2R2;UBE2J1;UBE2QL1;BIRC6
prerank,titin binding (GO:0031432),-0.4436945678466134,-1.1884077813275897,0.26498422712933756,0.6369930818038287,1.0,2/13,2.16%,CAMK2D;CALM1
prerank,histone acetyltransferase activity (GO:0004402),0.5454558700611913,1.1866361507849255,0.2914634146341463,1.0,1.0,13/30,18.38%,BRCA2;HAT1;EPC2;ARRB1;SRCAP;EPC1;MCM3AP;TADA2A;BAZ1A;KAT6A;TAF10;NAA60;NAA40
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5428716761801763,1.1866025984227047,0.28606060606060607,1.0,1.0,12/28,24.19%,FADD;TRIM37;CASP8AP2;EDA;RIPK1;TRAF6;TRAF2;FEM1B;TRAF4;DAB2IP;BID;BABAM2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.6003141729240291,1.1865398162318934,0.28486646884273,1.0,1.0,5/11,12.13%,ITPR1;RASA3;TRPA1;TRPM2;ITPR3
prerank,endonuclease activity (GO:0004519),0.5144348550197032,1.1819086514994852,0.30363036303630364,1.0,1.0,5/49,5.31%,ANKLE1;ZRANB3;AGO2;ERCC4;MRE11
prerank,transcription cis-regulatory region binding (GO:0000976),0.4910875702114506,1.1794209577587977,0.094,1.0,1.0,85/406,16.42%,BRCA1;E2F7;E2F8;UHRF1;E2F2;CDK5RAP2;GLI3;RBL1;HMGB2;E2F1;ZBTB8A;ZFP69;RB1;SP3;SETX;ZFP41;ETV6;TWIST2;TEAD1;AGO2;CTCF;E2F3;TFDP1;NFE2;BCOR;RFXAP;ACTN4;CUX1;NFIL3;ZNF568;TBL1XR1;TCF7L2;SOX6;GRHL2;PSPC1;ELK1;SIM1;ZBTB7B;FOXO3;LMX1B;SMAD6;BNC2;IRF1;ZFP90;KLF11;YAP1;NONO;NFYA;ARID4A;PLAGL1;LONP1;ZBTB20;HMGB1;NR3C1;SFPQ;TAL1;HNRNPL;HDAC1;AHR;NKX2-1;TBX18;STOX1;TAF4;KMT2D;SOX9;SMAD4;ATF5;RORA;TWIST1;POU2F2;YY1;FOXK2;FOXM1;SMAD3;ARNT;PER1;RBAK;DR1;ATF1;NFKB1;TP53;DRAP1;PURA;ZNF25;SUV39H2
prerank,lipid phosphatase activity (GO:0042577),-0.4278964256540152,-1.1783793443142425,0.22258064516129034,0.6533632318567124,1.0,5/14,21.13%,PLPPR1;PLPP3;INPP5K;EPHX2;PLPPR4
prerank,voltage-gated ion channel activity (GO:0005244),-0.43023507921096543,-1.175671193893958,0.2591362126245847,0.6521792944859398,1.0,4/14,9.49%,HCN1;ANO6;GPR89B;GPR89A
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.36081005202093225,-1.1647833226868098,0.21559633027522937,0.6720807297909359,1.0,6/23,4.87%,KIF16B;PLEKHA5;WDR45B;CLVS1;SNX14;SNX3
prerank,metallopeptidase activity (GO:0008237),0.48855198886020834,1.16459253131104,0.2785714285714286,1.0,1.0,23/113,14.20%,KEL;BMP1;MMP28;MMP24;MMP25;TRABD2B;MMP14;ADAM12;NLN;ADAMTS10;ADAMTS5;ADAMTS14;ADAMTS9;ADAMTSL2;PSMD14;ADAMTS2;ADAMTS16;ADAM17;ADAMTSL3;ADAM9;ADAM19;BRCC3;ADAMTS1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.48808504553314597,1.1629141093776978,0.129,1.0,1.0,67/346,14.64%,DTL;BRCA1;NEURL1B;UHRF1;BARD1;UBE2T;UBE2C;UBE2S;RFWD3;RNF168;TRIM37;TRIML2;BRAP;PDZRN3;RNF220;UBE2K;BCOR;UHRF2;NEDD4;MYCBP2;UBR4;SIAH2;RNF43;FANCL;TRIM59;PML;UBE2N;RNFT2;PRPF19;CUL5;MEX3C;RNF31;RC3H2;UBR5;TRIM28;VPS18;RNF40;SMURF1;CUL3;UBE2R2;SH3RF1;CUL4B;OBI1;RNF145;HERC2;TRIM63;SMURF2;FBXW11;TRIP12;TRIM6;ITCH;RNF121;IRF2BP1;UBE2J1;BTRC;FBXO27;ZNRF2;FBXO25;XIAP;RC3H1;HLTF;TRIM5;RNF114;UBE2QL1;ZNRF1;ZFP91;BIRC6
prerank,sequence-specific DNA binding (GO:0043565),0.4884093806012564,1.1604688925475684,0.083,1.0,1.0,99/590,14.43%,E2F7;NR2E3;E2F8;UHRF1;EN1;PIF1;E2F2;PBX4;GLI2;TCFL5;GLI3;E2F1;FOXE1;TERF1;CBFB;ZNF32;SP3;ZFP41;ELF2;TEAD1;SP2;ZSCAN29;CTCF;E2F3;HNRNPD;NFE2;STN1;TFCP2L1;MBD1;HIVEP1;CUX1;BHLHE41;KLF5;SRF;TCF7L1;ELF4;NFIB;KLF13;MAPT;MAEL;SP8;GZF1;HOXC4;TCF7L2;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;RFX2;ELK1;POU2F1;ZBTB2;POU3F2;ZBTB7B;PRRX2;OLIG2;FOXO3;LMX1B;KDM2B;PLAGL2;ZNF23;CREB5;KLF11;ZIC5;LONP1;ZBTB20;KMT2A;HOXB6;MEOX2;NR4A2;NR3C1;CXXC5;HNRNPU;XPA;CPSF4;AHR;TERF2;ERH;TBX18;RBPJ;NR4A1;ZIC4;SOX9;SMAD4;HDAC2;ATF5;ELK4;RORA;HEY2;FOXL1;RARB;POU2F2;SMG6;YY1;FOXK2;SMAD3;ARNT
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5132453034464659,1.1583783075746137,0.3119047619047619,1.0,1.0,8/34,13.09%,RACGAP1;IQGAP2;GBF1;ZFYVE16;ZFYVE1;MAPKAP1;CYTH3;BTK
prerank,metal ion binding (GO:0046872),0.48586021825051434,1.1577959244053784,0.114,1.0,1.0,70/477,12.91%,TOP2A;EFCAB11;MELK;PIF1;PLK1;PON1;FIGNL1;GEN1;CDH15;MAST2;LOXL2;ADGRV1;PLSCR2;SCUBE1;CDH18;CDH24;ANXA9;ANXA2;FBN1;NLK;ITPR1;PAM;IDH3A;TDP2;TPM4;DYRK3;PRNP;GSS;HPRT1;CDH4;NUDT5;STK3;ANXA3;PDXK;RAP2A;ANXA5;NDUFAB1;CABCOCO1;MAP3K20;ENPP2;HPGDS;PPP3CA;CDC42BPA;ENPP3;LRRK2;FKBP9;PGM1;ATP2A2;TPPP;SLC8A1;PPA1;MARK2;TKT;EYA2;CDC42BPG;TRPM2;CALM2;SRPK1;ANXA1;ENPP1;CALB1;MICU1;ITPR3;MSH6;TRPM4;POSTN;SIK2;MEX3B;DUT;MAN1C1
prerank,ion gated channel activity (GO:0022839),-0.36225876431304765,-1.1558394259877502,0.24873096446700507,0.6870189366551226,1.0,9/24,15.73%,ANO3;ANO6;ANO1;ANO10;TMEM63B;ANO4;KCNT1;TTYH2;TTYH3
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.3892238131122833,-1.1535310342180867,0.26394052044609667,0.6845439251484198,1.0,17/18,61.12%,DHRS11;HSD17B7;HSD17B8;HSD11B1;HSD17B10;HSD17B2;HSD3B7;HSD17B14;HSD17B1;SRD5A2;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3;RDH5
prerank,acetylation-dependent protein binding (GO:0140033),0.5462944535341274,1.1529256359141036,0.3278061224489796,1.0,1.0,9/20,20.70%,BRD9;PHIP;SMARCA4;KMT2A;BRD4;MLLT3;PSME4;ATAD2B;TRIM24
prerank,lysine-acetylated histone binding (GO:0070577),0.5462944535341274,1.1529256359141036,0.3278061224489796,1.0,1.0,9/20,20.70%,BRD9;PHIP;SMARCA4;KMT2A;BRD4;MLLT3;PSME4;ATAD2B;TRIM24
prerank,pseudouridine synthase activity (GO:0009982),-0.4344502292581686,-1.152922241092348,0.2916666666666667,0.6778198733378281,1.0,11/13,43.85%,PUS10;TRUB1;DKC1;PUS3;RPUSD4;PUS1;PUS7L;RPUSD1;PUSL1;RPUSD2;RPUSD3
prerank,GTPase regulator activity (GO:0030695),0.48205694474169714,1.152565123011468,0.22868605817452356,1.0,1.0,41/212,10.55%,IQGAP3;ECT2;RACGAP1;ARHGAP22;ARHGAP11A;USP6NL;IQGAP2;RGS12;GPSM2;ARHGAP10;ARHGAP28;ASAP1;DEPDC5;EVI5L;ACAP2;TBC1D25;ARHGAP18;OCRL;STXBP5;TBC1D13;ARRB1;CDC42EP2;TBC1D2B;ASAP2;ARHGAP24;LRRK2;ALDH1A1;SYDE2;GNAQ;ARHGAP19;RGS3;CPEB2;TBC1D7;LLGL2;RIC8B;NPRL3;RANGAP1;SRGAP2;MYO9B;ARHGAP35;ERRFI1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.5158126685094998,1.1505352987343518,0.317016317016317,1.0,1.0,14/33,21.11%,PNLDC1;ERI2;CNOT6L;ERI1;CNOT6;EXOSC7;ERI3;CNOT7;PNPT1;ANGEL2;EXOSC10;XRN2;PAN2;DIS3
prerank,protein tyrosine kinase activity (GO:0004713),0.49031587941174576,1.1484007518658006,0.29399796541200407,1.0,1.0,13/108,7.60%,MELK;TTK;WEE1;MATK;DYRK1A;STYK1;BAZ1B;FGFR4;FGFR2;KIT;MUSK;PDGFRA;EPHA4
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.5569190242784594,1.147588753309906,0.32226832641770403,1.0,1.0,6/18,13.92%,ANXA2;RAB10;ANXA1;PDLIM5;BAIAP2L1;TMOD3
prerank,E-box binding (GO:0070888),0.5160167750843733,1.146604237735355,0.3241695303550974,1.0,1.0,9/34,17.39%,ATOH8;ZEB1;BHLHE41;TCF4;TAL1;AHR;TWIST1;PER1;TFAP4
prerank,SUMO binding (GO:0032183),0.5846113761054269,1.1435700709394416,0.3274596182085169,1.0,1.0,8/13,23.71%,CASP8AP2;SERBP1;PML;HERC2;SIMC1;RNF111;UBA2;USP25
prerank,5'-nucleotidase activity (GO:0008253),-0.43513569061851404,-1.1430041660039842,0.27450980392156865,0.6939572149085034,1.0,6/13,30.03%,NT5M;NT5C3B;NT5DC1;NT5DC3;NT5C3A;NT5C1A
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.2865077357745084,-1.1415101121517641,0.22535211267605634,0.6896694152008735,1.0,25/57,25.20%,COX4I1;COX5A;NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;UQCR10;UQCRQ;NDUFB6;COX8A;NDUFB10;NDUFA10;UQCRC1;COX5B;NDUFS6;NDUFA1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.34114085161568247,-1.1373367445984504,0.2538860103626943,0.6919166139698258,1.0,8/27,19.28%,SLC22A8;ANO1;SLC22A6;SLC5A5;SLC26A11;SLC25A11;LRRC8A;SLC26A2
prerank,signal sequence binding (GO:0005048),0.5142468230396725,1.136955703220084,0.3376318874560375,1.0,1.0,4/35,5.14%,KPNA2;KPNA3;BRAP;TNPO1
prerank,cation:chloride symporter activity (GO:0015377),-0.4705382711679181,-1.136574690643776,0.31215469613259667,0.6860213631549653,1.0,3/10,16.25%,SLC6A1;SLC12A9;SLC12A2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.4230182923730995,-1.1358109126607707,0.2879746835443038,0.6799725265269212,1.0,7/13,20.96%,PIP4K2A;PIP4K2B;PIK3C2B;PIP5K1A;PIK3CD;PIK3CA;PIP4K2C
prerank,dynactin binding (GO:0034452),0.571472977443529,1.1353702510045396,0.3305439330543933,1.0,1.0,3/12,6.64%,GSK3B;MAPT;BICD2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.569542603579258,1.1338772474735108,0.3319209039548023,1.0,1.0,7/14,19.61%,RPP40;TSEN34;RPP30;POP1;TSEN2;PRORP;RPP21
prerank,vitamin D receptor binding (GO:0042809),0.5664768237097446,1.1329480956853646,0.33475783475783477,1.0,1.0,5/14,13.64%,MED14;THRAP3;MED30;MED24;MED1
prerank,protein phosphatase 1 binding (GO:0008157),-0.3750977943048877,-1.1327920938512195,0.24778761061946902,0.6801329426156935,1.0,7/21,22.80%,PPP1R16B;SHOC2;PPP1R3B;SH3RF2;PPP1R11;KCNQ1;PPP1R3C
prerank,tau protein binding (GO:0048156),-0.30656045576841123,-1.1324261068116315,0.2605042016806723,0.6735754070921395,1.0,12/40,7.83%,EP300;MARK3;HSP90AB1;ACTB;APOE;BIN1;TAOK2;BRSK1;PRKAA1;PPP2CB;LGMN;MAP1A
prerank,single-stranded RNA binding (GO:0003727),0.4967140611312393,1.129772146116975,0.33180252583237657,1.0,1.0,12/43,15.53%,DDX11;ILF3;AGO2;DHX9;HNRNPA1;EIF4H;FMR1;LONP1;HNRNPU;STRBP;AQR;FXR1
prerank,fibroblast growth factor binding (GO:0017134),0.5222354741355947,1.1290483341795843,0.3260025873221216,1.0,1.0,4/21,9.43%,CEP57;FGFR4;FGFR2;FGFRL1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.4504155723697655,-1.1262323841943154,0.3235294117647059,0.6817232765765577,1.0,5/10,18.25%,PIK3R3;PIK3C2B;ATM;PIK3CD;PIK3CA
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.44501489467094635,-1.1254190232595036,0.3159509202453988,0.6762500426922033,1.0,5/11,37.86%,KCNJ3;KCNQ1;KCNJ8;KCNE4;KCNH2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.4824048092703369,1.1236325624863344,0.3403141361256545,1.0,1.0,12/69,16.79%,ESCO2;CERS6;CERS5;SOAT1;PORCN;ZDHHC18;SOAT2;ZDHHC15;HHAT;KAT6A;ZDHHC3;ZDHHC21
prerank,thyroid hormone receptor binding (GO:0046966),0.509354681429755,1.123312539786456,0.3293124246079614,1.0,1.0,12/28,20.07%,TRIP6;THRAP3;MED30;MED24;ZNHIT3;TRIP12;MED1;JMJD1C;BRD8;ARID5A;MED16;GTF2B
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.5167199467748942,1.1232042347742286,0.3442028985507246,1.0,1.0,10/29,17.32%,CIT;CDKN2D;CDKN2C;PKIG;SPRED1;CDKN1B;RPTOR;SPRED2;PRKAR2B;PRKAR2A
prerank,leucine zipper domain binding (GO:0043522),0.5811811136249905,1.1211833947651633,0.3548387096774194,1.0,1.0,3/10,11.76%,PMF1;ERC1;MRTFA
prerank,insulin-like growth factor I binding (GO:0031994),-0.4117525876876492,-1.1206398531651134,0.32971014492753625,0.6805346605975356,1.0,4/13,12.36%,ITGA6;INSR;ITGB4;IGFBP4
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.5551143407615448,1.1200247897214037,0.36666666666666664,1.0,1.0,6/14,16.14%,MTMR14;MTMR1;MTMR2;MTMR9;MTMR3;PTEN
prerank,nucleotidase activity (GO:0008252),-0.40137713326471725,-1.1182216452723444,0.2857142857142857,0.6792526777248961,1.0,7/15,30.03%,BPNT2;NT5M;NT5C3B;NT5DC1;NT5DC3;NT5C3A;NT5C1A
prerank,semaphorin receptor binding (GO:0030215),-0.35136307397750494,-1.1167466151861591,0.2936170212765957,0.6758380988354049,1.0,17/23,38.73%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;SEMA5B;RIT2;SEMA6C;SEMA3G;SEMA4C;SEMA4A;SEMA3E;SEMA4G;SEMA3F;SH3BP1
prerank,sodium channel activity (GO:0005272),-0.31114588714224206,-1.1166223447117278,0.267515923566879,0.6691570288877611,1.0,10/37,21.30%,GRIK1;HCN1;SCN1A;GRIK4;SCN9A;SCN3A;SCN8A;SCN1B;KCNK1;GRIK2
prerank,H4 histone acetyltransferase activity (GO:0010485),0.5777491212155513,1.1148673924510346,0.34514637904468415,1.0,1.0,3/10,8.80%,BRCA2;HAT1;MSL3
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5265701090059806,1.1138858555005946,0.34704370179948585,1.0,1.0,7/20,14.73%,MAGI3;CASK;GUK1;DTYMK;TJP2;DLG1;AK7
prerank,symporter activity (GO:0015293),-0.4505544383910056,-1.1109239660377284,0.3294460641399417,0.676109997436985,1.0,3/10,23.34%,SLC5A6;SLC5A5;MFSD2A
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5582896670501066,1.1090558557857728,0.34674063800277394,1.0,1.0,2/15,10.19%,GPR171;P2RY1
prerank,neuropeptide receptor activity (GO:0008188),-0.3305674121634506,-1.1074250275523831,0.2737430167597765,0.6772136641414853,1.0,5/29,10.55%,SORCS3;SORCS1;GPR37;OPRM1;HCRTR2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.5426410631219605,1.1074107338550885,0.37991858887381275,1.0,1.0,6/16,16.14%,MTMR14;MTMR1;MTMR2;MTMR9;MTMR3;PTEN
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.4035260302119228,-1.1057167053944374,0.3028169014084507,0.6749390546365459,1.0,10/15,55.24%,CCR9;CMKLR1;CX3CR1;CCR5;CCR2;GPR17;CCRL2;CCR1;ACKR4;CCR6
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.4619025728140634,1.1056956151720665,0.217,1.0,1.0,83/431,13.72%,KIF14;KIFC1;PIF1;PLK1;TRIP13;SMC4;RAD51;RANBP17;TUBB6;HASPIN;MAST2;TUBA1C;RRM1;MAP4K4;KSR1;STK17B;MCM6;BMPR1A;TUBE1;RTEL1;RHOA;MTHFD1L;MAP4K2;GCK;NLK;RAB10;CARS2;RRAD;DHX9;PMVK;DYRK3;BLM;GSS;SARS2;RHOT1;STK3;MYH10;PDXK;RAP2A;ATL2;WNK1;MAP3K20;ATL3;RAB22A;CDC42BPA;RAB29;RASEF;TUBD1;DARS2;LRRK2;GUK1;ABCF3;RHOQ;DNM2;LONP1;PIM1;PPIP5K1;MARK2;PXK;P2RY1;CDC42BPG;MYO9B;TGFBR1;HNRNPU;DRG1;SRPK1;PRPS1L1;PRPS1;TWF1;RND2;RAC1;ABCA1;ENPP1;RRAS;SEPHS1;TSR1;MSH6;SIK2;BTK;PRKCI;DRG2;ARF4;MVK
prerank,platelet-derived growth factor binding (GO:0048407),-0.4462158213039462,-1.105008075453741,0.3300970873786408,0.669932063619331,1.0,4/11,9.22%,COL6A1;PDGFRB;COL5A1;COL1A2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.5491030756185737,1.1033414175668106,0.3853727144866385,1.0,1.0,3/15,8.47%,ALDH3A1;ALDH1A2;ALDH1A1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5659396967427088,1.10322623418194,0.35410764872521244,1.0,1.0,4/12,18.81%,AIFM2;NQO1;CRYZL1;DHRS4
prerank,chloride channel inhibitor activity (GO:0019869),-0.45152616267908713,-1.10255881762448,0.35103244837758113,0.6692936044929947,1.0,3/10,5.02%,STX8;STX7;WNK2
prerank,actinin binding (GO:0042805),0.5205842376750881,1.100062481330121,0.3658854166666667,1.0,1.0,8/21,15.74%,CSRP2;PDLIM4;CACNA1C;PDLIM5;SYNPO2;PKD2;CSRP3;NFKB1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5557192970462049,1.0971027609727342,0.35958395245170877,1.0,1.0,5/12,10.91%,TENT2;TENT4A;TUT1;PAPOLB;TENT5D
prerank,adenylate cyclase binding (GO:0008179),-0.44241145691585143,-1.0959605760569884,0.3518005540166205,0.6778377691896096,1.0,3/10,6.66%,CALM1;AKAP6;CAP1
prerank,actin binding (GO:0003779),0.4591485435584907,1.092686132717623,0.3514056224899598,1.0,1.0,47/170,17.60%,KIF18A;GAS2L3;ANLN;VASH2;IQGAP2;SYNE2;MACF1;SPTB;PARVA;ACTN4;SPEF1;ADD2;SLC6A2;MAPT;PDLIM4;SSH2;MYH10;MICAL3;MLPH;CXCR4;PHACTR1;LRRK2;EPS8L1;EMD;MYO9B;HNRNPU;SMTN;TWF1;CAPZA1;EZR;PHACTR2;MRTFA;PDLIM5;DMTN;SYNPO2;PRKCE;TLN2;ITGB1;ADD1;LCP1;DBN1;PLEKHH2;TNNT3;VPS16;COBL;SHROOM2;TRPV4
prerank,vinculin binding (GO:0017166),0.5560495838620896,1.092554920284407,0.3580060422960725,1.0,1.0,4/11,11.42%,CTNNA1;SORBS3;TLN1;SYNM
prerank,calcium channel regulator activity (GO:0005246),-0.3020472406235919,-1.0923972633037822,0.2887323943661972,0.6795037877721142,1.0,13/37,21.15%,PRKG1;CALM1;FKBP1A;SGK1;CACNG7;NRXN1;CACNG4;SLC30A1;SRI;CACNG8;INAFM1;REM1;PACSIN3
prerank,receptor tyrosine kinase binding (GO:0030971),-0.2725044058045678,-1.091547371157075,0.2702702702702703,0.6751401584610226,1.0,19/56,18.99%,NRG3;GRB14;GAS6;SQSTM1;PIK3R1;DUSP3;SOCS5;TOB1;IRS1;FLT3LG;ANGPT2;PTPN14;SHC1;ELMO2;CBLB;FIZ1;CBL;SHC4;SHC3
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.38691143488272106,-1.090608574314251,0.32550335570469796,0.6708017685657157,1.0,3/15,4.87%,PLA2G4A;PLEKHA5;SNX3
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.23359671157744116,-1.0900123009426559,0.24324324324324326,0.665748537407835,1.0,30/91,21.62%,KIF16B;PLEKHA5;KRIT1;ADAP2;WDR45B;CLVS1;STXBP6;SNX14;SNX3;KCNH1;TTPAL;SNX21;LAPTM4B;SYT7;SYTL2;PFN1;GSN;VILL;SDCBP;LDLRAP1;HIP1;RPH3A;FCHO2;COMMD1;EXOC1;RAB35;KCNQ1;TIRAP;AVIL;OSBPL2
prerank,calcium-activated potassium channel activity (GO:0015269),0.5746181931420832,1.0898838923169907,0.37753510140405616,1.0,1.0,4/11,14.78%,KCNN4;KCNMB2;KCNMB3;KCNMB4
prerank,copper ion binding (GO:0005507),0.4861610310613529,1.0880368719998208,0.37543053960964407,1.0,1.0,10/42,17.80%,LOXL3;LOXL2;PAM;PRNP;SOD3;TYR;COA6;TP53;CCS;LACC1
prerank,ATPase activator activity (GO:0001671),-0.35939937086034274,-1.084665354099317,0.36065573770491804,0.6716525672132223,1.0,5/20,9.08%,ATP1B1;DNAJC24;DNAJC19;DNAJA1;ATP1B3
prerank,pre-mRNA binding (GO:0036002),0.4966593260093332,1.0791748974282527,0.3847072879330944,1.0,1.0,8/28,13.47%,TRA2B;HNRNPA1;SLBP;ERI1;CELF2;HNRNPU;HNRNPL;RBM4
prerank,GTPase activator activity (GO:0005096),0.4509704829885654,1.0776938921366972,0.323,1.0,1.0,61/313,11.26%,IQGAP3;ECT2;RACGAP1;PCP2;ARHGAP22;ARHGAP11A;USP6NL;IQGAP2;RANGRF;DENND2C;ARHGAP10;FNIP1;ARHGAP28;ASAP1;RCBTB2;DEPDC5;EVI5L;MYCBP2;ACAP2;TBC1D25;ARHGAP18;OCRL;DENND4C;STXBP5;TBC1D13;DNMBP;FGD4;EIF2B1;DENND2A;ARRB1;CDC42EP2;VAV2;TBC1D2B;FGD1;ASAP2;ARHGAP24;ANKRD27;LRRK2;RAB3IL1;ALDH1A1;SYDE2;GNAQ;ARHGAP19;RGS3;TBC1D7;FARP1;LLGL2;EPS8L1;RIC8B;NPRL3;RANGAP1;DENND5A;SRGAP2;MYO9B;HERC2;ARHGAP35;ERRFI1;CYTH3;FGD6;RAPGEF4;ARHGEF18
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.4019891117901233,-1.074023412853253,0.35570469798657717,0.6903380449002686,1.0,6/14,37.86%,KCNJ3;KCNQ1;KCNJ8;KCNIP2;KCNE4;KCNH2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.5409288907865774,1.0722643102809768,0.40486409155937053,1.0,1.0,3/13,8.47%,ALDH3A1;ALDH1A2;ALDH1A1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.49693047289321135,1.0698198598053956,0.398505603985056,1.0,1.0,5/27,7.46%,PRIM1;POLR1A;PRIMPOL;POLR1B;POLR2A
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.3986041059773743,-1.064718449253309,0.38721804511278196,0.7060400116808351,1.0,6/13,20.57%,IL1R1;PDGFRB;PDGFD;VEGFA;VEGFD;ITGB3
prerank,hormone receptor binding (GO:0051427),-0.38730703024665014,-1.0628906825920086,0.35335689045936397,0.7038659464602536,1.0,5/14,27.51%,SOCS2;JAK2;PTHLH;ADCYAP1;JAK1
prerank,phosphatase binding (GO:0019902),0.44834262740638986,1.0602762790634659,0.4262125902992776,1.0,1.0,30/105,18.67%,NEK2;CEP192;MAST2;ANAPC7;KCNN4;CDC27;PDLIM4;RPA2;ANK1;WNK1;MTMR9;EIF2AK3;AP3B1;CHCHD3;DLG1;SPRED1;CDKN1B;SMAD3;MTMR3;TP53;ANAPC5;PPP3R1;SIRPA;PPME1;MVP;SMAD2;TERF2IP;BAD;MAPK14;KIFAP3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.534137730551738,1.0594017174150534,0.3988355167394469,1.0,1.0,3/12,8.17%,AGO2;EIF4E;LARP1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5293272864201912,1.0582931591602107,0.41316526610644255,1.0,1.0,2/14,5.88%,RDH11;RDH12
prerank,phospholipase activity (GO:0004620),-0.2520353797304935,-1.0572457322764555,0.31746031746031744,0.7099969919130561,1.0,11/67,9.38%,PLA2G4A;PLAAT3;ABHD6;ABHD12;ABHD16A;PNPLA6;LYPLA1;PLCB3;PNPLA8;GPLD1;PLD3
prerank,LRR domain binding (GO:0030275),0.5267122643661395,1.0549525300196532,0.39882697947214074,1.0,1.0,4/14,11.76%,PMF1;ROBO1;ERC1;MRTFA
prerank,channel activity (GO:0015267),0.4654630884677197,1.049093231101563,0.4284090909090909,1.0,1.0,6/41,12.03%,AQP1;TRPA1;PDPN;MCUB;SLC14A1;CHRNB1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.43936782417509646,1.0483021352127013,0.332,1.0,1.0,130/732,15.87%,E2F7;NR2E3;E2F8;UHRF1;MXD3;EN1;E2F2;MYBL1;PBX4;GLI2;TCFL5;GLI3;HMGB2;E2F1;FOXE1;ATOH8;ZNF32;PBX3;SP3;HOXC5;TEAD1;SP2;ZSCAN29;CTCF;E2F3;ZEB1;NFE2;TFCP2L1;ZNF260;NFIA;HIVEP1;DHX9;WIZ;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;ELF4;NFIB;THRAP3;KLF13;ZNF568;ZNF697;CCAR1;SP8;IKZF1;GZF1;HOXC4;TCF7L2;SOX6;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;GLIS3;RFX2;ELK1;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;ZBTB7B;PRRX2;OLIG2;FOXO3;ZNF23;IRF1;CREB5;KLF11;ZBTB25;HOXB3;NFYA;PLAGL1;ZIC5;ZBTB20;HOXB6;MEOX2;NR4A2;CARF;MYPOP;NR3C1;HNRNPU;TAL1;TEAD3;ZBTB24;KCNIP3;ZNF585B;ZNF585A;CHD2;HDAC1;AHR;NKX2-1;KLF9;TBX18;RBPJ;NR4A1;ZIC4;SOX9;SMAD4;ZNF394;ZNF496;ELK4;RORA;HEY2;FOXL1;RARB;POU2F2;YY1;FOXK2;DNMT3A;RUVBL2;SMAD3;ARNT;FOXP4;SOX1;E2F4;PER1;ZNF445;ATF1;HOXB7;ZNF112;NFKB1;ZBTB7C;TP53;PKNOX2
prerank,mRNA 3'-UTR binding (GO:0003730),0.45040658553233265,1.0468676149212526,0.4368421052631579,1.0,1.0,26/79,15.83%,ILF3;PABPC4;LARP4B;SERBP1;FMR1;YBX3;RBMS2;CELF2;LARP1;TUT1;RNF40;CPEB2;PUM2;HNRNPU;RBMS3;MEX3D;RBM4;LARP4;DAZAP1;RC3H1;RBMS1;PABPC1;SECISBP2;HNRNPA2B1;FXR1;TP53
prerank,Notch binding (GO:0005112),-0.3316264185939309,-1.03934156810081,0.3893805309734513,0.7458232728742356,1.0,9/22,20.56%,DNER;SNED1;JAG1;KCTD10;DTX1;JAG2;NOTCH4;SNW1;HIF1AN
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5410988139351569,1.038883907959757,0.4228295819935691,1.0,1.0,3/10,17.80%,ADA;CDA;LACC1
prerank,myosin binding (GO:0017022),0.4459535888653148,1.0386901891617821,0.44408251900108575,1.0,1.0,10/55,9.28%,TRIOBP;TRAK1;RHOA;KIRREL1;RAB10;STXBP5;MLPH;CXCR4;SPATA6;LLGL2
prerank,histone deacetylase activity (GO:0004407),0.49186138620089187,1.0376119585312475,0.4196078431372549,1.0,1.0,9/19,22.43%,MIER1;MIER3;HDAC8;HDAC1;HDAC2;HDAC4;SIRT2;SIRT3;MIER2
prerank,ubiquitin protein ligase activity (GO:0061630),0.4334984008973273,1.037232325192558,0.42126379137412234,1.0,1.0,47/228,15.65%,NEURL1B;UHRF1;RFWD3;TRIM37;TRIML2;BRAP;PDZRN3;RNF220;UBE2K;UHRF2;NEDD4;MYCBP2;UBR4;SIAH2;RNF43;FANCL;TRIM59;RNFT2;PRPF19;MEX3C;RC3H2;UBR5;VPS18;SMURF1;CUL3;SH3RF1;RNF145;HERC2;UBOX5;TRIM63;SMURF2;TRIP12;TRIM6;ITCH;RNF121;IRF2BP1;FBXO27;ZNRF2;XIAP;RC3H1;HLTF;TRIM5;RNF114;ZNRF1;FBXO17;NSMCE1;ASB2
prerank,ribonuclease P activity (GO:0004526),0.534861299916842,1.0323303393957528,0.4330827067669173,1.0,1.0,5/11,19.61%,RPP40;RPP30;POP1;PRORP;RPP21
prerank,protein tyrosine kinase binding (GO:1990782),-0.25179081523385216,-1.0314489770256112,0.391304347826087,0.7579025280792255,1.0,24/71,18.99%,NRG3;ACVR1;GRB14;BMPR2;NEDD9;GAS6;SQSTM1;CDH5;DUSP3;DUSP22;SOCS5;TOB1;FLT3LG;ANGPT2;GRM5;PTPN14;PTPN11;SHC1;ELMO2;CBLB;FIZ1;CBL;SHC4;SHC3
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.4302018556737945,1.0306362559058684,0.44410876132930516,1.0,1.0,40/188,15.83%,BRCA1;CDK5RAP2;HMGB2;CTCF;LIN54;BCOR;DHX9;ZNF568;TBL1XR1;TCF7L2;SOX6;PSPC1;ELK1;FOXO3;SMAD6;BNC2;IRF1;KLF11;YAP1;NONO;NFYA;ARID4A;ZBTB20;HMGB1;SFPQ;TAL1;HNRNPL;AHR;NKX2-1;TBX18;KMT2D;SMAD4;ATF5;POU2F2;YY1;FOXK2;SMAD3;PER1;NFKB1;TP53
prerank,CoA hydrolase activity (GO:0016289),-0.35537991932241497,-1.0270432223604975,0.396,0.7614349349023706,1.0,6/16,25.11%,ACOT11;NUDT7;ACOT7;ACOT13;HIBCH;ACOT6
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5171518814031112,1.0223517660642338,0.42196531791907516,1.0,1.0,5/12,18.34%,CASP8AP2;APAF1;CTSH;BCL2L13;BAD
prerank,flavin adenine dinucleotide binding (GO:0050660),0.44304970035113495,1.0217814274208603,0.47316538882803943,1.0,1.0,14/53,14.87%,AIFM2;DPYD;MTHFR;XDH;MICAL3;AGPS;QSOX1;NOX4;KMO;SQOR;CYBB;GFER;ACADL;CYB5R1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.42885275912047055,1.0203858378843567,0.46,1.0,1.0,42/269,11.40%,BRCA1;CCNB1;UBE2T;UBE2C;RAD18;SMC6;TRIM37;RB1;TRIOBP;GSK3B;UBE2K;GPI;NLK;DDRGK1;CHEK2;FAF1;RPA2;SLF1;CXCR4;FANCL;ARRB1;PML;FBXW7;UBE2N;CUL5;POLR2A;RNF31;STAM;TRIM28;RNF40;MFN2;SMAD6;CUL3;AXIN2;CUL4B;PSMD1;IKBKG;PARP9;HERC2;UBOX5;ARRDC1;BAG5
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5179284421125465,1.0187063896232083,0.45294117647058824,1.0,1.0,2/12,7.72%,CTSE;SPPL2B
prerank,hexosaminidase activity (GO:0015929),0.5212911286604314,1.0184726147033414,0.4329446064139942,1.0,1.0,2/12,3.28%,SPAM1;HYAL1
prerank,phosphatase activator activity (GO:0019211),0.5117858634000054,1.0180211621550572,0.43878954607977994,1.0,1.0,6/14,20.13%,FRS2;PPP2R5C;CALM2;BMP2;PPP2R5B;PHACTR4
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.42489673323985555,1.0142844651036158,0.458,1.0,1.0,147/831,15.87%,E2F7;NR2E3;E2F8;MXD3;EN1;E2F2;MYBL1;PBX4;GLI2;TCFL5;GLI3;RBL1;E2F1;FOXE1;ATOH8;ZBTB8A;ZFP69;ZNF32;RB1;PBX3;SP3;HOXC5;ZFP41;ETV6;TWIST2;TEAD1;SP2;ZSCAN29;CTCF;E2F3;ZEB1;TFDP1;NFE2;TFCP2L1;RFXAP;ACTN4;ZNF260;NFIA;HIVEP1;CUX1;DHX9;WIZ;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;ELF4;NFIB;THRAP3;KLF13;ZNF568;ZNF697;CCAR1;SP8;IKZF1;GZF1;HOXC4;TCF7L2;SOX6;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;GLIS3;RFX2;ELK1;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;SIM1;ZBTB7B;PRRX2;OLIG2;FOXO3;LMX1B;ZNF23;IRF1;CREB5;ZFP90;KLF11;ZBTB25;HOXB3;NFYA;PLAGL1;ZIC5;ZBTB20;HOXB6;MEOX2;NR4A2;CARF;MYPOP;NR3C1;HNRNPU;TAL1;TEAD3;ZBTB24;KCNIP3;GTF2A1;ZNF585B;ZNF585A;CHD2;HDAC1;NKX2-1;KLF9;TBX18;STOX1;RBPJ;NR4A1;ZIC4;SOX9;SMAD4;ZNF394;ATF5;ZNF496;ELK4;RORA;TWIST1;HEY2;FOXL1;RARB;POU2F2;YY1;FOXK2;DNMT3A;RUVBL2;FOXM1;SMAD3;ARNT;FOXP4;SOX1;E2F4;PER1;RBAK;ZNF445;ATF1;HOXB7;ZNF112;NFKB1;ZBTB7C;TP53;PKNOX2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.41851628115342243,-1.0142304135175069,0.42902208201892744,0.7853176984383158,1.0,6/10,26.07%,DPP9;DPP8;PRCP;DPP10;FAP;DPP3
prerank,ubiquitin-specific protease binding (GO:1990381),-0.32990392921907113,-1.012701254772844,0.42857142857142855,0.7820460651894889,1.0,10/19,24.63%,PRKN;DERL1;SELENOS;RHBDD2;SART3;SYVN1;PARK7;RAD23A;CHMP3;SPATA2
prerank,bHLH transcription factor binding (GO:0043425),0.4841491758814527,1.0122597805836158,0.44587628865979384,1.0,1.0,4/19,14.34%,FHL2;BHLHE41;TWIST1;SMAD3
prerank,retinoic acid receptor binding (GO:0042974),0.4833557113326061,1.0114258218787031,0.42597402597402595,1.0,1.0,7/17,20.21%,CNOT1;ACTN4;ASXL1;NR4A2;MED1;ARID5A;MED25
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5064930362580976,1.0107338084308284,0.44296296296296295,1.0,1.0,7/12,24.71%,POU2F1;GTF2A1;HDAC1;RUVBL2;GTF2B;H3-3A;RELA
prerank,exopeptidase activity (GO:0008238),-0.25781984521715606,-1.0086961015243927,0.4222222222222222,0.7857803122938888,1.0,12/50,14.52%,LNPEP;CPE;CTSZ;LAP3;ACE;METAP1D;ENPEP;CTSA;DPP9;DPP8;XPNPEP1;PRCP
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.4214477967651908,1.007470290246118,0.48293172690763053,1.0,1.0,46/232,15.65%,NEURL1B;UHRF1;RFWD3;TRIM37;TRIML2;BRAP;PDZRN3;RNF220;UHRF2;NEDD4;MYCBP2;UBR4;SIAH2;RNF43;FANCL;TRIM59;RNFT2;PRPF19;MEX3C;RC3H2;UBR5;VPS18;SMURF1;CUL3;SH3RF1;RNF145;HERC2;TRIM63;SMURF2;NSMCE2;TRIP12;TRIM6;ITCH;RNF121;IRF2BP1;FBXO27;ZNRF2;XIAP;RC3H1;HLTF;TRIM5;RNF114;ZNRF1;FBXO17;NSMCE1;ASB2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.4220078629938179,1.0066866615061272,0.493,1.0,1.0,129/731,15.87%,E2F7;NR2E3;E2F8;MXD3;EN1;E2F2;MYBL1;PBX4;GLI2;TCFL5;GLI3;E2F1;FOXE1;ATOH8;ZNF32;PBX3;SP3;HOXC5;TEAD1;SP2;ZSCAN29;CTCF;E2F3;ZEB1;NFE2;TFCP2L1;ZNF260;NFIA;HIVEP1;DHX9;WIZ;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;ELF4;NFIB;THRAP3;KLF13;ZNF568;ZNF697;CCAR1;SP8;IKZF1;GZF1;HOXC4;TCF7L2;SOX6;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;GLIS3;RFX2;ELK1;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;ZBTB7B;PRRX2;OLIG2;FOXO3;ZNF23;IRF1;CREB5;KLF11;ZBTB25;HOXB3;NFYA;PLAGL1;ZIC5;ZBTB20;HOXB6;MEOX2;NR4A2;CARF;MYPOP;NR3C1;HNRNPU;TAL1;TEAD3;ZBTB24;KCNIP3;ZNF585B;ZNF585A;CHD2;HDAC1;AHR;NKX2-1;KLF9;TBX18;RBPJ;NR4A1;ZIC4;SOX9;SMAD4;ZNF394;ZNF496;ELK4;RORA;TWIST1;HEY2;FOXL1;RARB;POU2F2;YY1;FOXK2;DNMT3A;RUVBL2;SMAD3;ARNT;FOXP4;SOX1;E2F4;PER1;ZNF445;ATF1;HOXB7;ZNF112;NFKB1;ZBTB7C;TP53;PKNOX2
prerank,poly(A) binding (GO:0008143),0.47176982008222024,1.0054426574313924,0.47244094488188976,1.0,1.0,10/21,15.89%,PABPC4;KHDRBS1;RBMS2;HNRNPU;RBMS3;LARP4;RBMS1;PABPC1;ZC3H14;DDX1
prerank,beta-tubulin binding (GO:0048487),0.4553097607658723,1.004917459167071,0.4650887573964497,1.0,1.0,8/31,17.60%,RACGAP1;SMC3;UXT;EMD;TAOK1;EML4;TBCD;TRPV4
prerank,disordered domain specific binding (GO:0097718),0.4651426339929878,1.0043634792447083,0.47307692307692306,1.0,1.0,7/23,17.83%,PPIL1;RB1;NUMA1;CALM2;TP53;KCNA1;SMAD2
prerank,FAD binding (GO:0071949),0.46593641339020697,1.003531918803398,0.4633838383838384,1.0,1.0,6/24,9.82%,MTHFR;MICAL3;AGPS;QSOX1;KMO;SQOR
prerank,P-type ion transporter activity (GO:0015662),0.49877123711339905,1.0029316599889404,0.45544554455445546,1.0,1.0,3/12,10.75%,ATP2B4;ATP2A2;ATP2B1
prerank,chemokine binding (GO:0019956),0.46000720468783873,1.0025492234700342,0.45161290322580644,1.0,1.0,6/30,15.00%,PLP2;PDPN;CXCR4;HMGB1;ITGB1;ITGAV
prerank,nucleosomal DNA binding (GO:0031492),0.4723973185577505,1.0019589119683805,0.4398447606727037,1.0,1.0,13/21,24.82%,SMARCC1;RBBP4;SMARCA4;HDAC1;HDAC2;MBD3;MBD2;CHD4;ACTL6A;H3-3A;SMARCC2;SMARCB1;HNRNPC
prerank,voltage-gated calcium channel activity (GO:0005245),-0.2911432384073363,-0.9993617894300504,0.4765625,0.8030875975104903,1.0,13/37,19.61%,CACNA2D1;CACNG7;CACNA1B;CACNG4;OPRM1;NCS1;CACNG2;CACNB2;CACNG3;CACNG8;CACNB1;CACHD1;CACNA2D2
prerank,phospholipase activator activity (GO:0016004),0.522597115878456,0.9949978364658334,0.46706586826347307,1.0,1.0,4/10,15.32%,ARHGAP6;PDPK1;BTK;SRC
prerank,tau-protein kinase activity (GO:0050321),0.47037970231542214,0.9946822288123764,0.47876447876447875,1.0,1.0,5/20,9.80%,DYRK1A;ROCK2;GSK3B;ROCK1;MARK2
prerank,cAMP binding (GO:0030552),-0.3862208143027081,-0.9912150175320209,0.44753086419753085,0.8169709739516625,1.0,5/11,18.60%,HCN1;CNBD2;PDE10A;PDE2A;PDE4D
prerank,fatty acid synthase activity (GO:0004312),-0.4215670931279309,-0.9910318009760263,0.45,0.8107314285133901,1.0,6/10,34.54%,ELOVL7;ELOVL6;CBR4;ELOVL1;OXSM;MCAT
prerank,GTPase inhibitor activity (GO:0005095),0.4909870266920077,0.9885748150230418,0.46589259796806964,1.0,1.0,4/13,16.57%,IQGAP2;CPEB2;IPO5;TNK2
prerank,death receptor activity (GO:0005035),-0.3989286884500724,-0.9854505167790781,0.4507936507936508,0.8177613049892081,1.0,4/11,11.61%,TNFRSF19;FAS;TNFRSF11A;TNFRSF1B
prerank,nuclear receptor coactivator activity (GO:0030374),0.426667792167378,0.9843101800859095,0.4923580786026201,1.0,1.0,14/52,13.64%,MED14;ACTN4;THRAP3;CCAR1;MED30;ELK1;CNOT6;MED24;NCOA2;PRKCB;SLC30A9;NCOA7;PPRC1;MED1
prerank,cadherin binding (GO:0045296),0.4155794550951893,0.9834006803192119,0.572,1.0,1.0,65/315,15.32%,DIAPH3;CIP2A;CCNB2;TMPO;CKAP5;ANLN;CDH15;MACF1;CDH18;CDH24;ANXA2;ZC3HAV1;PARVA;ASAP1;GPRC5A;RAB10;PACSIN2;UBAP2;ARHGAP18;SNX1;SERBP1;MRE11;CDH4;STK24;EIF4H;AFDN;CTNNA1;CNN2;SCRIB;SH3GLB1;LARP1;CORO1B;ABCF3;NCK1;ABI1;EPS8L1;PICALM;EMD;ERC1;MARK2;RAB1A;RANGAP1;TLN1;NDRG1;TWF1;CAPZA1;CRKL;EZR;ANXA1;PDLIM5;TES;WASF2;TJP2;EHD1;BAIAP2L1;CAST;CLIC1;DLG1;TMOD3;ITGB1;CAPG;MPRIP;CLINT1;VAPA;SRC
prerank,hyaluronic acid binding (GO:0005540),-0.3904391582924249,-0.982501625846404,0.4857142857142857,0.818760509602745,1.0,7/10,36.55%,CEMIP;LAYN;IMPG2;C1QBP;HYAL2;LYVE1;CHODL
prerank,Hsp70 protein binding (GO:0030544),-0.2914778479450357,-0.9819962434227462,0.5032679738562091,0.8133675406235039,1.0,12/31,24.85%,PRKN;DNAJA1;GPR37;PACRG;STUB1;DNAJC18;METTL21A;PPEF2;DNAJB12;RPS3;TSC1;HIKESHI
prerank,cardiolipin binding (GO:1901612),0.5053780614108702,0.9816029074467318,0.46824224519940916,1.0,1.0,2/10,14.52%,STOML2;GSDMD
prerank,transferrin receptor binding (GO:1990459),0.5064714697562045,0.981587919873551,0.48540706605222733,1.0,1.0,3/10,9.78%,RGMA;SNX1;IKBKG
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.5066139495874831,0.9814137202241457,0.48328267477203646,1.0,1.0,4/11,10.85%,UBE2K;PRPF19;UBR5;UBOX5
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.40881204142281924,0.980986650442338,0.53420523138833,1.0,1.0,27/147,12.60%,ECT2;PCP2;RANGRF;DENND2C;FNIP1;RCBTB2;MYCBP2;DENND4C;DNMBP;FGD4;EIF2B1;DENND2A;VAV2;FGD1;ANKRD27;RAB3IL1;FARP1;EPS8L1;RIC8B;DENND5A;HERC2;CYTH3;FGD6;RAPGEF4;ARHGEF18;DENND1A;DOCK11
prerank,aspartic-type peptidase activity (GO:0070001),0.5052036166280705,0.9808183945881904,0.49039881831610044,1.0,1.0,1/10,2.13%,CTSE
prerank,small GTPase binding (GO:0031267),0.41109401128378575,0.9806441290952512,0.551654964894684,1.0,1.0,38/170,13.48%,BIRC5;USP6NL;IQGAP2;RANGRF;TRIOBP;EXOC4;EVI5L;MYCBP2;OCRL;MYO1C;AFDN;MLPH;FGD4;BICD2;CDC42EP2;YBX3;RAB29;FGD1;GCC1;ANKRD27;LRRK2;GOLGA5;TBC1D7;PICALM;ERC1;MAPKAP1;RANGAP1;SRGAP2;LSM2;MYO9B;FGD6;NDRG1;RAPGEF4;ABCA1;CHM;RANBP2;EHD1;EXOC8
prerank,manganese ion binding (GO:0030145),0.4222593854288232,0.9792401652584672,0.4771968854282536,1.0,1.0,9/48,12.43%,LARGE1;B4GALT1;PRIMPOL;TDP2;GALNT1;B4GALT7;PIM1;MPPED2;GYG1
prerank,metallocarboxypeptidase activity (GO:0004181),0.45236398997176636,0.9774629673709712,0.48621553884711777,1.0,1.0,3/26,6.14%,VASH2;AGBL2;CPXM1
prerank,protein phosphatase binding (GO:0019903),0.4109644927010371,0.9766018374889092,0.5387755102040817,1.0,1.0,27/117,18.67%,NEK2;MASTL;ATP2B4;ANAPC7;KCNN4;CDC27;MAPT;PDLIM4;RPA2;ANK1;MTMR9;EIF2AK3;AP3B1;AKAP11;ENSA;CDKN1B;PTPA;MTMR3;TP53;ANKLE2;ANAPC5;SIRPA;PPME1;MVP;BAD;MAPK14;KIFAP3
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.3093976124348685,-0.9764310489163729,0.4803921568627451,0.8209146172197793,1.0,7/25,13.03%,PARP8;TIPARP;ART3;PARP6;PARP1;SIRT5;PARP16
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.2996518515458944,-0.9749560868654318,0.504424778761062,0.8179860357017175,1.0,4/24,4.87%,PLA2G4A;PLEKHA5;CERT1;SNX3
prerank,alpha-tubulin binding (GO:0043014),0.4442671073641918,0.9740337795265575,0.5042219541616405,1.0,1.0,9/31,20.66%,RACGAP1;SETD2;TRAPPC14;INO80;TAOK1;EML4;TRPV4;DIP2B;SNCA
prerank,RNA stem-loop binding (GO:0035613),0.49166367916926,0.9732951541076499,0.5045045045045045,1.0,1.0,6/12,14.57%,DHX9;MYH10;FMR1;RC3H2;RC3H1;EPRS1
prerank,calcium ion binding (GO:0005509),0.4047224919283882,0.9685054027542189,0.596,1.0,1.0,40/323,12.91%,EFCAB11;MELK;PON1;CDH15;LOXL2;ADGRV1;PLSCR2;SCUBE1;CDH18;CDH24;ANXA9;ANXA2;FBN1;ITPR1;PAM;TPM4;PRNP;CDH4;ANXA3;ANXA5;NDUFAB1;CABCOCO1;ENPP2;HPGDS;PPP3CA;ENPP3;FKBP9;ATP2A2;SLC8A1;TKT;TRPM2;CALM2;ANXA1;ENPP1;CALB1;MICU1;ITPR3;TRPM4;MEX3B;MAN1C1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.40855504058737724,0.9684196545714848,0.5603621730382293,1.0,1.0,21/173,10.84%,E2F8;EN1;TCFL5;ZFP69;ETV6;SP2;CTCF;ZEB1;BHLHE41;NFIL3;GZF1;ZBTB2;MXD1;FOXO3;ZFP90;ZBTB25;PLAGL1;ZBTB20;MYPOP;NR3C1;KCNIP3
prerank,protein phosphatase 2A binding (GO:0051721),0.456085359253106,0.968069930638845,0.49302915082382764,1.0,1.0,7/23,17.37%,MASTL;MAPT;ENSA;PTPA;TP53;ANKLE2;PPME1
prerank,GDP binding (GO:0019003),-0.2377191428681436,-0.9652014135654049,0.582089552238806,0.8359963539173169,1.0,17/63,15.27%,RAB28;RAP1A;GNAI1;RAB27B;RAB5B;RERG;RALB;MRAS;RASL12;DYNC1LI1;RAB5A;RAB2A;RIT1;RAP2C;RAB12;RRAGC;ARL8B
prerank,SUMO transferase activity (GO:0019789),0.4683935265286063,0.9646541817032501,0.5041322314049587,1.0,1.0,7/16,24.16%,TRIM28;NSMCE2;RANBP2;EGR2;HDAC4;PIAS1;UBE2I
prerank,MAP kinase kinase kinase activity (GO:0004709),0.4971137725874957,0.9645334702649249,0.503725782414307,1.0,1.0,3/11,9.15%,MAP3K1;MAP3K20;MAP3K4
prerank,ribonuclease P RNA binding (GO:0033204),0.5034402136505035,0.9642390743480135,0.5052790346907994,1.0,1.0,4/10,19.61%,RPP40;RPP30;POP1;RPP21
prerank,cGMP binding (GO:0030553),-0.37952181374876587,-0.9620169329485828,0.5139318885448917,0.8377615152049016,1.0,9/11,58.22%,PDE10A;PDE2A;PDE11A;CNGB1;CNGB3;RAPGEF2;CNGA2;CNGA4;CNGA3
prerank,endopeptidase activity (GO:0004175),0.40006091874404637,0.9578337868021234,0.5975975975975976,1.0,1.0,39/257,14.20%,KEL;ESPL1;CTSE;MMP28;MMP24;MMP25;USP1;SENP1;TRABD2B;CASP7;MMP14;USP18;NLN;USP37;TASP1;ADAMTS10;PLAU;ADAMTS5;ADAMTS14;ADAMTS9;HTRA2;PSMB1;ADAMTSL2;USP16;ADAMTS2;ADAMTS16;TPP2;PSMB9;USP28;ADAM17;CASP8;CTSH;ADAMTSL3;USP9X;USP47;ADAM9;ADAM19;HTRA3;ADAMTS1
prerank,growth factor receptor binding (GO:0070851),-0.21881999285203807,-0.9548653165028518,0.6521739130434783,0.848666968504193,1.0,24/95,20.57%,IL1R1;PSEN1;VEGFC;SNX4;PDGFRB;PIBF1;FGF2;NCSTN;ERBB4;TGFA;FGF1;GRB2;PDGFD;SNX2;SDCBP;HIP1;SHC1;VEGFA;VEGFB;LINGO1;VEGFD;IL1RAP;HBEGF;ITGB3
prerank,ligand-gated cation channel activity (GO:0099094),-0.22560084073307526,-0.9545454179518827,0.42857142857142855,0.8430166827934602,1.0,20/75,23.70%,GRIK1;GRIN3A;GRIN2A;KCNJ3;GRIN2B;GRIK4;KCNJ6;KCNN2;CHRNA7;GRIA1;KCNJ10;GRIN1;MCOLN1;GRIA2;KCNK1;KCNJ12;GRIK2;P2RX4;KCNN3;PTK2B
prerank,calcium:sodium antiporter activity (GO:0005432),-0.3886716802653033,-0.9535607467707217,0.5285714285714286,0.8390043241278139,1.0,3/10,5.78%,SLC8A3;SLC24A2;SLC3A2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.39800786985770004,0.9509677600963967,0.613,1.0,1.0,49/254,15.83%,NR2E3;E2F2;MYBL1;E2F3;TFDP1;TFCP2L1;RFXAP;MDM4;NFIA;ZFP62;KLF5;SRF;ELF4;NFIB;HOXC4;ELF1;HOXA7;GMEB1;GRHL2;TCF4;MYBL2;ELK1;FOXO3;PLAGL2;IRF1;HOXB3;PLAGL1;MEOX2;NR4A2;NR3C1;ZNF585B;ZNF585A;RBPJ;NR4A1;SOX9;SMAD4;ATF5;ELK4;YY1;RLF;FOXK2;SMAD3;E2F4;ZNF445;ATF1;HOXB7;ZNF112;NFKB1;TP53
prerank,protein tyrosine phosphatase activity (GO:0004725),0.40637425042661307,0.9497797355668246,0.5526315789473685,1.0,1.0,18/71,17.66%,CDKN3;EYA4;PTPN2;ACP1;CDC25B;CDC25C;CDC25A;EYA2;PTPN21;PTPRS;PTPRA;PTPN13;PTPRU;MTMR3;PTEN;PTPRK;PTPRE;CDC14A
prerank,adenyl nucleotide binding (GO:0030554),-0.37855385329786084,-0.9474002384764796,0.5375,0.8410425063563873,1.0,7/11,33.41%,SIL1;HSPH1;PFN1;HSPBP1;BAG3;GRPEL1;BAG2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.37855385329786084,-0.9474002384764796,0.5375,0.8410425063563873,1.0,7/11,33.41%,SIL1;HSPH1;PFN1;HSPBP1;BAG3;GRPEL1;BAG2
prerank,snRNA binding (GO:0017069),0.4157244408242037,0.9466701702801021,0.5359179019384265,1.0,1.0,12/42,16.59%,COIL;LSM11;DDX39B;TUT1;LSM2;HNRNPU;SNRNP35;SF3B3;DDX21;LSM7;LSM4;PRPF4
prerank,pyrophosphatase activity (GO:0016462),0.4115136719750071,0.9461623213459568,0.5260243632336655,1.0,1.0,13/50,13.59%,DHX9;LHPP;NUDT5;ENPP3;ITPA;PPA1;TRPM2;ENPP1;PLPP1;PLPP5;RNGTT;DXO;NUDT4
prerank,NF-kappaB binding (GO:0051059),0.44778037626670236,0.9459738346175939,0.5424164524421594,1.0,1.0,5/24,12.62%,SETD6;GSK3B;FAF1;HDAC1;HDAC2
prerank,glucuronosyltransferase activity (GO:0015020),0.4567130599726973,0.9458950154734834,0.5227568270481144,1.0,1.0,2/19,6.42%,LARGE1;CHSY1
prerank,phosphotyrosine residue binding (GO:0001784),-0.2620996507074754,-0.9442862838175754,0.5203252032520326,0.8426025535518904,1.0,11/37,14.54%,PIK3R3;PIK3R1;SHE;BCAR3;IRS1;PFN1;ABL1;GRB2;PTPN11;LDLRAP1;SHC1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.46790583734515845,0.9436836992665999,0.5138121546961326,1.0,1.0,5/13,21.18%,BMP6;BMP2;SRC;BMP3;BMP5
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.24345718142194306,-0.9422816993544685,0.62,0.8408493786993523,1.0,16/49,18.81%,PLCXD3;DUSP11;FRA10AC1;DUSP3;PRUNE1;ENPP6;PTPN22;ACP2;PTPRO;GDPD3;ATP1A2;GDPD1;PPP5C;EPHX2;PPP1CB;ACP6
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.44047515755366684,0.9411685779779774,0.5240963855421686,1.0,1.0,6/29,16.56%,SLC25A21;SLC38A7;SLC19A1;SLC25A30;SLC1A5;SLC25A22
prerank,pentosyltransferase activity (GO:0016763),-0.2650696627946696,-0.9409562010771942,0.524822695035461,0.8379230679258245,1.0,9/36,13.03%,UPP2;PARP8;TIPARP;ART3;PARP6;PARP1;SIRT5;QTRT2;PARP16
prerank,RNA binding (GO:0003723),0.3937884876438534,0.9407817256674429,0.778,1.0,1.0,312/1321,18.24%,TOP2A;BRCA1;MKI67;NUSAP1;RAD51AP1;BARD1;KPNA2;ZGRF1;DDX11;HMGB2;RBM15;PNLDC1;ZC3H7A;ILF3;SYNCRIP;SMC1A;NAP1L1;MEX3A;LBR;FLYWCH2;MACF1;SETX;ADK;DEK;MOV10;PABPC4;MYEF2;TRIP6;DGCR8;ROCK2;SREK1;LARP4B;HDGF;AGO2;ANXA2;ZC3HAV1;SRSF4;HNRNPD;TRA2B;CNOT1;BICC1;ALG13;RBFOX2;CSTF3;PATL1;ACTN4;FIP1L1;DNTTIP2;KHDRBS1;PNISR;DNA2;UBAP2;DHX9;PRKDC;DIAPH1;SRBD1;PEG10;HNRNPA1;DDX50;SRF;TNPO1;EIF4E;SRSF10;SARS2;SERBP1;UPF3B;FAM120A;PRPF38B;THRAP3;MAPT;CCAR1;YLPM1;NUDT5;MYH10;LSM3;MBNL3;EIF4ENIF1;RAVER2;EIF4H;SLBP;CTNNA1;HMGN2;G3BP1;EXD1;PSIP1;RBM25;SAMD4A;FNDC3B;CAPRIN1;TPR;NMD3;ERI1;UBE2N;DDX39B;PSPC1;MAP3K20;PRPF40A;FMR1;RRS1;HNRNPH1;TXN;NOSIP;SRSF7;NUCKS1;YBX3;POLR2A;RBMS2;FUS;MEX3C;MATR3;DHX8;RC3H2;DNAJC21;PPIG;RPP40;MRM1;SAP18;CELF2;DARS2;LARP1;TRIM28;TUT1;TUT7;HNRNPUL1;DARS1;PELP1;NQO1;HMGB3;BCLAF1;PPP1R8;WDR33;PRPF3;NOL6;UTP3;MRM3;CPEB2;RBM42;NONO;SF3A2;PUM2;LONP1;MAP4;SRPRA;PRRC2B;HMGB1;MARK2;PCF11;HOXB6;RANGAP1;MRTO4;NOL11;DDX18;LSM2;SCAF8;SRSF3;SFPQ;HNRNPU;FASTKD5;YTHDF2;RBPMS2;TAF15;RARS2;SAMSN1;MRPL13;RBM15B;HNRNPL;SRPK1;SRRM1;CRKL;CPSF4;DHX37;CHD2;RPP30;EZR;GANAB;POP1;ESF1;SNRNP35;FAM32A;HTATSF1;ERH;SUGP2;EXOSC7;HNRNPUL2;COA6;EIF3C;SUMO2;RBMS3;DAP3;HNRNPH2;TSR1;FUBP1;MRPL1;TES;RPS17;SSRP1;HDAC2;NOM1;PPP1CC;ILF2;MEX3B;SIDT1;DUT;TCF20;PPAN;MEX3D;DXO;POLR1G;CAST;PTBP2;TUT4;RBM4;PPRC1;DHFR;DDX56;DDX21;LARP4;NUDT4;LSM7;SRP72;DRG2;DAZAP1;EIF1AX;SMG6;STRBP;YY1;RC3H1;ERI3;WBP4;EIF4A2;HLTF;TRMT2A;RBMS1;PRRC2A;NOL12;PABPC1;SNTB2;MAK16;EPRS1;EWSR1;AQR;LUC7L3;ZC3H14;TFB1M;SECISBP2;KIN;RBM19;HNRNPA2B1;ZC3H7B;FXR1;CKAP4;ADD1;GNL3;ACO1;LSM4;IPO5;HELB;PPIL4;UNK;DDX1;ZCCHC8;NUP42;CNOT4;RBM27;ZC3H18;RCC2;CISD2;LARP1B;PNPT1;TEP1;PURA;RALY;MSN;RPL22L1;AKAP1;METTL3;KHNYN;DENR;STXBP1;DHX38;SRP9;NUP98;MRPS24;UNC50;RBM10;PYM1;HNRNPLL;FCF1;PHF6;BZW1;MRPL45;TPD52L2;EDC3;ZC3H8;ASCC3;EIF3H;ZNF346;USO1;SRPK2;LUC7L2;ABT1;CWC22;MRPL42;PKN2;MRPL37;MRPL2;DDX10;MRPL20;RPL34;BUD13;GPATCH4;DDX59
prerank,mRNA binding (GO:0003729),0.3926802075077072,0.9402860541311394,0.6406406406406406,1.0,1.0,69/249,17.41%,TYMS;RBM15;SYNCRIP;PABPC4;MYEF2;LARP4B;AGO2;SRSF4;TRA2B;RBFOX2;CSTF3;KHDRBS1;DHX9;SRBD1;SERBP1;UPF3B;MYH10;EIF4ENIF1;SLBP;G3BP1;RBM25;SAMD4A;TPR;FMR1;YBX3;RBMS2;RC3H2;CELF2;LARP1;TUT1;RNF40;PPP1R8;CPEB2;PUM2;PCF11;SCAF8;HNRNPU;YTHDF2;RBPMS2;MRPL13;HNRNPL;SNRNP35;RBMS3;FUBP1;DXO;PTBP2;RBM4;DHFR;LARP4;DAZAP1;RC3H1;RBMS1;PABPC1;AQR;LUC7L3;SECISBP2;HNRNPA2B1;FXR1;GNL3;ACO1;UNK;TP53;METTL3;KHNYN;DENR;NUP98;ANGEL2;HNRNPLL;EDC3
prerank,actin monomer binding (GO:0003785),-0.29268054149313566,-0.9399374561812528,0.5619047619047619,0.8340674807489099,1.0,6/22,16.18%,TMSB4X;NOS3;PFN1;ABL1;TMSB10;MTSS1
prerank,BMP receptor binding (GO:0070700),0.4679191221281469,0.9380241820169526,0.5070621468926554,1.0,1.0,5/12,21.18%,BMP6;BMP2;SRC;BMP3;BMP5
prerank,filamin binding (GO:0031005),0.4756858760497059,0.9366676003106637,0.5535444947209653,1.0,1.0,4/11,12.87%,RFLNA;DPYSL4;DPYSL3;SYNPO2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.3542025219544276,-0.9349341814557834,0.5555555555555556,0.8398384561944068,1.0,6/12,18.25%,PIK3R3;PIK3C2B;ATM;PIK3R6;PIK3CD;PIK3CA
prerank,store-operated calcium channel activity (GO:0015279),-0.3755314063058353,-0.9319240369786024,0.5512820512820513,0.8411253887344456,1.0,3/10,10.27%,TRPC5;TRPC3;TRPC1
prerank,protein kinase inhibitor activity (GO:0004860),0.4142551436653056,0.9311015632041171,0.5545350172215844,1.0,1.0,12/42,20.66%,CIT;CEP43;PARVA;NCK1;SPRED1;CDKN1B;QARS1;RPTOR;SPRED2;SH3BP5;TRIB1;SNCA
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4096890116374206,0.9304828019283867,0.531322505800464,1.0,1.0,12/37,16.27%,CARS2;SARS2;VARS1;DARS2;DARS1;IARS2;TARS2;PARS2;RARS2;EPRS1;QARS1;LARS1
prerank,voltage-gated potassium channel activity (GO:0005249),-0.2194672102189804,-0.9297726858184475,0.625,0.8405561550772565,1.0,14/80,13.30%,KCNC2;HCN1;KCNB1;KCNJ3;KCNQ3;KCNH1;KCNJ6;KCNN2;KCNS3;KCNH7;KCNJ10;KCNA6;KCNA2;KCNT1
prerank,myosin II binding (GO:0045159),0.4844697986085574,0.9292863583060252,0.5442278860569715,1.0,1.0,3/10,9.28%,TRIOBP;STXBP5;LLGL2
prerank,cysteine-type peptidase activity (GO:0008234),0.39904792461975996,0.9288786185105288,0.5850052798310454,1.0,1.0,20/73,19.02%,ESPL1;USP1;CASP7;USP18;USP37;USP21;USP16;USP28;CASP8;CTSH;USP9X;USP47;OTUD7B;SFRP1;GGH;USP48;USP14;ATG4C;USP46;USP20
prerank,Toll-like receptor binding (GO:0035325),-0.3722374794427595,-0.9264991727884146,0.5574712643678161,0.8422337086531128,1.0,9/11,48.24%,UNC93B1;TIRAP;TOLLIP;MYD88;CD36;TLR6;TLR1;S100A9;TLR2
prerank,cholesterol transfer activity (GO:0120020),0.4576028028038315,0.9260907480432549,0.5438829787234043,1.0,1.0,1/16,1.29%,GRAMD1C
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.40026064100572256,0.9257863290024463,0.5521064301552107,1.0,1.0,11/55,10.75%,ATP2B4;ANXA9;ANXA2;ITPR1;PKD2L2;CUL5;MCU;ATP2A2;SLC24A3;TRPM2;ATP2B1
prerank,pyridoxal phosphate binding (GO:0030170),0.4347566418149512,0.9256334934739391,0.5465425531914894,1.0,1.0,6/20,19.92%,PDXK;PYGB;AGXT;ABAT;ACCS;PYGL
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4512242211792967,0.925556545775981,0.5480378890392422,1.0,1.0,6/15,15.83%,LPCAT1;AGPAT2;LCLAT1;AGPAT3;AGPAT1;ABHD4
prerank,voltage-gated anion channel activity (GO:0008308),-0.32973478899128733,-0.924987709261562,0.5492424242424242,0.839546932551523,1.0,4/15,9.49%,ANO6;ANO1;GPR89B;GPR89A
prerank,tRNA methyltransferase activity (GO:0008175),-0.32766416020912115,-0.9243202874928017,0.5197132616487455,0.8354012754200031,1.0,7/16,35.54%,TRMT9B;THUMPD3;LCMT2;TRMT44;TYW3;TRMT12;BCDIN3D
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.4137172457952122,0.922991268127419,0.5430303030303031,1.0,1.0,1/30,0.69%,BIRC5
prerank,thioesterase binding (GO:0031996),0.4816803405163265,0.9223077579991396,0.5492537313432836,1.0,1.0,5/11,21.77%,HAUS7;RAC1;TRAF6;TRAF2;TRAF4
prerank,epidermal growth factor receptor binding (GO:0005154),-0.27681380202371136,-0.9222923479062298,0.6084656084656085,0.8343780741356489,1.0,9/25,20.19%,SNX4;ERBB4;TGFA;GRB2;SNX2;HIP1;SHC1;LINGO1;HBEGF
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.45915909372601643,0.9208397890647101,0.5521557719054242,1.0,1.0,5/13,14.68%,LPCAT1;AGPAT2;LCLAT1;AGPAT3;AGPAT1
prerank,outward rectifier potassium channel activity (GO:0015271),0.46143960736097817,0.920489738352872,0.5487256371814093,1.0,1.0,3/11,16.35%,KCNK2;PKD2;KCNT2
prerank,zinc ion binding (GO:0008270),0.3824641656841114,0.9178399891895181,0.686,1.0,1.0,51/293,15.83%,UHRF1;TK1;ACMSD;GLI2;BAZ1B;RASSF1;UPB1;CTCF;ZEB1;ADA;PRIMPOL;LVRN;MDM4;MBD1;MYCBP2;PAM;BLM;SORD;PTGR2;PDXK;ENPP2;SMPDL3A;ENPP3;PHF2;TRIM28;KDM2B;ZFYVE1;USP16;CDA;DUSP12;APIP;KMT2A;CXXC5;TRHDE;LIMS1;ENPP1;CALB1;ZDHHC15;TES;SEC24D;RC3H1;SMPD1;KDM5C;SMAD3;CA2;EPRS1;RBAK;NPEPPS;KAT6A;LANCL1;TP53
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.4643104219863547,0.9177122660100282,0.5402298850574713,1.0,1.0,4/12,10.48%,TGFBR3L;BMPR1A;TGFBR3;TGFBR1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4663320200586259,0.9170838823331756,0.5407407407407407,1.0,1.0,5/12,24.19%,TRIM37;TRAF6;TRAF2;TRAF4;BABAM2
prerank,cysteine-type endopeptidase activity (GO:0004197),0.38974005977892234,0.9163291264350232,0.5987525987525988,1.0,1.0,18/78,19.02%,ESPL1;USP1;CASP7;USP18;USP37;CAPN15;USP16;USP28;CASP8;CTSH;USP9X;USP47;CAPN5;SFRP1;USP48;USP14;USP46;USP20
prerank,peptide hormone receptor binding (GO:0051428),-0.37086818429194257,-0.9145196277935592,0.5429447852760736,0.8464128523079428,1.0,4/11,34.41%,PSMC5;PTHLH;ADCYAP1;GNRH1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.45437201315286874,0.9141425776807705,0.5328671328671328,1.0,1.0,1/13,2.38%,GPSM2
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.24242277270653817,-0.913418771037829,0.625,0.8430635483233817,1.0,6/49,3.34%,PLA2G4A;CPNE8;PCLO;MCTP1;ANXA6;SYT1
prerank,TBP-class protein binding (GO:0017025),0.4216450496359718,0.9126231753103998,0.554089709762533,1.0,1.0,10/21,21.65%,PSMC2;TAF12;GTF2A1;AHR;RUVBL2;YEATS2;DR1;DRAP1;GTF2B;GTF2A2
prerank,palmitoyltransferase activity (GO:0016409),-0.2675614821197232,-0.9122835416384965,0.6060606060606061,0.839942747670366,1.0,11/28,23.28%,GLUL;ZDHHC5;ZDHHC1;ZDHHC13;ZDHHC7;ZDHHC8;GOLGA7;ZDHHC16;ZDHHC20;ZDHHC4;ZDHHC17
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.46906281995758103,0.9121081123116856,0.5620542082738944,1.0,1.0,5/12,19.35%,SLC19A1;SLC25A25;SLC25A42;SLC25A17;SLC25A5
prerank,kinase activity (GO:0016301),0.38512142529204,0.9105423348859016,0.6319018404907976,1.0,1.0,29/109,17.97%,MASTL;MAP4K4;GSK3B;PMVK;PDXK;IPMK;EPHA4;PAPSS2;LRRK2;FN3K;PPIP5K1;PIK3CB;IP6K2;DGKE;SEPHS1;PANK4;AGK;PKMYT1;PRKD1;PANK2;MVK;TAOK1;TRRAP;STK39;RFK;GK5;PI4KB;GK;PKN2
prerank,glucose transmembrane transporter activity (GO:0005355),-0.3208107871033884,-0.910441271788477,0.5760869565217391,0.838491839010093,1.0,5/17,29.16%,SLC2A1;SLC2A3;SLC2A10;SLC5A11;SLC5A3
prerank,monocarboxylic acid binding (GO:0033293),0.43702059173977853,0.9100318567746725,0.5466155810983397,1.0,1.0,1/18,3.24%,CYP26B1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.2968034608752951,-0.906566938332176,0.5528455284552846,0.8414597238258846,1.0,9/21,19.40%,AKAP8L;RYR2;AKAP6;GSKIP;AKAP7;ARFGEF2;ARFGEF1;AKAP8;KCNQ1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.47099948754831017,0.9059846348751007,0.5863141524105754,1.0,1.0,2/10,9.83%,NOX4;CYBB
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.33706554936430844,-0.9051404956561726,0.5559701492537313,0.8387807288479611,1.0,5/13,31.59%,SREBF2;ECH1;IDI1;MIF;EBP
prerank,protein phosphatase activator activity (GO:0072542),0.45671132190839314,0.9041628172435718,0.5702005730659025,1.0,1.0,6/13,20.13%,PPP2R5C;CALM2;PTPA;PPP2R5B;IGFBP3;PHACTR4
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.2873503915664948,-0.9007725508536132,0.5727272727272728,0.8424907288144888,1.0,5/21,25.13%,GLRB;CHRNA7;GRIK2;P2RX4;P2RX7
prerank,GTPase binding (GO:0051020),0.3763953850329554,0.9004072980884386,0.6953907815631263,1.0,1.0,41/195,14.60%,BIRC5;USP6NL;IQGAP2;RANGRF;TRIOBP;EXOC4;EVI5L;MYCBP2;OCRL;MYO1C;AFDN;MLPH;FGD4;BICD2;CDC42EP2;STOML2;YBX3;RAB29;FGD1;GCC1;ANKRD27;LRRK2;GOLGA5;TBC1D7;PICALM;ERC1;MAPKAP1;RANGAP1;SRGAP2;LSM2;MYO9B;FGD6;NDRG1;RAPGEF4;ABCA1;CHM;RANBP2;EHD1;EXOC8;EPRS1;DOCK7
prerank,RNA cap binding (GO:0000339),0.44045216160473777,0.9003087069657529,0.5538461538461539,1.0,1.0,3/16,8.17%,AGO2;EIF4E;LARP1
prerank,adenylyltransferase activity (GO:0070566),0.42522977108663407,0.8998043690740304,0.5676020408163265,1.0,1.0,8/21,20.26%,TENT2;TENT4A;TUT1;PAPOLB;NMNAT1;COASY;GPHN;NMNAT2
prerank,NAD binding (GO:0051287),0.4116273902168573,0.8995428722342875,0.5721331689272503,1.0,1.0,5/26,10.39%,ZC3HAV1;CTBP1;SORD;ALDH1A1;PARP9
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.29476845738037477,-0.8988756114139573,0.6225490196078431,0.8409330820484248,1.0,6/20,15.02%,SLC39A10;SLC39A13;SLC39A7;SLC30A1;SLC30A4;SLC39A1
prerank,ligand-gated calcium channel activity (GO:0099604),0.427065408948997,0.8988565446621097,0.5551128818061088,1.0,1.0,6/19,12.52%,ITPR1;RASA3;TRPA1;TRPM2;ITPR3;TRPM4
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.44898834264881016,0.8986553365145229,0.5757142857142857,1.0,1.0,6/12,24.55%,FXN;XDH;CISD2;ISCA2;SDHB;CIAPIN1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.3254601074464418,-0.8972538677660242,0.5849673202614379,0.8391608602611447,1.0,5/14,15.85%,SLC1A2;SLC25A13;SLC25A12;SLC17A6;SLC1A1
prerank,steroid hydroxylase activity (GO:0008395),0.4352672660352664,0.8964021159095554,0.5655737704918032,1.0,1.0,1/16,2.73%,CYP39A1
prerank,sterol transfer activity (GO:0120015),0.4396360087543816,0.8956470658454136,0.562992125984252,1.0,1.0,1/17,1.29%,GRAMD1C
prerank,growth factor activity (GO:0008083),-0.21481320992277372,-0.8952084646898623,0.6607142857142857,0.83797528840939,1.0,18/74,24.36%,NRG3;VEGFC;JAG1;FGF2;IGF2;TGFA;GRN;FGF1;VEGFA;JAG2;VEGFB;INHBA;VEGFD;CSPG5;HBEGF;BDNF;FGF10;FGF7
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.25505249601466107,-0.8933825669136733,0.684931506849315,0.8363509864960201,1.0,21/35,37.13%,TRMT9B;DTWD2;PUS10;AARS1;QTRT2;PTRH2;QTRT1;NT5C3A;LCMT2;DTWD1;ALKBH1;DUS3L;ELAC2;QRSL1;MRPL58;GATC;TYW3;TRMT12;BCDIN3D;TRPT1;DUS2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.4756747628539396,0.8925816656115851,0.5863095238095238,1.0,1.0,4/10,22.21%,PML;ANKRD13D;DNAJB2;DAXX
prerank,cell adhesion mediator activity (GO:0098631),-0.28174833172244185,-0.8918590266930085,0.6180904522613065,0.8347185866398273,1.0,8/24,19.11%,BSG;CNTN6;ESAM;BCAM;CNTN2;NTNG1;NEXN;ROBO4
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.39104534063966884,0.8917576380196222,0.576036866359447,1.0,1.0,18/35,25.42%,AGO2;POU2F1;SMARCA4;NR3C1;GTF2A1;HDAC1;TAF4;RUVBL2;DR1;TP53;DRAP1;FOXP1;GTF2B;UBTF;H3-3A;SMARCB1;RELA;BAZ2A
prerank,active ion transmembrane transporter activity (GO:0022853),-0.23849989946969913,-0.8898687812476221,0.6918238993710691,0.8338601802146077,1.0,7/37,8.12%,SLCO1C1;SLC22A8;SLCO2B1;COX4I1;COX5A;SLCO2A1;SLC22A6
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.4405013334025131,0.8897286958016349,0.5850144092219021,1.0,1.0,3/14,9.83%,NOX4;KMO;CYBB
prerank,alkali metal ion binding (GO:0031420),0.43653288166005455,0.8894761240451804,0.6022727272727273,1.0,1.0,3/13,10.90%,PDXK;ACAT1;DRG1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3858418549098054,0.8879673041994748,0.5874049945711184,1.0,1.0,12/49,18.55%,RAD18;ZRANB3;RNF168;UIMC1;AGAP3;IKBKG;BRCC3;OTUD7B;RNF169;RAD23B;EPS15;ZBTB1
prerank,nuclear receptor binding (GO:0016922),0.37358620455074343,0.8862097234409362,0.6459183673469387,1.0,1.0,34/111,20.24%,TRIP6;CNOT1;MED14;ACTN4;ASXL1;THRAP3;LCOR;TCF7L2;MED30;ARID1A;MED24;SMARCA4;ZNHIT3;NR4A2;MMS19;NCOA2;GRIP1;PRKCB;TRIP12;NR4A1;NCOA7;PPID;MED1;SMAD3;JMJD1C;DCAF1;BRD8;TAF10;FOXP1;ARID5A;MED16;GTF2B;MED25;RNF14
prerank,ubiquitin protein ligase binding (GO:0031625),0.37249349574228846,0.886135580746499,0.754,1.0,1.0,37/254,11.40%,BRCA1;UBE2T;RAD18;SMC6;TRIM37;RB1;TRIOBP;GSK3B;UBE2K;GPI;NLK;CHEK2;FAF1;RPA2;SLF1;CXCR4;FANCL;ARRB1;PML;FBXW7;UBE2N;CUL5;POLR2A;RNF31;TRIM28;RNF40;MFN2;SMAD6;CUL3;AXIN2;CUL4B;PSMD1;IKBKG;HERC2;UBOX5;ARRDC1;BAG5
prerank,R-SMAD binding (GO:0070412),0.4285496107717644,0.8844181384859299,0.5867549668874172,1.0,1.0,7/18,19.38%,PMEPA1;SMAD6;SMURF1;SMAD4;SMAD3;SMAD2;PPM1A
prerank,inward rectifier potassium channel activity (GO:0005242),-0.2774595336326231,-0.883605935257343,0.6507177033492823,0.8408964792520489,1.0,10/24,30.85%,KCNJ3;KCNJ6;KCNN2;KCNJ10;KCNK1;KCNJ12;KCNN3;ABCC9;KCNJ8;KCNJ15
prerank,transition metal ion binding (GO:0046914),0.3695161669326763,0.8834698618949383,0.79,1.0,1.0,65/397,15.50%,UHRF1;TK1;ACMSD;GLI2;LOXL3;LOXL2;BAZ1B;RASSF1;UPB1;CTCF;ZEB1;LARGE1;B4GALT1;ADA;PRIMPOL;LVRN;MDM4;MBD1;MYCBP2;PAM;TDP2;GALNT1;BLM;PRNP;SORD;PTGR2;PDXK;ENPP2;AGMO;SMPDL3A;ENPP3;PHF2;B4GALT7;TRIM28;KDM2B;SOD3;TYR;ZFYVE1;USP16;CDA;DUSP12;PIM1;MPPED2;APIP;KMT2A;CXXC5;TRHDE;LIMS1;ENPP1;CALB1;COA6;ZDHHC15;GYG1;TES;SEC24D;RC3H1;SMPD1;KDM5C;SMAD3;CA2;EPRS1;RBAK;NPEPPS;KAT6A;LANCL1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4634566447050247,0.8830482541134871,0.5915080527086384,1.0,1.0,4/11,17.43%,SLC19A1;SLC25A25;SLC25A42;SLC25A17
prerank,1-phosphatidylinositol binding (GO:0005545),0.4374102838395329,0.8826331688497857,0.6088154269972452,1.0,1.0,8/15,22.50%,SESTD1;ZFYVE16;ZFYVE1;PICALM;ZFYVE9;SNAP91;EEA1;SNX9
prerank,diacylglycerol kinase activity (GO:0004143),-0.3555620928456053,-0.8813331347671616,0.6018518518518519,0.8404056894026867,1.0,6/11,24.52%,DGKB;DGKG;DGKI;DGKQ;DGKD;DGKK
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.3657314325319401,-0.8810334292823295,0.6210191082802548,0.8357846991463453,1.0,2/10,15.78%,SLC6A1;SLC6A11
prerank,N-acyltransferase activity (GO:0016410),0.39077227750244714,0.8781525044907493,0.5974025974025974,1.0,1.0,3/32,3.19%,NAT14;CERS6;CERS5
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.29224130262378345,-0.8731612928754284,0.6228070175438597,0.846947687405975,1.0,10/19,29.62%,NRG3;GAS6;GRM5;DGKQ;AFAP1L2;EFNA5;EGF;ERBB3;PAK2;CD24
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.4118790773101355,0.8729946368739945,0.5732323232323232,1.0,1.0,6/22,15.45%,ZRANB3;RNF168;UIMC1;IKBKG;OTUD7B;RNF169
prerank,phosphoric diester hydrolase activity (GO:0008081),0.39277647232091667,0.87216791484887,0.6049528301886793,1.0,1.0,12/35,18.26%,APEX2;TDP2;ENPP2;SMPDL3A;ENPP3;MPPED2;ENPP1;SMPD1;PLCB4;SMPD3;GDE1;SMPD2
prerank,neuropeptide receptor binding (GO:0071855),0.44118039743321397,0.8705459841050859,0.5972027972027972,1.0,1.0,1/14,3.51%,AGRP
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.31001175481135984,-0.8684798924463634,0.6413793103448275,0.8518638755196772,1.0,5/15,15.85%,SLC1A2;SLC25A13;SLC25A12;SLC17A6;SLC1A1
prerank,RNA polymerase II complex binding (GO:0000993),0.3894026025740325,0.8633931142565245,0.6266195524146054,1.0,1.0,8/32,12.85%,AGO2;DHX9;ELOF1;PCF11;SCAF8;HNRNPU;RPRD1A;BRD4
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.3587735265220273,-0.8618046421503717,0.6758409785932722,0.860266273957341,1.0,4/10,8.12%,SLCO1C1;SLCO2B1;SLCO2A1;SLC22A6
prerank,nucleotide diphosphatase activity (GO:0004551),-0.31675082603967736,-0.8616002019177478,0.6564625850340136,0.8554999714114305,1.0,6/14,22.66%,FHIT;NUDT3;ENPP4;ENPP5;NUDT6;NUDT12
prerank,androgen receptor binding (GO:0050681),-0.2732747351786148,-0.8613820874870617,0.6818181818181818,0.85072756033003,1.0,8/25,20.34%,EP300;PRPF6;PRMT2;KDM4C;DDX5;TGFB1I1;PARK7;SNW1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.2465065552525661,-0.8603102602541294,0.732484076433121,0.8480602792275147,1.0,10/32,23.52%,SLC6A6;SFXN2;SLC3A2;SLC7A5;SLC1A1;SLC38A5;SLC25A38;SFXN3;SLC36A1;SLC6A7
prerank,heme binding (GO:0020037),0.36838964021647913,0.8577054676844919,0.668824163969795,1.0,1.0,12/65,18.39%,DGCR8;CYP26B1;PTGES2;NOX4;PGRMC2;CYBB;CYB5B;HCCS;SRC;CYB5A;THAP4;PTGIS
prerank,endoribonuclease activity (GO:0004521),-0.2479256172237888,-0.8567752761831391,0.6967741935483871,0.8501779059366572,1.0,13/32,27.69%,AGO1;AGO3;NYNRIN;DICER1;RIDA;ENDOV;ZC3H12A;EXOG;NOB1;TSNAX;RNASEL;INTS11;ZC3H12B
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.3086446341831083,-0.8560264425244998,0.6408450704225352,0.8466895883217206,1.0,6/15,18.25%,PIK3R3;PIK3C2B;ATM;PI4KA;PIK3CD;PIK3CA
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.29354255106111055,-0.8558306242829028,0.6983471074380165,0.8371744647885166,1.0,7/17,27.95%,EPHA5;EPHB2;EPHA8;EFNB3;EPHB4;EPHA2;EPHB3
prerank,ephrin receptor activity (GO:0005003),-0.29354255106111055,-0.8558306242829028,0.6983471074380165,0.8371744647885166,1.0,7/17,27.95%,EPHA5;EPHB2;EPHA8;EFNB3;EPHB4;EPHA2;EPHB3
prerank,UDP-glycosyltransferase activity (GO:0008194),0.36406410652439,0.8549633001141376,0.6670135275754423,1.0,1.0,6/70,6.42%,HAS3;HYAL1;LARGE1;B4GALT1;B3GNT8;CHSY1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3975813888871019,0.8548449530617354,0.6217228464419475,1.0,1.0,4/27,7.46%,TENT2;POLR1A;POLR1B;POLR2A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.341816229259885,-0.8544734360532925,0.6646525679758308,0.8347949127866043,1.0,2/11,20.20%,DDAH2;PADI2
prerank,ATPase regulator activity (GO:0060590),-0.23544252734064253,-0.8492707783560204,0.7368421052631579,0.8398629542262102,1.0,8/38,10.63%,ATP1B1;DNAJC24;DNAJC19;SIL1;DNAJA1;HSPH1;ATP1B3;PFN1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.42121435470440016,0.8491897324351729,0.6181818181818182,1.0,1.0,2/14,14.10%,CAPN15;CAPN5
prerank,calcium channel inhibitor activity (GO:0019855),0.4408826164932772,0.8485635926810892,0.6134699853587116,1.0,1.0,3/11,10.93%,ITPR1;MCUB;CALM2
prerank,metalloaminopeptidase activity (GO:0070006),0.4216459777174364,0.8477332535952447,0.6292749658002736,1.0,1.0,4/16,15.05%,MMP14;LVRN;TRHDE;NPEPPS
prerank,metalloexopeptidase activity (GO:0008235),0.3696287679073932,0.846563004271389,0.6548279689234184,1.0,1.0,11/51,18.08%,VASH2;MMP14;LVRN;AGBL2;CPXM1;CPQ;TRHDE;NPEPPS;AGTPBP1;METAP1;DPEP1
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.29232650557276685,-0.8440290362014892,0.6378600823045267,0.8444311349915175,1.0,5/17,25.11%,ACOT11;PPT1;ACOT7;ACOT13;ACOT6
prerank,MAP kinase phosphatase activity (GO:0033549),-0.32229198502087814,-0.8438771617481521,0.632258064516129,0.8399846316627977,1.0,4/12,28.16%,DUSP3;DUSP1;DUSP8;DUSP6
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.4249030367654656,0.8436253065742657,0.6160458452722063,1.0,1.0,4/14,17.41%,MINDY4;USP9X;OTUD7B;MINDY3
prerank,carboxypeptidase activity (GO:0004180),0.3765342253203176,0.8410000634936803,0.6358313817330211,1.0,1.0,4/35,9.15%,VASH2;AGBL2;CPXM1;SCPEP1
prerank,GABA receptor binding (GO:0050811),0.427940530834751,0.8356644918450465,0.6555386949924128,1.0,1.0,1/11,3.22%,TRAK1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.34896981651102893,0.8334817737746991,0.7847082494969819,1.0,1.0,31/181,14.43%,RBL1;SETD6;RB1;MIER1;RBBP8;GSK3B;DDRGK1;ACTN4;DHX9;BHLHE41;FAF1;MKKS;TCF7L2;ARID1A;ELK1;SMARCA4;MIER3;MTA3;PARP9;TAL1;TEAD3;NCOA2;HDAC1;TAF4;RBPJ;HDAC2;NCOA7;HEY2;MED1;SMAD3;ARNT
prerank,glycerophospholipid flippase activity (GO:0140333),0.43715102358870667,0.8330441938885924,0.6651515151515152,1.0,1.0,2/11,4.57%,ABCA4;ABCB4
prerank,transcription coactivator binding (GO:0001223),0.3912855816430911,0.8314288731922794,0.617948717948718,1.0,1.0,5/20,14.34%,CIT;AHR;SMAD4;RORA;SMAD3
prerank,RNA polymerase core enzyme binding (GO:0043175),0.37602946273274473,0.8273194856192991,0.653755868544601,1.0,1.0,8/33,12.67%,AGO2;DHX9;ELOF1;PCF11;SCAF8;HNRNPU;SPTY2D1;RPRD1A
prerank,mRNA 5'-UTR binding (GO:0048027),0.39132555050585766,0.8261901616890532,0.6641883519206939,1.0,1.0,4/24,8.17%,SYNCRIP;MYH10;FMR1;LARP1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.40625482426471726,0.8218688432722664,0.6602209944751382,1.0,1.0,5/14,18.34%,CASP8AP2;APAF1;CTSH;BCL2L13;BAD
prerank,phosphatidylinositol binding (GO:0035091),0.34611141516692234,0.8207711122741862,0.7349896480331263,1.0,1.0,30/91,22.50%,ITPR1;NUMA1;SNX1;PARD3B;MAPT;SESTD1;ZFYVE16;ZFYVE1;PICALM;SNX27;PITPNB;PIGU;AIDA;APPL2;ITPR3;DENND1A;MITD1;EXOC8;C2CD2L;PASK;PLEKHF2;ZFYVE9;DPEP1;SNAP91;EEA1;MYO1E;GPAA1;APPL1;PHF12;SNX9
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.38685320474833024,0.8195709457980026,0.6295336787564767,1.0,1.0,5/20,14.68%,LPCAT1;AGPAT2;LCLAT1;AGPAT3;AGPAT1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.3960275159902602,0.8189751880900729,0.6208791208791209,1.0,1.0,4/15,15.58%,SETD3;KMT2A;KMT2D;SETD4
prerank,cell-cell adhesion mediator activity (GO:0098632),0.3619936567839712,0.8171070718130934,0.6692737430167598,1.0,1.0,11/42,17.29%,ANXA2;RAB10;DSCAML1;DSCAM;ANXA1;EMB;PDLIM5;BAIAP2L1;TMOD3;SIRPA;CD47
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3639392777616816,0.8158024083025973,0.6770472895040369,1.0,1.0,8/38,12.29%,SPAG9;FRS2;LRRK2;NCK1;MMS19;GRIP1;MAPK8IP3;NCK2
prerank,ribosomal small subunit binding (GO:0043024),0.40766237999494487,0.8156589856943136,0.6484268125854993,1.0,1.0,4/17,9.42%,EIF4H;LARP1;CPEB2;PIM1
prerank,receptor ligand activity (GO:0048018),0.3410896158979252,0.8155006470770924,0.8353413654618473,1.0,1.0,16/245,11.40%,TNFSF13B;HMGB2;ARTN;ERFE;WNT2B;BMP6;IL18;INSL6;FAM3C;SFRP2;WNT6;HMGB1;AGT;EDA;CNTF;BMP2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.42823691602490227,0.8135628361043945,0.6656534954407295,1.0,1.0,5/10,24.93%,SIRPA;CD47;DSG2;CXADR;CD200
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4238359926455749,0.8128207775714044,0.6756352765321375,1.0,1.0,3/10,16.84%,B4GALT1;B4GALT7;B3GALT2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.402392104789773,0.8121219076902101,0.6578947368421053,1.0,1.0,3/11,12.13%,ITPR1;TRPC7;ITPR3
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.3224544900269186,-0.8111467740131364,0.7027027027027027,0.8960776429279134,1.0,4/11,29.16%,SLC2A10;SLC5A11;SLC2A9;SLC5A3
prerank,I-SMAD binding (GO:0070411),0.4131451610134963,0.8099907970968206,0.6830985915492958,1.0,1.0,6/13,17.83%,SMAD6;SMURF1;TGFBR1;SMAD4;SMAD3;SMAD2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.3850654567824868,0.8075002036078952,0.6590909090909091,1.0,1.0,4/18,10.48%,TGFBR3L;BMPR1A;TGFBR3;TGFBR1
prerank,translation elongation factor activity (GO:0003746),-0.29615343786308423,-0.8031015071194635,0.6983606557377049,0.9048133416641567,1.0,5/14,25.03%,EEF1A1;EEF2;EEF1B2;TSFM;EIF5A2
prerank,DNA-binding transcription factor binding (GO:0140297),0.33778370562074617,0.8017887434201225,0.8346693386773547,1.0,1.0,41/189,19.41%,RBL1;CBX5;RB1;MIER1;RBBP8;GSK3B;DDRGK1;DHX9;FHL2;BHLHE41;SRF;EIF4E;CTBP1;MKKS;TCF7L2;ELK1;MIER3;YAP1;HMGB1;MTA3;CXXC5;TAL1;RUNX1T1;TEAD3;HDAC1;RBPJ;HDAC2;TWIST1;HEY2;TLE4;SMAD3;TLE3;TP53;PURA;RERE;SMAD2;EGR2;RBL2;ZFPM2;SKI;ZFPM1
prerank,gap junction channel activity (GO:0005243),0.39005900922338577,0.801769287084505,0.6765083440308087,1.0,1.0,3/22,12.35%,GJD3;GJC1;GJA1
prerank,endopeptidase activator activity (GO:0061133),0.41179269128969787,0.8016744690808315,0.6853035143769968,1.0,1.0,3/10,20.44%,PSMD14;ADRM1;PSME3
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3201167444957586,-0.7999145467824516,0.7287066246056783,0.9048680014973258,1.0,2/12,14.38%,SLC2A1;SLC2A3
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3285445990949209,-0.7966437010974549,0.7178683385579937,0.905528081558047,1.0,4/10,22.03%,ANO6;ANO1;CLCN2;CLCN4
prerank,wide pore channel activity (GO:0022829),0.3843133600632491,0.7959258658987709,0.6848101265822785,1.0,1.0,3/23,12.35%,GJD3;GJC1;GJA1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.4130936654939311,0.7948767512133967,0.6755952380952381,1.0,1.0,2/10,12.75%,CASP7;CASP8
prerank,cyclic nucleotide binding (GO:0030551),-0.25673973789535376,-0.7932844791084658,0.7455357142857143,0.9061222350515207,1.0,6/21,18.60%,HCN1;KCNH1;CNBD2;PDE10A;PDE2A;PDE4D
prerank,alanine transmembrane transporter activity (GO:0022858),-0.3041372634851618,-0.7921996681941353,0.7714285714285715,0.902864093750102,1.0,2/12,5.78%,SLC6A6;SLC3A2
prerank,acid-thiol ligase activity (GO:0016878),0.39971118220851093,0.7915247022601147,0.6902404526166902,1.0,1.0,2/13,14.01%,ACSS1;AACS
prerank,calcium activated cation channel activity (GO:0005227),0.38292050526485,0.7904029812026098,0.6785714285714286,1.0,1.0,5/17,14.78%,KCNN4;KCNMB2;KCNMB3;TRPM4;KCNMB4
prerank,tRNA binding (GO:0000049),-0.21065826429455836,-0.7872570266642416,0.8297872340425532,0.9059084695754274,1.0,16/43,30.20%,EEF1A1;TRMT9B;AARS1;NSUN2;SARS1;DALRD3;TRMT10B;KARS1;TRMT10A;IGHMBP2;RPUSD4;ALKBH1;YARS2;PTCD1;YRDC;XPOT
prerank,potassium ion leak channel activity (GO:0022841),0.3847649981543773,0.786613636979832,0.6717241379310345,1.0,1.0,3/15,12.53%,KCNK2;KCNK12;KCNK6
prerank,sulfuric ester hydrolase activity (GO:0008484),0.39056691060148074,0.7848959707876115,0.6920821114369502,1.0,1.0,5/12,19.28%,SULF2;SULF1;ARSB;ARSI;ARSG
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.35184410703297797,0.7845224738695836,0.6864801864801865,1.0,1.0,11/33,21.25%,AGO2;DHX9;ELOF1;PCF11;SCAF8;HNRNPU;RPRD1A;DRAP1;RPRD1B;GTF2B;SMYD2
prerank,NADP binding (GO:0050661),0.35995322518700856,0.7842983078055934,0.7215496368038741,1.0,1.0,8/32,19.52%,GMDS;LBR;DPYD;TM7SF2;DHFR;DHCR7;CRYZL1;ME3
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.3674629428486936,0.7836233847521198,0.7037974683544304,1.0,1.0,4/22,13.10%,ILF3;CPEB2;RBMS3;MEX3D
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.39358123801122513,0.783013761599721,0.6946022727272727,1.0,1.0,5/12,19.94%,PDE3B;PDE7B;PDE7A;PDE4B;PDE4A
prerank,general transcription initiation factor binding (GO:0140296),0.35396500831228683,0.7821915517934181,0.7025,1.0,1.0,8/25,16.11%,PSMC2;TAF12;GTF2A1;AHR;RUVBL2;YEATS2;DR1;DRAP1
prerank,hexosyltransferase activity (GO:0016758),0.32789312217474986,0.7820116875552111,0.7787971457696228,1.0,1.0,12/101,12.43%,POMT1;HAS3;HYAL1;LARGE1;B4GALT1;B3GNT8;CHSY1;B4GALT7;HAS1;POFUT1;TMTC4;GYG1
prerank,cation transmembrane transporter activity (GO:0008324),0.3372019623852574,0.7812206528297032,0.7277777777777777,1.0,1.0,10/48,18.42%,SLC25A15;SLC38A7;SLC25A2;SLC38A9;SLC15A4;SLC1A5;SLC36A4;SLC7A1;SLC6A9;SLC38A2
prerank,neuropeptide hormone activity (GO:0005184),0.3702874856319265,0.7776918706792522,0.7101631116687579,1.0,1.0,1/22,3.51%,AGRP
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.33154841143743563,0.7773374602312125,0.7351648351648352,1.0,1.0,17/54,22.43%,MIER1;UPB1;DARS1;NADSYN1;MIER3;HDAC8;HINT1;HDAC1;ASRGL1;HDAC2;NTAN1;NTAQ1;ASPA;HDAC4;NAAA;SIRT2;MIER2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3918901360688464,0.776885391728893,0.6946107784431138,1.0,1.0,3/11,24.63%,SLC25A47;SLC25A29;SLC22A4
prerank,syntaxin-1 binding (GO:0017075),-0.24234324115784123,-0.7757349461865723,0.8108108108108109,0.9198449188668707,1.0,8/22,17.60%,UNC13B;SYT1;SYNPR;SNPH;CPLX1;VAMP3;SNAP25;SYPL1
prerank,muscle alpha-actinin binding (GO:0051371),0.3868843774226895,0.7729460068126727,0.702158273381295,1.0,1.0,4/15,15.59%,PDLIM4;PDLIM5;SYNPO2;PKD2
prerank,Tat protein binding (GO:0030957),-0.3112357843373518,-0.77124159983804,0.7445652173913043,0.9217485585405782,1.0,2/10,7.57%,ACTB;DNAJA1
prerank,G protein-coupled receptor binding (GO:0001664),-0.16800291526215538,-0.7690527474797831,1.0,0.9204391273472351,1.0,24/132,17.54%,PRKN;GNAI1;GNA12;HOMER1;BICD1;ARHGEF12;GNAL;DNAJA1;ITGB4;GNA14;ACE;GPRASP2;PACRG;AGTR1;PSMC5;STUB1;PTCH1;TAFA5;SDCBP;S1PR1;DVL1;LRP6;USP33;PICK1
prerank,ribonuclease activity (GO:0004540),0.3343133003764689,0.7672370085327481,0.7344086021505376,1.0,1.0,12/56,16.47%,AGO2;RNASE6;RNASEH2A;RPP40;CNOT6;PPP1R8;RNASE1;EXOSC7;RNASE12;SMG6;CNOT7;KHNYN
prerank,myosin V binding (GO:0031489),-0.27775709405915755,-0.7665296934687374,0.7746478873239436,0.919394886106415,1.0,8/15,28.43%,RAB6B;RAB27B;RAB11A;RAB39B;RAB3D;RAB6A;RAB3B;RAB14
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.3170104644625727,0.7661186146424654,0.7934224049331963,1.0,1.0,17/100,14.53%,RACGAP1;IQGAP2;ARFIP1;GBF1;MAPT;SESTD1;ZFYVE16;ZFYVE1;OSBPL8;SNX27;MAPKAP1;CYTH3;CLVS2;DENND1A;BTK;GSDMD;ATG2A
prerank,phosphatase activity (GO:0016791),0.32710074404879086,0.7653084287837982,0.7712486883525709,1.0,1.0,10/73,14.02%,PON1;LHPP;OCRL;LPIN2;PHOSPHO2;DUSP12;PLPP1;PLPP5;PPP1CC;ARMT1
prerank,endopeptidase inhibitor activity (GO:0004866),0.3238789469902565,0.7628659688786708,0.7776617954070981,1.0,1.0,7/82,9.77%,SERPINB8;SERPINA9;ANXA2;PRNP;SERPINE1;ROCK1;AGT
prerank,anion transmembrane transporter activity (GO:0008509),0.38563411417982546,0.76049607287697,0.7138686131386861,1.0,1.0,3/12,10.74%,SLC19A1;SLC4A2;SLC39A8
prerank,aminopeptidase activity (GO:0004177),0.3498168044309569,0.757675186787602,0.7109471094710947,1.0,1.0,6/26,18.00%,MMP14;LVRN;TRHDE;CTSH;NPEPPS;METAP1
prerank,snoRNA binding (GO:0030515),0.34471082522991253,0.7572070698496335,0.7296650717703349,1.0,1.0,6/30,13.59%,PRKDC;NUDT5;DHX37;TSR1;DDX21;NUDT4
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.38958541479229275,0.7571747247246376,0.7046783625730995,1.0,1.0,2/11,12.75%,CASP7;CASP8
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.38905166654526824,0.7561761813124291,0.6985714285714286,1.0,1.0,2/11,9.29%,PIGN;PTDSS2
prerank,potassium:proton antiporter activity (GO:0015386),0.39301561388702266,0.7557382251581977,0.7360482654600302,1.0,1.0,1/10,8.59%,SLC9A5
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.37691889913612586,0.7548738391720442,0.7275280898876404,1.0,1.0,4/14,18.07%,MTHFR;PYCR1;DHFR;BLVRB
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.3733465373400287,0.7537006273048252,0.7404692082111437,1.0,1.0,5/13,17.32%,GSK3B;EZR;SOX9;PRKAR2B;PRKAR2A
prerank,neurexin family protein binding (GO:0042043),0.3999268825947971,0.7535501744780393,0.7297297297297297,1.0,1.0,4/10,19.51%,NLGN3;SYTL4;NLGN2;SYTL5
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3374539888488365,0.7534441066178938,0.7331730769230769,1.0,1.0,7/29,20.69%,PPM1D;TPR;MAPKAPK3;MAPK14;DUSP7;ATF7;MAPKAPK2
prerank,transforming growth factor beta receptor binding (GO:0005160),0.36232803988580037,0.7511973589163068,0.7012987012987013,1.0,1.0,6/18,17.83%,TGFBR3L;TGFBR3;SMAD6;TGFBR1;SMAD3;SMAD2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.35525955320100666,0.7509585823913469,0.7219321148825065,1.0,1.0,8/20,25.16%,SENP1;USP21;USP9X;USP47;EIF3H;COPS5;USP25;UFSP2
prerank,hormone activity (GO:0005179),0.3272352020325147,0.7501017373024282,0.7595212187159956,1.0,1.0,4/54,9.77%,AGRP;ERFE;INSL6;AGT
prerank,sodium channel regulator activity (GO:0017080),0.32869391196105313,0.7490547216623072,0.7485515643105446,1.0,1.0,3/37,4.42%,ATP2B4;RANGRF;NEDD4
prerank,enoyl-CoA hydratase activity (GO:0004300),0.39683667870651973,0.745028262010043,0.7476489028213166,1.0,1.0,1/10,2.68%,ECHDC3
prerank,phosphatidic acid binding (GO:0070300),0.3478641639786879,0.741747939607076,0.7408854166666666,1.0,1.0,7/19,22.23%,PACSIN2;SESTD1;MAPKAP1;GSDMD;SMPD3;GRAMD1B;RAPGEF6
prerank,ribosome binding (GO:0043022),0.3202552418110478,0.7374110014422984,0.7653631284916201,1.0,1.0,13/46,19.35%,SERBP1;ERI1;EFL1;FMR1;NCLN;CPEB2;EIF3C;SRP72;MAIP1;PYM1;MTIF3;ETF1;CCDC47
prerank,potassium channel activity (GO:0005267),0.30936831383587154,0.736537494996946,0.8134020618556701,1.0,1.0,16/89,17.07%,AQP1;CCDC51;KCNN4;KCNK2;KCNH4;KCNH8;GRIK3;KCNMB2;KCNMB3;KCNK12;KCNK6;KCNMB4;KCNB2;PKD2;KCNT2;KCNA1
prerank,GTP binding (GO:0005525),0.3065069016686692,0.7364530705427866,0.8855421686746988,1.0,1.0,35/172,18.22%,RANBP17;TUBB6;TUBA1C;TUBE1;RHOA;RAB10;RRAD;RHOT1;RAP2A;ATL2;ATL3;RAB22A;RAB29;RASEF;TUBD1;LRRK2;RHOQ;DNM2;DRG1;RND2;RAC1;RRAS;SEPHS1;TSR1;DRG2;ARF4;ARL4A;RHOC;GNL3;ARF3;RRAS2;RAB13;NRAS;KRAS;ARL5A
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.22569837387733818,-0.7345257352454015,0.8571428571428571,0.9607738973459015,1.0,8/23,29.21%,PLCB3;PLCG1;CHRM3;PLCE1;PLCH1;PLCD1;PLCB1;PLCD3
prerank,MAP kinase activity (GO:0004707),0.36325026305459795,0.7310192307567732,0.7620357634112792,1.0,1.0,2/14,4.01%,NLK;MAPK4
prerank,guanyl ribonucleotide binding (GO:0032561),0.3040399199669578,0.730039621306134,0.9119119119119119,1.0,1.0,39/196,18.22%,RANBP17;TUBB6;TUBA1C;TUBE1;RHOA;RAB10;RRAD;RHOT1;RAP2A;SLC19A1;ATL2;ATL3;RAB22A;RAB29;RASEF;TUBD1;LRRK2;RHOQ;DNM2;MPPED2;MIEF1;DRG1;RND2;RAC1;RRAS;SEPHS1;TSR1;GNAI3;DRG2;ARF4;ARL4A;RHOC;GNL3;ARF3;RRAS2;RAB13;NRAS;KRAS;ARL5A
prerank,protease binding (GO:0002020),0.3055693477760288,0.7275893180566911,0.8409785932721713,1.0,1.0,19/99,16.97%,BRCA2;FADD;ANXA9;GSK3B;ANXA2;PRNP;LCOR;DERL2;SERPINE1;RIOK3;BDKRB2;ADRM1;INSL3;ITGB1;ITGAV;TP53;STIM1;PTEN;LDLR
prerank,death domain binding (GO:0070513),-0.2875937753372729,-0.7261254529267339,0.8,0.9668030670078848,1.0,6/11,21.90%,CRADD;BCL2;IRGM;DAPL1;BCL2L1;RACK1
prerank,mannose binding (GO:0005537),-0.2791034319822,-0.7243171104545159,0.7993527508090615,0.9642546095698817,1.0,8/12,53.50%,CLN5;LMAN2L;LMAN2;LMAN1;ACR;COLEC11;LMAN1L;CLEC4D
prerank,sterol binding (GO:0032934),0.316226896132619,0.72245272257357,0.8106951871657754,1.0,1.0,17/56,20.89%,GRAMD1C;TSPO2;SOAT1;OSBPL8;SCAP;ABCA1;SOAT2;SIDT1;RORA;VDAC2;STARD3;SYP;ERLIN1;INSIG2;GRAMD1B;TSPO;INSIG1
prerank,galactosyltransferase activity (GO:0008378),0.3728711340736761,0.7213939601699357,0.7732732732732732,1.0,1.0,2/11,7.97%,B4GALT1;B4GALT7
prerank,secondary active transmembrane transporter activity (GO:0015291),0.32124709219771963,0.7206283036699535,0.8075639599555061,1.0,1.0,9/51,13.35%,SLCO4A1;SLC20A2;SLC35D1;SLC16A10;SLC35D2;SLC16A2;MCU;SLC25A30;SLCO3A1
prerank,potassium channel regulator activity (GO:0015459),0.3122093008591067,0.7194692389132608,0.8084632516703786,1.0,1.0,12/49,19.34%,WNK1;KCNMB2;KCNMB3;KCNIP3;AKAP9;ADRB2;ENSA;DLG1;KCNMB4;DPP6;WNK3;AMIGO1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.3607766847411333,0.7167491175438702,0.7813822284908322,1.0,1.0,4/13,18.18%,SLC38A7;SLC15A4;SLC7A1;SLC25A29
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.3037068917384901,0.7148157641574283,0.8082340195016251,1.0,1.0,11/53,18.42%,SLC25A15;SLC38A7;SLC25A2;SLC38A9;SLC15A4;SLC1A5;SLC25A22;SLC36A4;SLC7A1;SLC6A9;SLC38A2
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.24698849755886929,-0.7147816597868974,0.8453237410071942,0.9712487271573849,1.0,9/17,29.49%,AK3;CMPK1;NME6;AK5;AK4;CMPK2;CLP1;AK1;NME2
prerank,translation initiation factor activity (GO:0003743),0.32595784111804593,0.7140879577894008,0.8129411764705883,1.0,1.0,13/36,22.92%,AGO2;EIF4E;EIF2B1;EIF3C;EIF4A2;MTIF3;EIF3H;EIF3I;EIF2D;COPS5;EIF5;EIF2B5;EIF3B
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.3607883198191062,0.713637552406255,0.7753623188405797,1.0,1.0,4/12,26.71%,SLC9A5;LETM1;SLC9B2;SLC9A8
prerank,protein kinase C activity (GO:0004697),0.35913978349990744,0.7125505042883471,0.7506963788300836,1.0,1.0,7/14,20.99%,PRKCB;PRKCA;PRKCE;PRKD1;PRKCI;PRKCD;PRKD3
prerank,CoA-ligase activity (GO:0016405),0.35519010452380817,0.7103576381125762,0.7673758865248227,1.0,1.0,2/14,14.01%,ACSS1;AACS
prerank,double-stranded RNA binding (GO:0003725),0.30428862549544766,0.708940952915604,0.8343949044585988,1.0,1.0,15/70,17.55%,ILF3;DGCR8;AGO2;DHX9;EIF4H;FMR1;RC3H2;HNRNPU;ILF2;SIDT1;STRBP;RC3H1;FXR1;MSN;ZNF346
prerank,frizzled binding (GO:0005109),0.32449023330649146,0.7058192903825297,0.7900943396226415,1.0,1.0,6/34,19.04%,WNT2B;RNF43;WNT6;WNT9A;SFRP1;WNT4
prerank,cholesterol binding (GO:0015485),0.3114849866302565,0.7031947856860825,0.8265193370165745,1.0,1.0,11/47,16.60%,GRAMD1C;TSPO2;SOAT1;OSBPL8;ABCA1;SOAT2;SIDT1;VDAC2;STARD3;SYP;ERLIN1
prerank,mannosyltransferase activity (GO:0000030),0.33268989010196104,0.7027428297874851,0.7860824742268041,1.0,1.0,4/21,15.82%,POMT1;TMTC4;ALG8;PIGM
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.1942438840656317,-0.7022981676286247,0.9312977099236641,0.9812223698468009,1.0,13/40,23.84%,PCMTD2;PCMTD1;HNMT;THUMPD3;N6AMT1;TPMT;NNMT;PRMT8;RRP8;METTL9;MEPCE;SUV39H1;COMT
prerank,protein phosphatase regulator activity (GO:0019888),0.300430432053657,0.7020836804591395,0.802863436123348,1.0,1.0,17/53,21.35%,PPP2R3A;PPP1R7;PPP2R5C;CALM2;PPP2R2D;ENSA;PPP1R15B;PTPA;PPP2R5B;PPP2R1B;ANKLE2;PPME1;PPP6R2;BOD1L1;PHACTR4;PPP4R1;EIF2AK2
prerank,chemoattractant activity (GO:0042056),0.3217535054954846,0.7004639912170052,0.7879948914431673,1.0,1.0,1/26,1.44%,HMGB2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.35864804544537904,0.6990745341628912,0.7847919655667145,1.0,1.0,3/10,18.08%,DPYSL4;DPYSL3;DPEP1
prerank,anion:anion antiporter activity (GO:0015301),0.3363593748001087,0.6990233095785423,0.786096256684492,1.0,1.0,2/17,8.20%,SLC19A1;SLC4A2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.36293794021059256,0.6972663494244773,0.804915514592934,1.0,1.0,1/11,3.44%,MAP4K2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.21661680374436904,-0.6966377314172943,0.9344262295081968,0.9825700731974053,1.0,8/24,23.28%,GLUL;ZDHHC1;ZDHHC7;ZDHHC8;GOLGA7;ZDHHC20;ZDHHC4;ZDHHC17
prerank,deubiquitinase activity (GO:0101005),0.2960115494035926,0.6952910033831361,0.831413612565445,1.0,1.0,26/88,22.61%,MINDY4;USP1;USP18;USP37;PSMD14;USP21;USP16;USP28;USP9X;USP47;BRCC3;OTUD1;OTUD7B;USP48;MINDY3;EIF3H;USP14;USP46;USP20;PAN2;OTUD3;COPS5;TANK;ZRANB1;USP2;MYSM1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.32873133178673086,0.694581679891383,0.7797927461139896,1.0,1.0,2/21,12.03%,ANXA9;CHRNB1
prerank,proton transmembrane transporter activity (GO:0015078),-0.18740488967679067,-0.6941398614785175,0.972027972027972,0.9801957089766485,1.0,15/39,34.22%,COX4I1;COX5A;NDUFA4;UQCR10;UQCRQ;CLCN4;COX8A;UQCRC1;COX5B;CTNS;ATP6V1B2;UQCRFS1;ATP6V1F;SLC9A1;COX6B1
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.20923485968264632,-0.6923571151151351,0.916256157635468,0.9770847263057746,1.0,11/26,31.85%,PPP1R1A;SET;PPP1R11;PPP1R14A;PABIR1;MGAT5;PPP1R14B;BOD1;SAG;STYXL1;CABIN1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.32090485532503465,0.689960100258224,0.7609819121447028,1.0,1.0,5/24,14.73%,PMVK;PPIP5K1;IP6K2;DTYMK;AK7
prerank,serine-type endopeptidase activity (GO:0004252),-0.16139499930879508,-0.689534962077063,0.9791666666666666,0.9748246562265543,1.0,11/80,21.38%,PCSK5;PIK3IP1;PCSK6;FURIN;PARL;MMP2;RHBDF1;PRSS12;PCSK1;FAP;RHBDF2
prerank,phospholipase C activity (GO:0004629),-0.20997827799041746,-0.6886285433914404,0.9230769230769231,0.9707196968173059,1.0,8/25,29.21%,PLCB3;PLCG1;CHRM3;PLCE1;PLCH1;PLCD1;PLCB1;PLCD3
prerank,alpha-actinin binding (GO:0051393),0.31882523821371456,0.6859033666904826,0.7849872773536896,1.0,1.0,5/24,15.59%,PDLIM4;CACNA1C;PDLIM5;SYNPO2;PKD2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.339234149403641,0.6841925175619663,0.8005738880918221,1.0,1.0,12/12,66.10%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;RHO;OPN1MW;OPN1MW3;RRH;GPR52;GPR88;OPN3
prerank,sodium:proton antiporter activity (GO:0015385),0.34847900510824564,0.6826974799888308,0.8029411764705883,1.0,1.0,1/11,8.59%,SLC9A5
prerank,GTPase activity (GO:0003924),0.2848304742333716,0.6825120843819951,0.9419419419419419,1.0,1.0,32/192,15.75%,RAB33B;RHOA;GNG8;ABCA4;RHOT1;RAP2A;ATL2;EFL1;ATL3;GNA13;RAB22A;RAB29;AGAP3;LRRK2;MFN2;GNAQ;RHOQ;DNM2;TPPP;SRPRA;RAB1A;DRG1;RND2;RAC1;RRAS;TSR1;GNAI3;DRG2;GNG5;GFM2;RHOC;MFN1
prerank,clathrin adaptor activity (GO:0035615),0.3369661020146003,0.6817329935772117,0.8125874125874126,1.0,1.0,2/15,5.98%,STON1;STON2
prerank,ribosomal large subunit binding (GO:0043023),0.3424957478195575,0.6809207168306944,0.7891654465592972,1.0,1.0,2/11,9.13%,NMD3;CPEB2
prerank,lipoprotein particle binding (GO:0071813),0.3157244925489285,0.6786425934667013,0.8103896103896104,1.0,1.0,4/20,16.97%,COLEC12;MAPT;LPL;LDLR
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.2678021752255035,-0.6773109447272643,0.8915989159891599,0.977042425649435,1.0,5/11,29.08%,PPP1R1A;PPP1R11;PPP1R14A;PABIR1;PPP1R14B
prerank,NAD+ binding (GO:0070403),0.34044224755348373,0.6761205690341467,0.8192419825072886,1.0,1.0,2/12,10.39%,ZC3HAV1;PARP9
prerank,sulfotransferase activity (GO:0008146),0.2999313800024138,0.6709057300607456,0.8250591016548463,1.0,1.0,4/33,10.90%,CHST15;CHST3;UST;HS2ST1
prerank,phospholipase binding (GO:0043274),0.33793644033929354,0.6703667521936324,0.8158995815899581,1.0,1.0,7/13,25.62%,ARHGAP6;PDPK1;BTK;SRC;FYN;BLNK;PAFAH1B1
prerank,potassium ion antiporter activity (GO:0022821),0.3328788040081079,0.6703105190748994,0.8175487465181058,1.0,1.0,2/15,9.38%,SLC9A5;SLC24A3
prerank,hydro-lyase activity (GO:0016836),0.2948342166626292,0.6657991417894327,0.835820895522388,1.0,1.0,7/41,16.58%,GMDS;ECHDC3;PCBD2;APIP;CA2;ACO1;ECI1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2819109535568408,0.6645808927250482,0.8875128998968008,1.0,1.0,14/85,17.53%,PON1;ENPP2;BCHE;TARS2;ACHE;DAGLB;APMAP;CA2;PON2;LPL;ABHD4;NOTUM;GDE1;PNPLA7
prerank,N-acetyltransferase activity (GO:0008080),0.3165290354770461,0.6640826545976886,0.8488372093023255,1.0,1.0,1/19,1.96%,NAT14
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3125436548674185,0.66364944319659,0.8221649484536082,1.0,1.0,3/25,9.79%,CYP26B1;MICAL3;KMO
prerank,acetylcholine receptor activity (GO:0015464),0.3071070946640225,0.6587330610706278,0.8345864661654135,1.0,1.0,2/22,12.03%,ANXA9;CHRNB1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2745201151982462,0.6568529307470992,0.9248730964467005,1.0,1.0,24/134,18.42%,SLC25A15;SLC25A21;SLCO4A1;SLC38A7;PDPN;SLC19A1;SLC25A2;SLC35D1;SLC25A25;SLC35D2;SLC39A8;GJA1;SLC38A9;SLCO3A1;SLC19A2;SLC15A4;SLC1A5;SLC25A42;SLC25A22;SLC36A4;SLC7A1;SLC25A17;SLC6A9;SLC38A2
prerank,triglyceride lipase activity (GO:0004806),-0.21556584934544357,-0.6552239519136202,0.8883928571428571,0.9931250179567508,1.0,6/20,31.16%,ABHD5;PLA2G15;PNPLA2;PNPLA3;LIPE;DDHD2
prerank,sialyltransferase activity (GO:0008373),0.3107910495699737,0.654972081688013,0.8223086900129701,1.0,1.0,6/20,15.46%,ST8SIA2;ST3GAL3;ST3GAL5;ST3GAL4;ST3GAL1;ST3GAL2
prerank,phosphatidate phosphatase activity (GO:0008195),0.32431134037110626,0.6495906263682977,0.8175074183976261,1.0,1.0,3/13,12.31%,LPIN2;PLPP1;PLPP5
prerank,semaphorin receptor activity (GO:0017154),0.33441032632515333,0.6490355333452629,0.837138508371385,1.0,1.0,6/11,23.44%,PLXNB2;PLXNB1;PLXND1;PLXNA2;PLXNB3;PLXNA1
prerank,ion channel inhibitor activity (GO:0008200),0.28574010740914363,0.6465987580888309,0.8543123543123543,1.0,1.0,7/35,13.52%,ITPR1;NEDD4;WNK1;KCNMB2;MCUB;CALM2;ENSA
prerank,ADP binding (GO:0043531),0.2994094841655826,0.6418959286079319,0.8595641646489104,1.0,1.0,6/25,15.29%,MYH10;LONP1;MYO9B;MIEF1;MSH6;PRKAG1
prerank,Wnt-activated receptor activity (GO:0042813),-0.23044299819474773,-0.6417309609970592,0.9239130434782609,0.9994230353660782,1.0,5/15,26.81%,FZD2;FZD4;FZD1;TSPAN12;FZD8
prerank,exoribonuclease activity (GO:0004532),0.32853055241601176,0.6414736471488117,0.8519061583577713,1.0,1.0,4/12,18.36%,CNOT6;EXOSC7;CNOT7;EXOSC10
prerank,amino acid transmembrane transporter activity (GO:0015171),0.2745868324374581,0.6407185130516101,0.8760964912280702,1.0,1.0,13/47,21.72%,SLC38A7;PDPN;SLC38A4;SLC16A2;SLC38A9;SLC1A5;SLC36A4;SLC7A1;SLC25A29;SLC38A2;SLC25A44;SLC7A11;SLC6A13
prerank,metal ion:proton antiporter activity (GO:0051139),0.3168724242357239,0.6373454348081399,0.8415841584158416,1.0,1.0,4/13,26.71%,SLC9A5;LETM1;SLC9B2;SLC9A8
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.27723694710764013,0.6361085119121178,0.8876889848812095,1.0,1.0,9/60,9.98%,FGFR4;FGFR2;KIT;MUSK;PDGFRA;CRIM1;EPHA4;FGFRL1;DDR2
prerank,O-methyltransferase activity (GO:0008171),-0.2590962214499363,-0.6358036837193981,0.9071207430340558,0.9988103016136755,1.0,4/10,23.84%,COQ3;CMTR1;MEPCE;COMT
prerank,omega peptidase activity (GO:0008242),0.26896544837527603,0.6357641673243001,0.9092805005213764,1.0,1.0,28/89,23.71%,USP1;USP18;USP37;PSMD14;USP21;USP16;USP28;ASRGL1;USP9X;USP47;BRCC3;OTUD1;OTUD7B;GGH;USP48;MINDY3;USP14;USP46;USP20;PAN2;OTUD3;COPS5;TANK;ZRANB1;USP2;MYSM1;APEH;USP25
prerank,ferrous iron binding (GO:0008198),0.30182977621907536,0.630336178732886,0.8659147869674185,1.0,1.0,2/21,3.91%,FXN;FTO
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.3246557137732589,0.6269608872486988,0.8677165354330708,1.0,1.0,3/10,16.42%,SETDB2;ASH1L;SUV39H2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.26616890788002867,0.626735991500055,0.9056603773584906,1.0,1.0,24/83,22.61%,USP1;USP18;USP37;PSMD14;USP21;USP16;USP28;USP9X;USP47;BRCC3;OTUD1;OTUD7B;USP48;MINDY3;USP14;USP46;USP20;PAN2;OTUD3;COPS5;TANK;ZRANB1;USP2;MYSM1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.22520609526662122,-0.626495177843449,0.9084249084249084,1.0,1.0,5/14,33.58%,SLC26A11;SLC25A11;SLC26A2;SLC26A6;SLC26A8
prerank,methyltransferase activity (GO:0008168),0.2743956058058264,0.6263188571329937,0.8843995510662177,1.0,1.0,10/46,17.46%,METTL27;AMT;EEF1AKMT2;MGMT;ASMT;METTL4;ARMT1;MRM2;METTL3;NSUN3
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.22010568672808417,-0.6251343764302315,0.9217081850533808,0.9961187499808304,1.0,2/16,12.60%,SLC44A1;SLC22A5
prerank,ephrin receptor binding (GO:0046875),0.29413065672922345,0.6236245318545635,0.8618090452261307,1.0,1.0,8/21,23.74%,EFNA1;EFNB1;ANKS1B;EFNB2;SRC;PTPN1;FYN;CRK
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.23116442866114872,-0.6205270516685171,0.9362416107382551,0.99433641120887,1.0,7/14,29.49%,CMPK1;NME6;AK5;AK4;CMPK2;AK1;NME2
prerank,NADPH binding (GO:0070402),0.3088622083943779,0.6155889754432474,0.8450704225352113,1.0,1.0,1/13,2.57%,LBR
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.3160790627832341,0.6154371215505567,0.8458149779735683,1.0,1.0,4/10,17.32%,PKIG;PRKAG1;PRKAR2B;PRKAR2A
prerank,estrogen receptor binding (GO:0030331),0.27602522177754313,0.6144185020289423,0.8751486325802615,1.0,1.0,7/32,16.10%,CNOT1;LCOR;MMS19;PPID;MED1;DCAF1;TAF10
prerank,phosphatidylcholine transporter activity (GO:0008525),0.2976178080624001,0.6138532590438801,0.8838451268357811,1.0,1.0,3/17,11.78%,ABCB4;PITPNB;ABCA1
prerank,serine-type peptidase activity (GO:0008236),-0.137874612174922,-0.6120202236769015,1.0,0.99444748611095,1.0,12/96,21.38%,PCSK5;PIK3IP1;PCSK6;FURIN;TPP1;PARL;MMP2;RHBDF1;PRSS12;PCSK1;FAP;RHBDF2
prerank,G protein-coupled receptor activity (GO:0004930),0.254841867880219,0.6117117631265456,0.986,1.0,1.0,24/239,16.36%,GPR171;LPAR3;ADGRV1;LPAR1;GALR1;NPFFR2;ADGRL1;GPR173;CXCR4;BDKRB2;NPR3;TAPT1;P2RY1;S1PR2;GLP2R;ADGRG2;ADRB2;GPR156;ELOVL4;LANCL1;GABBR2;CYSLTR2;ADGRD1;GPR135
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.2881001590249386,0.6112782371012562,0.8816936488169365,1.0,1.0,6/21,19.94%,PDE3B;PDE7B;PDE1A;PDE7A;PDE4B;PDE4A
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.3067341402204575,0.6075082408540949,0.8726483357452967,1.0,1.0,5/12,24.25%,PHF2;JMJD1C;KDM4B;HR;KDM1A
prerank,cation channel activity (GO:0005261),0.25514619909408554,0.6062429204246619,0.9302809573361083,1.0,1.0,20/94,20.22%,AQP1;ANXA9;ANXA2;TRPA1;PKD2L2;CUL5;CALHM2;MCU;SLC24A3;TRPM2;PIEZO1;TRPM4;PKD2;KCNA1;TRPV4;KCNQ4;TRPM6;TMEM63A;KCNK5;PIEZO2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.2735478742130182,0.5982111440550669,0.8829787234042553,1.0,1.0,6/30,17.01%,SLC25A37;SLC39A11;SLC39A8;SLC39A6;SLC30A10;SLC25A28
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.2744404431214818,0.5956007955620813,0.8877419354838709,1.0,1.0,7/24,20.69%,MYLK3;PHKA2;CAMK1D;MAPKAPK3;CAMKV;DAPK1;MAPKAPK2
prerank,Hsp90 protein binding (GO:0051879),0.26591033363293826,0.594673801307361,0.9054373522458629,1.0,1.0,5/33,13.26%,MAPT;HDAC8;NR3C1;AHR;PPID
prerank,transforming growth factor beta binding (GO:0050431),0.2768406308322159,0.594392478045275,0.8935897435897436,1.0,1.0,4/23,15.00%,TGFBR3L;TGFBR3;TGFBR1;ITGAV
prerank,protein phosphorylated amino acid binding (GO:0045309),0.2614286802592597,0.5900741010573501,0.8866213151927438,1.0,1.0,11/42,20.49%,NEDD4;FBXW7;VAV2;SAMSN1;CRKL;NCK2;PIN1;SHB;YES1;PTPN5;SHF
prerank,phosphatase inhibitor activity (GO:0019212),0.2825617841480502,0.5879344794788504,0.8861256544502618,1.0,1.0,5/20,19.60%,ANP32E;ENSA;PPME1;STYX;BOD1L1
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.2736951665320608,0.586083024195191,0.912883435582822,1.0,1.0,7/23,22.14%,PDE3B;PDE7B;PDE1A;PDE7A;PDE4B;PDE4A;ADPRM
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.2665161067447114,0.5833783923034865,0.9024096385542169,1.0,1.0,3/27,9.72%,SLC9A5;SLC8A1;CNNM4
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.2876081749142647,0.5810076135226996,0.8995983935742972,1.0,1.0,4/16,16.56%,SLC38A7;SLC25A30;SLC1A5;SLC25A22
prerank,FMN binding (GO:0010181),-0.23295757628511804,-0.5727061721348538,0.9580838323353293,1.0,1.0,8/11,46.17%,NOS3;MTRR;NOS1;NDOR1;DUS2;PNPO;POR;NOS2
prerank,histone demethylase activity (GO:0032452),0.26117370696308373,0.5710477656147853,0.9110012360939431,1.0,1.0,9/27,25.23%,PHF2;KDM2B;KDM5C;JMJD1C;KDM4B;KDM2A;HR;KDM1A;KDM5A
prerank,glutathione transferase activity (GO:0004364),0.2654281824120098,0.5708923246427348,0.9134860050890585,1.0,1.0,6/23,22.11%,HPGDS;LANCL1;GSTT1;MGST3;GSTM5;GSTZ1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.24336390520405196,0.5704526704552563,0.9437367303609342,1.0,1.0,17/74,19.09%,ADK;PDXK;IPMK;PAPSS2;PIK3CB;DGKE;PANK4;AGK;PANK2;MVK;RFK;NOL9;GK5;PI4KB;GK;GALK2;COASY
prerank,O-acyltransferase activity (GO:0008374),0.2635147297584658,0.5703862360776135,0.9178571428571428,1.0,1.0,3/30,12.02%,LPCAT1;SOAT1;SOAT2
prerank,adrenergic receptor binding (GO:0031690),0.2777746288394265,0.5677198283969933,0.9040902679830748,1.0,1.0,1/16,4.42%,NEDD4
prerank,transaminase activity (GO:0008483),0.2860842182241258,0.5652160681467484,0.8951255539143279,1.0,1.0,2/11,10.09%,AGXT;ABAT
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.23998413540109442,0.5635693432015907,0.9391965255157437,1.0,1.0,10/55,18.42%,SLC38A7;PDPN;SLC38A4;SLC19A1;SLC16A2;SLC38A9;SLC19A2;SLC36A4;SLC7A1;SLC38A2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.29589145523849536,0.5624387425160312,0.9187592319054653,1.0,1.0,2/11,13.59%,NUDT5;NUDT4
prerank,solute:sodium symporter activity (GO:0015370),0.2589228241136538,0.5622426655691103,0.9267399267399268,1.0,1.0,1/27,4.09%,SLC20A2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.2951172705435573,0.5612145104581057,0.9158878504672897,1.0,1.0,3/10,21.63%,KDM2B;KDM4B;KDM2A
prerank,tropomyosin binding (GO:0005523),0.26891956013599166,0.5604455347824635,0.9226666666666666,1.0,1.0,5/16,22.28%,TMOD3;TNNT3;TMOD1;LMOD1;TMOD2
prerank,calcium channel activity (GO:0005262),0.23492975597841004,0.5557393292891272,0.9538784067085954,1.0,1.0,15/84,16.38%,ANXA9;ANXA2;CACNA2D3;PKD2L2;CUL5;MCU;SLC24A3;CACNA1C;TRPM2;TRPC7;TRPM4;ITGAV;PKD2;CACNB4;TPCN2
prerank,low-density lipoprotein particle binding (GO:0030169),0.2688303559105135,0.5545021177638441,0.9142461964038727,1.0,1.0,1/16,3.24%,COLEC12
prerank,RNA methyltransferase activity (GO:0008173),0.26671052023161057,0.5543382355557758,0.9149214659685864,1.0,1.0,8/19,27.81%,METTL4;METTL8;MRM2;METTL3;TGS1;TRMT5;TRDMT1;TRMT13
prerank,SH2 domain binding (GO:0042169),0.24797296979073388,0.551901048288655,0.9323843416370107,1.0,1.0,6/31,17.60%,NLK;KHDRBS1;AFAP1;SRC;SH3PXD2B;TRPV4
prerank,cytokine activity (GO:0005125),0.2283783524156724,0.5442890729796002,0.9797365754812564,1.0,1.0,10/131,12.51%,CKLF;WNT2B;BMP6;IL18;FAM3C;WNT6;HMGB1;CNTF;BMP2;WNT9A
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.22912054120426956,-0.5430140919069875,0.9695121951219512,1.0,1.0,3/10,16.95%,CACNA1B;CACNB2;CACNB1
prerank,peptidase activator activity (GO:0016504),0.2524981035752347,0.541339525497229,0.944516129032258,1.0,1.0,6/22,21.08%,CASP8AP2;PSMD14;ADRM1;PSME4;PSME3;TANK
prerank,phosphatidylglycerol binding (GO:1901611),0.2647829088687289,0.5389875935186124,0.9345661450924608,1.0,1.0,2/13,14.52%,STOML2;GSDMD
prerank,cytochrome-c oxidase activity (GO:0004129),-0.19245175099038553,-0.5350126336588005,0.978021978021978,1.0,1.0,5/15,24.09%,COX4I1;COX5A;NDUFA4;COX8A;COX5B
prerank,N-methyltransferase activity (GO:0008170),0.2548033588069173,0.5341371251909606,0.9411764705882353,1.0,1.0,4/20,14.97%,SETD3;METTL15;METTL5;TFB1M
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.27820668501853596,0.5337690484726774,0.9402777777777778,1.0,1.0,1/12,5.13%,B3GNT8
prerank,nucleoside-diphosphatase activity (GO:0017110),0.2685890119065446,0.5333123856258531,0.9218523878437048,1.0,1.0,2/12,16.44%,NUDT5;SLC25A42
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.22700217236579154,0.5332025888335201,0.9671610169491526,1.0,1.0,10/72,14.60%,ANXA9;ANXA2;SESTD1;PICALM;MAPKAP1;TWF1;SNX18;SVIL;GSDMD;CAPG
prerank,C-C chemokine receptor activity (GO:0016493),0.25229582415485163,0.5303588646464285,0.9461538461538461,1.0,1.0,1/21,6.30%,CXCR4
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.24329393555802548,0.5290555934755661,0.9398315282791817,1.0,1.0,1/29,1.97%,HPSE
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.22449303259444503,-0.5287146303677485,0.9641791044776119,1.0,1.0,5/10,33.01%,NAA25;NAA80;NAA30;NAA16;NAA10
prerank,AMP binding (GO:0016208),0.26188537453363175,0.527104536551058,0.9456366237482118,1.0,1.0,4/11,22.87%,MPPED2;PRKAG1;PYGL;PRKAG3
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.23218859008044568,0.5268709414346869,0.9658590308370044,1.0,1.0,3/46,6.07%,LARGE1;B3GNT8;PIGA
prerank,chemokine activity (GO:0008009),0.23727813455551183,0.5236941687760083,0.9472450175849941,1.0,1.0,1/31,4.98%,CKLF
prerank,cytokine receptor binding (GO:0005126),0.22278674238197232,0.5226256716677583,0.9741735537190083,1.0,1.0,12/83,20.27%,FADD;TRIP6;IL18;TGFBR3;CNTF;ADAM17;SPRED1;SMAD3;SPRED2;SMAD2;TYK2;TRAF6
prerank,endopeptidase regulator activity (GO:0061135),0.230713782467966,0.5213799817188495,0.9513888888888888,1.0,1.0,10/40,24.04%,PSMD14;ADRM1;CAST;USP14;PROS1;PSME3;TFPI;RECK;PSMF1;ITIH2
prerank,iron ion binding (GO:0005506),0.2286785451791655,0.5159301253234896,0.9704271631982475,1.0,1.0,4/48,7.90%,FXN;FTO;AGMO;PHF2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.20450892024971878,-0.5109087045639025,0.9769452449567724,1.0,1.0,3/10,28.16%,DUSP1;DUSP8;DUSP6
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.20450892024971878,-0.5109087045639025,0.9769452449567724,1.0,1.0,3/10,28.16%,DUSP1;DUSP8;DUSP6
prerank,rRNA binding (GO:0019843),0.2257579086817414,0.5080573553834405,0.9649321266968326,1.0,1.0,6/42,13.57%,MRPL18;ERI1;RRS1;FASTKD5;PPAN;DDX21
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.2599087429165321,0.5062200834087973,0.9671150971599403,1.0,1.0,1/11,12.03%,CHRNB1
prerank,phosphate ion binding (GO:0042301),-0.20612603565151896,-0.5044003571421469,0.9858757062146892,1.0,1.0,10/10,79.41%,RPH3A;PDE2A;ADSS1;CHST14;SLC34A2;G6PC1;MTHFD2;RELA;PNP;ADSS2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.2333033232605905,0.5022733995638899,0.9619631901840491,1.0,1.0,2/26,6.42%,B3GNT8;CHSY1
prerank,chemokine receptor binding (GO:0042379),0.2241838333643758,0.5011293242916601,0.9700115340253749,1.0,1.0,2/35,12.83%,CKLF;ITCH
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.2279260394721543,0.5004382785637689,0.9619500594530321,1.0,1.0,7/31,21.56%,AQP1;PKD2;KCNA1;KCNQ4;KCNK5;SLC12A8;KCNC4
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.2237085361461098,0.49716602611697935,0.9675,1.0,1.0,5/25,16.04%,SESTD1;ZFYVE1;MAPKAP1;PLEKHA1;DAPP1
prerank,CXCR chemokine receptor binding (GO:0045236),0.24835438813542327,0.49540228262203784,0.9664723032069971,1.0,1.0,10/11,58.15%,ITCH;CXCL9;CXCL2;CXCL13;PPBP;PF4;CXCL1;CXCL5;YARS1;CXCL10
prerank,antiporter activity (GO:0015297),0.2412571033016223,0.4939361232744304,0.9554390563564875,1.0,1.0,3/20,13.10%,SLC35D1;SLC35D2;SLC25A30
prerank,C-C chemokine binding (GO:0019957),0.2292159745516848,0.4903333262242903,0.9601494396014943,1.0,1.0,1/22,6.30%,CXCR4
prerank,mechanosensitive ion channel activity (GO:0008381),0.2509625162370146,0.48549974627988685,0.9523121387283237,1.0,1.0,3/12,20.22%,PIEZO1;TMEM63A;PIEZO2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.24826956213025628,0.48524619494348786,0.9571005917159763,1.0,1.0,1/12,5.78%,FRS2
prerank,solute:proton symporter activity (GO:0015295),0.23345219346906543,0.47813758589894456,0.9689703808180536,1.0,1.0,5/16,23.20%,SLC39A8;SLC15A4;SLC15A1;SLC17A5;SLC11A2
prerank,kinase inhibitor activity (GO:0019210),0.21479620986083553,0.4757052899950951,0.9728453364817001,1.0,1.0,7/33,20.66%,PARVA;NCK1;CDKN1B;QARS1;SH3BP5;TRIB1;SNCA
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.17084379744654507,-0.4751624163430664,0.9963636363636363,1.0,1.0,13/15,54.45%,SLC4A8;SLC26A2;SLC26A6;CFTR;SLC26A8;SLC4A11;SLC26A4;SLC4A3;SLC26A7;SLC26A3;SLC4A1;SLC26A5;SLC26A1
prerank,carbohydrate kinase activity (GO:0019200),-0.1823488795430293,-0.47322379632962175,0.9937694704049844,0.998590385800492,1.0,11/11,81.78%,HK1;NAGK;POMK;XYLB;KHK;HK3;GALK1;HK2;GNE;FGGY;GALK2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.25269897062515695,0.47284618195801914,0.9624060150375939,1.0,1.0,10/10,74.75%,ANKRD13D;DNAJB2;DNAJC2;IDE;ANKRD13A;USP15;FAN1;FAAP20;LAPTM5;ANKRD13B
prerank,peptidase inhibitor activity (GO:0030414),0.211964387955577,0.46768860950656804,0.9869668246445498,1.0,1.0,9/33,24.04%,CAST;SIMC1;USP14;PROS1;TFPI;RECK;PSMF1;GPC3;ITIH2
prerank,receptor antagonist activity (GO:0048019),0.22153846153846168,0.4655563576333997,0.9800266311584553,1.0,1.0,17/17,77.87%,DKK3;LRPAP1;PXDN;DKK4;IL1RN;DKK1;ADH7;WFIKKN2;DKKL1;AGTR2;FST;WFIKKN1;IGSF1;CCL5;ESR2;IL18BP;DKK2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.19765420212932977,0.46199775728072756,0.9873684210526316,1.0,1.0,4/75,5.88%,PTGR1;RDH11;SORD;RDH12
prerank,cAMP response element binding (GO:0035497),0.23968111293108169,0.4618642738398072,0.9777777777777777,1.0,1.0,4/10,24.21%,CREB5;CREB3L2;ATF7;ATF2
prerank,solute:anion antiporter activity (GO:0140323),0.22523837182868633,0.4598994435865218,0.9736842105263158,1.0,1.0,1/14,8.20%,SLC4A2
prerank,fibroblast growth factor receptor binding (GO:0005104),0.21913543035770366,0.4564546265906799,0.9769526248399488,1.0,1.0,1/21,5.78%,FRS2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.20532626505652926,0.4409243831939342,0.9843184559710495,1.0,1.0,3/32,9.08%,FTO;KDM2B;HSPBAP1
prerank,chemokine receptor activity (GO:0004950),0.20443837309973234,0.44049979710582554,0.9863692688971499,1.0,1.0,1/24,6.30%,CXCR4
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.21663308329793093,0.4359225086431475,0.9791955617198336,1.0,1.0,4/14,22.60%,CIAO3;ACO1;ISCA2;SDHB
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.18389615172356882,0.43553404607093765,0.9957356076759062,1.0,1.0,6/73,12.21%,GALR1;BDKRB2;NPR3;S1PR2;NLRP6;GLP2R
prerank,retinoid X receptor binding (GO:0046965),0.219085872257021,0.4349080487787564,0.9827338129496402,0.9981910108581724,1.0,3/11,20.21%,NR4A2;ARID5A;MED25
prerank,CCR chemokine receptor binding (GO:0048020),-0.1340329269825311,-0.4339553631774754,1.0,0.9978878594159227,1.0,28/28,86.63%,CX3CL1;NARS1;CCL13;CCL19;CCL15;CCR2;CCL2;CCRL2;CCL5;CCL11;CCL4;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13;CCL22;CCL17;CCL24;CCL26;CCL25;CCL14;CNIH4;NES
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.2213200075227135,0.42347077348267065,0.9863636363636363,0.9984853268027003,1.0,4/10,23.29%,DSE;GLCE;DSEL;GNE
prerank,telomerase RNA binding (GO:0070034),0.19443441577600729,0.4145904643786834,0.982256020278834,0.9980634754219202,1.0,6/22,19.77%,HNRNPU;SMG6;TEP1;EXOSC10;TERT;SNRPB
prerank,cytokine receptor activity (GO:0004896),0.16999088107486318,0.40196718036931117,0.9989550679205852,0.9979671833528341,1.0,2/83,5.85%,IL1RL1;LEPR
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.20534609019799868,0.39225118693159805,0.9940828402366864,0.9971703269149486,1.0,4/11,23.30%,NAA20;NAA60;NAA40;NAA50
prerank,gated channel activity (GO:0022836),0.1734323337915041,0.3429641527777679,1.0,0.9988505621497948,1.0,3/14,20.22%,PIEZO1;TMEM63A;PIEZO2
